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Parkinson’s disease (PD) is an incurable, neurodegenerative movement 
disorder, impacting nearly one million Americans. By 2030 the number of 
people with PD (PwPD) is expected to double and with this growing 
population, informal caregiver responsibility will also increase. Nutritional 
status worsens as PD progresses, which impacts cognition, body composition, 
ability to perform activities of daily living (ADL) and quality of life (QOL), and 
increases caregiver burden. Nutritional screening and intervention for PwPD 
can improve health outcomes, but are often excluded from PD treatment 
plans.  
Given the negative impact of PD on mobility and increased caregiver 
burden, digital technology could improve access to health care services for 
PwPD and their caregivers, making them excellent candidates for digital 
health. Digital health services (i.e. wearable devices, videoconferencing, 
phone apps) are used in PD management across many health disciplines, but 
have not been implemented for nutritional management of PD. Understanding 
how nutritional status changes overtime for PwPD, and including PwPD and 
their caregivers in the formative stage is critical to developing effective digital 
health services. The aim of this body of research is to:  1) describe how the 
nutrition status of PwPD changes overtime, 2) describe the diet quality and 
self-reported nutrition concerns of PwPD and their informal caregivers, 3) 
collect formative data around digital health to manage nutrition for PwPD and 
their caregivers through dyadic interviewing.  
The first chapter focuses on tracking the nutritional status of eight 
PwPD over four years and examines how disease sequelae, conditions that 
result from PD, may influence nutritional status. Findings reveal that the 
majority of PwPD were either at “possible-” or “at nutrition-” risk throughout the 
four years. There was a modest decrease in weight and body mass index. 
Findings suggest that PwPD can benefit from ongoing nutrition screening 
throughout the course of PD.  
Chapter two evaluates the diet quality via Healthy Eating Index (HEI)-
2015 scores and self-reported nutrition concerns identified from qualitative 
interviews of twenty PwPD and their informal caregivers. This chapter also 
explores if a consistent pattern existed between nutrition concerns coded and 
diet quality scores of PwPD and caregivers. Mean HEI-2015 scores of PwPD 
and caregivers translate to an F letter grade and both PwPD and caregivers 
have intake inconsistent with the Dietary Guidelines for Americans. 
Participants also have low HEI-2015 component scores for whole grains, fatty 
acid ratios, and greens & beans. Qualitative themes specifically around dietary 
concerns related to PD sequelae include: change in appetite, amount eaten 
and/or weight, gastrointestinal issues, food-medication management, 
chewing/swallowing issues, change in taste/smell. No consistent pattern 
between HEI-2015 scores and self-reported nutrition concerns were detected. 
Findings suggest this population could benefit from nutrition services to better 
health outcomes.   
Chapter 3 examines twenty PwPD’s and their caregivers’ perception 
and acceptance of digital health for managing nutrition and health through 
semi-structured dyadic interviews and questionnaires. This study also 
evaluates the participants’ level of digital competence. Phrases from 
interviews related to perceptions of digital health were sub-coded into three 
categories: Perceived Usefulness, Perceived Ease of Use and Awareness of 
Digital Health. Phrases related to Acceptance of digital were sub-coded into 
Accept, Neutral or Reject. An Average Dyadic Acceptance Rate for digital 
health was obtained through averaging the percent of phrases coded as 
Accept from each interview transcript. To integrate the two data sets, 
qualitative codes were transformed into variables and compared to digital 
competence scores. Twenty-five (62.5%) participants used the internet for at 
least 5 health-related purposes. The Average Dyadic Acceptance Rate was 
54.4%. Dyads rejected digital health devices if they did not see the added 
benefit. The majority of phrases coded revealed participants found digital 
health useful, but hard to use, and about half of the phrases coded indicate 
dyads needed education about existing digital health mediums. Findings 
suggest dyads are accepting of technology but are not utilizing technology to 
its full potential. Perceiving technology as hard to use and digital competence 
scores, implies education is warranted prior to providing a digital nutrition 
service.   
This body of research supports the need for nutrition screening and 
services among both PwPD and caregivers, who present with poor diet quality. 
Findings from this study also suggest more research is needed to figure out 
how to increase acceptability of digital health among this population. However, 
low diet quality scores, current technology usage, and perceived usefulness of 
digital health suggests technology may be a way to increase access to 
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This dissertation is presented in manuscript format and contains three 
chapters that are from two different studies through the University of Rhode 
Island. Upon completion of the final dissertation submission, three manuscripts 
will be submitted for publication to the specified journal highlighted on each 
manuscript title page. Chapter one will be submitted to Movement Disorders, 
chapter two will be submitted to the Journal of the Academy of Nutrition and 
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Background: Parkinson’s disease (PD), a neurodegenerative disease, results 
in motor and non-motor changes that can impact nutritional status. How 
nutrition assessment markers change longitudinally has not been examined. 
The purpose of this study was to track the nutritional status of people with 
Parkinson’s disease (PwPD) over time.  
Methods: This study was an observational, longitudinal study examining 
people with PwPD with assessments analyzed at baseline, year 2 and year 4. 
The assessments included: the dietary screening tool (DST), height and 
weight to calculate body mass index (BMI), fasting glucose and lipid profiles, 
and blood pressure. A one-way repeated measures ANCOVA compared 
outcomes variables over time.  
Results: Eight PwPD were assessed. The baseline age was 67.1±4.0 years 
and time since diagnosis was 8.1±7.5 years. There was no change in mean 
DST scores overtime (64.0±13.8 vs. 66.4±8.8 vs. 64.3±13.2) and majority of 




Participants experienced weight declines (176.3±29.7lbs vs. 169.0±25.5lbs, 
hp2=0.01) and BMI (27.6 kg/m2 vs. 26.6±2.2, hp2=0.02) from baseline to year 
4. The number of PwPD with elevated glucose (>100mg/dL) increased from 
one to four, but the number of PwPD with suboptimal HDL-C decreased from 
four to two.  
Conclusion: The presence of nutrition risk, experienced weight loss, and 
changes in biochemical and clinical values, suggest that interdisciplinary 
intervention strategies may need to be designed and tested in this population. 
Key words: Parkinson’s disease, nutritional status, diet quality, longitudinal 




















Parkinson’s disease (PD) is an incurable, progressive 
neurodegenerative disease that traditionally occurs in the second half of life.1 
Over 900,000 Americans are diagnosed with PD2,3, and that number is 
expected to double by 2030.3  People with PD (PwPD) typically live about 15 
after diagnosis and just recently researchers are investigating what post one 
year from diagnosis.4  Parkinson’s disease-specific sequelae, conditions that 
result from PD, impact motor and non-motor function5 and worsen as the 
disease progresses.5 Common motor sequelae (slowness of movement, 
tremors, and balance issues), and common non-motor sequelae (changes in 
smell and taste, gastrointestinal issues and difficulty swallowing), are all 
associated with compromised nutritional status.6-8 Monitoring these changes 
overtime provides how nutrition health outcomes among PwPD change 
overtime in light motor and non-motor sequelae. 
While PD sequelae tracking is a part of normal care, comprehensive 
nutrition assessment have not been incorporated, and this impairs the ability to 
provide effective, critical nutrition intervention.9  To our knowledge, this is the 
first study to track sequelae while concurrently completing a nutrition 
assessment.  Nutritional and weight status in PwPD varies over the course of 
the disease.8 These fluctuations can occur due to decline in cognitive and 
physical functioning.8  Fluctuations in weight and nutrition status can further 
compromise body composition, biochemical and clinical levels, cognitive and 




hospital stays.12,13 The purpose of this longitudinal, observational study was to 
track the nutritional status of PwPD over four years. A secondary aim of this 
study was to describe changes in PD sequelae, as these sequelae may help 
explain the possible changes in nutritional status that occur. It was 
hypothesized that change in motor and non-motor sequelae overtime can 
influence nutrition status and dietary intake, which in turn can impact health 




This was an ancillary study of a five-year observational, longitudinal study 
assessing the nutritional, cardio-metabolic, cognitive and physical function 
status of PwPD and acquired brain injury (ABI) (Longitudinal Study of 
Communication, Nutrition and Physical Activity). To be eligible for the original 
study, persons recruited via flyers, word-of-mouth, and announcements in 
support groups, had to be between 18-85 years of age and one-year post-PD 
or -ABI diagnosis; for this study, we only used data from PwPD. Participants 
completed assessment visits (~3 hours each) at the University of Rhode 
Island’s Speech and Hearing Clinic every six months for five years. 
Specifically, for this study, PwPD’s were assessed at baseline, years two and 
four.  The University’s Institutional Review Board approved this study (IRB 
HU1314-006) and subjects provided written consent in accordance to the 






Nutrition assessment includes the examination of anthropometric 
measures, biochemical markers, clinical data, and dietary intake.14,15 
Comprehensive nutrition assessments examined change in nutrition status 
overtime. This included assessments of diet quality, biochemical, 
anthropometric, and clinical data. To assess diet quality, participants 
completed the dietary screening tool (DST), a 25-item questionnaire validated 
and used to identify dietary patterns and nutritional risk in older adults.16 A 
total of 105 points can be achieved and scores can be categorized as: at risk 
(<60), possible risk (60-75), and not at nutrition risk (>75). Serum total 
cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density 
lipoprotein cholesterol (HDL-C), triacylglycerol, and glucose were obtained 
using a finger stick (Cholestech® LDX system, Hayward, CA) after a 12-hour 
fast. Blood pressure was measured using an automatic blood pressure 
machine. Height and weight were measured in duplicate and used to calculate 
body mass index (BMI, kg of body weight/height in meters2).  The following 
criteria were used to characterize suboptimal assessment markers: 1) BMI >28 
kg/m2;17 2) systolic >130 mmHg and diastolic blood pressure  >80 mmHg; 3) 
total cholesterol (TC) >200mg/dL; 4) high-density lipoprotein cholesterol (HDL-
C) <40mg/dL; 5) low-density lipoprotein cholesterol (LDL-C) >100mg/dL; 6) 
triacylglycerol (TAG) >150mg/dL; 7) fasting glucose >100mg/dL.  
The following assessments were used to describe change in disease 




physical functioning. The Repeatable Battery for the Assessment of 
Neuropsychological Status (RBANS) 19 assessed cognitive function; scores 
<80 were indicative of cognitive impairment. Both the Swallowing Quality of 
Life (SWAL-QOL) Survey20 and a timed swallow test (ml/s) 21 assessed 
swallow function. A SWAL-QOL score of <75% and a time swallow speed of 
<10ml/s was considered suboptimal. Finally, a medical history questionnaire is 
used to identify health-related conditions and changes in health conditions at 
each assessment visit. 
Statistical Analysis. Data were analyzed in SPSSv26. Categorical 
variables are represented as numbers and percentages and continuous 
variables are reported as mean±standard deviations. Data were assessed for 
normality and non-normally distributed data were transformed (square root or 
reflect and square root) for analyses, mean±standard deviations of variation 
before transformation are reported. A repeated measures analysis of 
covariances was used to examine change overtime among outcome variables. 
Time since diagnosis was used as a covariate. A Bonferroni adjustment was 
made for multiple comparisons. Analyses were 2-tailed and a p<0.05 indicates 
statistical significance. Participants were then individually analyzed for 
suboptimal scores across each outcome variable and the frequency of sub-
optimal scores were reported.  
Results  
 Eight PwPD were analyzed over four years. At baseline, the mean age 




diagnosis was 8.1±7.5 years, ranging from 1-23 years. Six out of eight 
participants were male (75%). All participants identified as Caucasian. One 
participant reported attending some college, another had a college degree, 
and six achieved a post-baccalaureate degree. At baseline, two participants 
identified as smokers but quit during the first two years of the study. Three 
participants had deep brain stimulation, and one participant had the diagnosis 
of PD with Lewy Body Dementia. Two PwPD had thyroid conditions, and one 
PwPD had a history of a myocardial infarction.   
Nutrition Assessment Markers. There was no significant change in 
nutrition assessment markers overtime (Table 1).  At baseline and year 2, 
seven participants were at possible- or at nutrition- risk, while six participants 
were at possible- or at- nutrition risk at year 4. Three PwPD had BMI scores 
>28kg/m2 at baseline, which decreased to two PwPD at years 2 and 4. For 
one PwPD height and weight could not be measured at year 4 due to 
functional decline. Over the four years, four participants experienced a ten 
pound or greater weight loss. One PwPD remained within one pound of their 
baseline body weight, and one PwPD experienced a six-pound weight gain.  
The number of PwPD with elevated systolic blood pressure (SBP) 
increased from four to seven overtime, but the number of PwPD with elevated 
diastolic blood pressure (DBP) decreased from five to two overtime. Only one 
participant had elevated total cholesterol at baseline, two participants had 
elevated total cholesterol at year 2 and one participant had elevated total 




four PwPD had elevated LDL-C at year 2 and three at year 4. Four participants 
presented with low HDL-C at year 1, which decreased to two participants at 
years 2 and 4. At baseline, three PwPD had abnormal fasting TAG levels, 
while one PwPD at year 2 and two PwPD at year 4 had elevated fasting TAG 
levels. One PwPD had elevated fasting glucose levels at baseline and year 2, 
however four participants had elevated levels at year 4. All participants had at 
least one suboptimal lab value or blood pressure reading at each visit.  
Disease Sequelae. Outcome variables used to describe disease 
sequelae at each time point are summarized in Table 2. At baseline all 
participants had RBANS scores indicative of normal cognitive functioning. At 
year 2 (37.5%, n=3) had RBANS scores <80 and 50% (n=4) had RBANS 
scores <80 at year 4. Three PwPD (37.5%) had SPPB scores <10 at baseline, 
while four (50%) had SPPB scores <10 at years 2 and 4. At baseline two 
PwPD had SWALQOL scores <75%, while four participants had suboptimal 
scores at year 2, and two PwPD at year 4. Two participants had suboptimal 
timed swallow speeds (<10 seconds) at baseline, and four participants had 
suboptimal timed swallow speeds at years 2 and 4.  
Discussion  
 
Findings indicate most PwPD were at nutrition risk overtime, 
experienced weight loss and presented with multiple cardiovascular risk 
factors. While there was no significant mean change in outcome variables 
related to cognition, physical functioning or swallowing, many participants 




Nutrition Related Outcome Variables. Throughout this study most 
PwPD were at possible or at nutrition risk. Previous research has found up to 
63% of PwPD to be categorized as with malnutrition or at risk for malnutrition 
22, however there is limited research regarding the overall diet quality of 
PwPD. The current study adds to previous research regarding weight status 
among PwPD. Previous research has found over 50% of PwPD to experience 
weight loss but present with elevated waist circumference.8,22  
This study also adds to the body of research on biochemical and clinical 
assessment markers that may help not only assess nutritional status, but also 
cardiometabolic status. Our sample presented with multiple cardiometabolic 
risk factors throughout the course of the study despite the modest decline in 
weight.  Overtime there was an increase in HDL-C levels among PwPD, while 
not significant, there was large effect size. Additionally, the number of PwPD 
with low HDL-C levels decreased by year 4.  Previous research suggests a 
cardiometabolic protective effect of PD and theorizes that optimal HDL-C 
levels among PwPD may explain this theory.23  While improvements in HDL-C 
levels were observed, the number of participants with elevated fasting glucose 
and triglycerides increased. This may be attributed to the change in taste 
PwPD experience, as an affinity for sugar and sweets is common8, which can 
impact glucose and triglyceride levels.    
Disease Sequelae Outcome Variables. The increase in the number of 
PwPD with suboptimal cognition, physical functioning, and swallowing is 




suboptimal assessment markers related to cognitive, physical, and swallow 
function.  Past research has found a relationship between physical activity 
level and/or physical functioning with cognition and well-being measures 
among PwPD.25,26  The decline in swallow function among participants may 
help explain the presence of weight loss and consistently poor diet quality 
among PwPD. Previous research has found PwPD with dysphagia are more 
likely to experience unintentional weight loss and to avoid foods that can be 
part of a nutritious diet, such as  fruits and vegetables.10  Current findings, 
along with this previous research, support the need for an interdisciplinary 
treatment approach for managing PD to promote health-related QOL. 
Study Strengths and Limitations. This is the first study to evaluate 
the change in nutritional status among a cohort of PwPD over four years in 
conjunction with change in motor and non-motor sequelae. This study 
provides subjective and objective data that provides a holistic picture of how 
the nutrition and health status of PwPD can change overtime. Finally, the 
interdisciplinary nature of this study can help inform future screenings and the 
care management of PwPD. Study results can be incorporated into the World 
Health Organization International Classification of Functioning, Disability, and 
Health (ICF) model has been used a framework to assess PwPD’s health,  
health related function and QOL.25 The ICF model consists of five domains 
that cover all aspects related to a person’s health status and human function 
and include: 1) body functions and structures, 2) activities, 3) mental health 




expand upon this interdisciplinary assessment of PwPD to also screen for 
mental health factors. 
While this study is novel, it is not without limitations. Our small sample 
size warrants tracking of a larger cohort of PwPD overtime. To see 
significance differences in DST scores, a total of 28 participants would have 
been needed to achieve a power of 0.80 and a large effect size (hp2=0.25).  
Based on our sample size of eight participants a power of 0.05 was achieved. 
The generalizability of study findings is limited by the fact that the majority of 
our participants were highly educated, white, male, and recruited from the 
University’s Speech and Hearing Clinic. However, epidemiological studies 
have reported the majority of American PwPD are white, and this could be due 
racial and socioeconomic disparities in receiving treatment for PD.27 
Additionally, one participant’s physical functioning had declined so much from 
baseline that a height and weight was not obtained at year 4. However, 
inability to complete certain assessments sheds light onto the progression and 
realities of PD.  Future research should track a larger, more diverse sample of 
PwPD to better understand how nutritional status changes throughout the 
course of PD and explore if a synergetic relationship exists between nutrition, 
cognition, physical functioning, and disease progression.   
Conclusion 
This study adds to the body of literature finding PwPD to have poor 
nutritional status and diet quality.9,28  Participants in this study experienced 




the need for routine, interdisciplinary assessment for PwPD to identify and 
treat disease sequelae and promote health-related QOL. Future research 
should explore the efficacy of interdisciplinary interventions.  This 
interdisciplinary team should include nutrition professionals, such as registered 
dietitians. Additionally, due to the observed decline in cognitive and physical 
functioning among PwPD research should also consider including informal 
caregivers whose role around buying, preparing, and serving nutritious foods 
may increase as PD advances. 
 
Chapter 1 Table and Figures  
 
Figure 1: Propose Mechanism of How Disease Sequalae Impact Nutrition 




















Table 1: Nutrition Assessment Markers Among PwPD Over 4 Years 
 Baseline Year 2 Year 4 p hp2 
DST 64.0±13.8 66.4±8.8 64.3±13.2 0.8 0.04 
Weight (lbs.) a 176.3±29.7 169.0±29.2 169.0±25.5 0.9 0.01 
BMI (kg/m2) a 27.6±3.4 26.6±3.1 26.6±2.2 0.9 0.02 
SBP (>130 mmHg) 141.4±22.4 140.3±17.2 144.1±14.5 0.06 0.38 
DBP (>80 mmHg) 81.1±10.4 78.8±14.2 80.1±12.4 0.9 0.46 
TC (>200mg/dL) 175.1±25.2 165.1±33.2 163.9±22.0 0.6 0.07 
LDL-C (100mg/dL) 104.0±22.6 93.75±30.9 87.4 ±36.2 0.99 0.0 
HDL-C (<40mg/dL) 44.1±17.4 49.0±17.7 48.1±12.4 0.53 0.1 
TAG (>150 mg/dL) 134.9±68.3 112.9 ±45.7 143.0±80.4 0.88 0.02 
GLU (>100mg/dL)a 89.0±9.4 89.2±7.2 95.0±12.2 0.66 0.07 
Statin Medication (n(%)) 6(75) 6(75) 6(75) NA NA 
BP Medication (n(%)) 4(50) 4(50) 3(37.5) NA NA 
an=7; effect size 0.01=small, 0.06=moderate; 0.14=large. Abbreviations: DST=dietary 
screening tool, BMI=body mass index, SBP=systolic blood pressure, DBP=diastolic blood 
pressure, TC=total cholesterol, LDL-C=low-density lipoprotein cholesterol, HDL-C=high 





Table 2: Change in Disease Sequelae (Cognition, Physical Function, 
Swallowing) Among PwPD Over Four Years  
 Baseline Year 2 Year 4 p hp2 
RBANS 93.0±13.3 88.6±22.4 81.6±24.2 0.4 0.1 
SPPB 9.9±1.8 8.8±2.1 8.4±3.3 0.8 0.03 
SWALQOL 77.3±12.4 72.5±12.2 75.6±16.1 0.3 0.2 
Swallow Speed (ml/secs) 15.7±9.8 15.01±11.1	 13.5±10.6 0.8 0.03 
an=7; hp2 values can be interpreted as: 0.01=small effect, 0.06=moderate effect, 0.14=large 
effect. Abbreviations: RBANS=Repeatable Battery for the Assessment of Neuropsychological 
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Background: People with Parkinson’s disease (PwPD) are often at nutritional 
risk. Limited research exists regarding the diet quality or nutritional concerns of 
PwPD and informal caregivers. Using patient-caregiver dyads is an innovative 
model to assess nutrition and understand dietary needs.  
Objective: Data collected from dyads were used to evaluate the diet quality 
and describe self-reported nutrition concerns of PwPD and their caregivers. 
Whether or not there was a consistent pattern between nutrition concerns and 
diet quality among PwPD and caregivers was also explored.   
Methodology: A mixed-methods study design assessed 20 PwPD-caregiver 
dyads.  During home visits, semi-structured, dyadic interviews were audio-
recorded for qualitative data and anthropometrics and questionnaires were 
collected. Two phone 24-hour recalls were completed to collect dietary intake. 
Dietary data was assessed for diet quality using the Healthy Eating Index 




Statistical Analyses Performed: Diet quality descriptives for PwPD and 
caregivers were reported as mean±standard deviation. Qualitative data was 
analyzed in NVivo and inter-coder reliability was >90%. Qualitative data was 
charted into framework matrices and reported as frequencies to quantify 
codes. A side-by-side comparison of themes and HEI-2015 scores for each 
participant was conducted. 
Results: Mean participant age was 68.1±11.2 years. Mean HEI-2015 scores 
for PwPD was 58.3±12.4 and 58.1±10.6 for caregivers, translating to an F 
letter grade. Dietary concerns related to PD sequelae included: change in 
appetite or amount eaten, gastrointestinal issues, food-medication 
management, chewing/swallowing issues, and change in taste/smell. A large 
amount of variation between HEI-2015 scores and self-reported nutrition 
concerns were detected.  
Conclusions: Poor diet quality may be attributed to self-reported nutrition 
concerns. Presence of poor diet quality and nutrition concerns among dyads 
suggests including both nutrition professionals and caregivers to promote 
nutritional health among PwPD. Future research should examine the number 
of nutrition concerns to help identify readiness to make dietary changes 
among dyads.  
Keywords (5 key words minimum): Parkinson’s disease, caregivers, 









Parkinson’s disease (PD) is a progressive neurodegenerative movement 
disorder that impacts nearly one million Americans.1,2 Disease stage and 
sequalae (conditions that result specifically from PD), physiological factors and 
treatments and associated side effects of PD can compromise dietary intake 
and quality.3,4 Disease sequelae impact motor (slowness of movement, 
shuffling/freezing gait, muscle rigidity5,6) and non-motor (fatigue, cognitive 
changes, difficulty swallowing, change in taste and smell, gastrointestinal 
issues3,7-9) function, which can worsen overtime and impact dietary intake, 
nutritional status, and body composition3  Suboptimal weight status and body 
composition can further impact physical function and cognition10-12, quality of 
life (QOL), and health outcomes.13 Consequently, informal caregiver 
responsibilities increase as PD progresses,14 and caregivers are typically 
responsible for performing the majority of activities of daily living (ADL) for 
people with PD (PwPD),15 including assisting with or doing the buying, 
preparing, and consuming meals and snacks.16,17  
Nutrition is integral in managing PD.3 However, there is limited research 
related to diet quality among PwPD and caregivers, populations who are at 
risk for poor dietary quality. To help improve dietary patterns in at-risk 
populations, understanding food choices and exploring acceptable sources of 
nutrition advice and support is essential.18 The Healthy Eating Index (HEI)-
2015 is a diet quality index that assesses the compliance with the Dietary 




recommendations informed by diet quality’s impact on health outcomes, such 
as weight status, diabetes, cancer and cardiovascular disease.19,20  
Adhering to the DGAs could help PwPD meet the requirements for what 
are several nutrients of concern, such as fiber21, fluid21, vitamin D22, vitamin 
E23, omega-3 fatty acids23, and protein22. These nutrients can be obtained 
through an adequate diet that aligns with the dietary guidelines. However, 
research has found that PwPD have poor diet quality inconsistent with dietary 
patterns that promote health, such as the DGA or the Mediterranean Diet 
Pattern.24,25 Findings warrants the exploration of differences in overall dietary 
patterns between PwPD and their informal caregivers.26  
 It is particularly important to assess the diet quality of caregivers, as 
caregiver stress and burden can adversely affect caregiver’s psychosocial and 
physical functioning, which can compromise care provided and the health of 
the patient-caregiver dyad27,28.  Research has examined the nutrient intake of 
PwPD and their spouses26, but has not specifically analyzed the diet quality in 
the context of the patient-caregiver dyads. Additionally, exploration of nutrition 
concerns of these dyads and how these concerns compare to diet quality have 
not been explored. Compared to the general population, caregivers for PwPD 
are more likely to have depression, anxiety, decreased health status27, and/or 
poorer QOL29, which may impact diet quality. Additionally, given the later 
onset of PD, most caregivers are older and have their own medical conditions 




Qualitative work is needed to explore PwPD’s and their caregivers’ views 
on dietary intake and decisions that impact that intake.  Such nutrition 
research has been used in similar populations, like older adults and their 
informal caregivers, to better understand factors impacting dietary choices and 
inform appropriate and acceptable services.31,32 This qualitative work has also 
been conducted to better understand various aspects of care among PwPD 
and their caregivers, such as coping with the disease33,34, managing cognitive 
changes35, and QOL.36 However, such an approach has not been used to 
understand the nutrition concerns of this population.   
Understanding the diet quality and the nutrition concerns of both PwPD 
and their caregivers can inform nutrition services for managing PD, and how 
best to facilitate dietary management from patient perspective. Additionally, 
gathering this information can help identify general services required to 
facilitate the process of learning to live with PD.37  As a result, to effectively 
design a nutrition intervention for PwPD and caregivers, assessing dietary 
quality as well as collecting qualitative information related to their nutrition 
concerns is vital to develop an effective and sustainable nutrition service. The 
main purposes of this study were to: 1) evaluate the diet quality among PwPD 
and their informal caregivers; 2) describe the self-reported nutrition concerns 
among PwPD and their informal caregivers; and 3) explore if there was a 
consistent pattern between self-reported nutrition concerns and dietary quality 







A concurrent mixed-method design38 was used to assess diet quality and 
nutrition concerns of PwPD and their informal caregivers. This mixed-methods 
design was chosen to gain a more complete understanding of nutritional 
needs of PwPD and caregivers through comparing and synthesizing both 
quantitative and qualitative data.38 Data was collected over four assessments 
completed between November 2018 and April 2019. Participants were 
recruited from support groups throughout New England, New York, and New 
Jersey via announcements and flyers at community centers, via healthcare 
providers, and through popular press coverage from the University. 
Assessment 1 was an informational phone call during which participants were 
screened for eligibility and informed about the study protocol. Both the PwPD 
and their informal caregiver were required to participate and needed to be 
community-dwelling, English-speaking, and ≥18 years old. Participants also 
needed to score >18 on the Telephone Montreal Cognitive Assessment (T-
MoCA), a cognitive screening tool.39,40  At the beginning of Assessment 2, 
which was an in-person visit, the study protocol was reviewed and both PwPD 
and their informal caregiver completed the informed consent process. 
Participants completed a timed-swallow test, questionnaires, and a semi-
structured, dyadic interview. Assessments 3 and 4 were phone calls during 
which participants completed two 24-hour recalls. Findings from this study 
were a part of a larger study seeking to inform features of a digital health 




Institutional Review Board (HU1819-001) was obtained.  
Data Collection  
Nutrition assessment data are highlighted in Table 2. The two 24-hour 
recalls included one week and one weekend day, and were conducted using 
the gold-standard, multiple-pass interview method.41 Participants received a 
food amounts booklet to help estimate and report accurate portion sizes. The 
24-hour recalls were entered into Nutrition Data System for Research 
Software 2017 (NDSR, University of Minnesota, Minneapolis, MN) and 
analyzed for total energy and nutrient intake. The NDSR data were assessed 
for diet quality using the HEI-2015 scoring metric.42 Outputs from NDSR were 
used to calculate HEI-2015 component scores derived using SAS codes.42 
Total HEI-2015 scores are based on 1-100; the higher the score, the better the 
diet quality. A graded approach was used to categorize HEI-2015 scores 
(A=90-100, B=80-89, C=70-79, D=60-69, and F=0-59).42  
During Assessment 2, height was measured using a stadiometer (Seca, 
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged and 
weight was obtained using a calibrated scale (Tanita HD351 digital scale, 
Arlington Heights, IL) to the closest 0.1 kg and in duplicate and then averaged.  
These values were used to calculate body mass index (BMI, kg of body 
weight/height in meters2). A foot-to-foot bioelectrical impedance analysis 
device (Tanita BF-556, Arlington Heights, IL), estimated body fat percentage.43 
Body fat was not obtained for participants with implanted medical devices. 




anthropometric tape (Fabrication Enterprises Inc. White Plains, NY) in 
duplicate and averaged.44 Finally, participants also completed a medical 
history and demographic information (age, gender, race/ethnicity, education 
level, employment status) survey. 
Semi-structured, dyadic interviewing was used to capture information 
related to dietary intake and nutrition concerns using a pre-prepared 
moderator guide (Appendix A). The research team developed the moderator 
guide with reference to previous literature.3,37,45 Twenty-four opened- and 
closed-ended questions were used that fit into one of three main domains: PD 
and Diet, Accessibility of Nutrition and Health Information, and Digital Health 
for PD. Semi-structured dyadic interviews also contained three closed-ended 
questions which provided insight into PwPD’s and caregivers’ perceptions of 
healthy eating and its usefulness for managing disease.  Interviews were 
conducted in the participants’ homes by a doctoral candidate who was also a 
registered dietitian (DL) and audio recorded using a digital recorder. The mean 
length of interviews were approximately 39 minutes and interviews lasted from 
21 to 64 minutes in length. 
Data Analyses  
Quantitative data analyses. Quantitative data was analyzed using SPSS 
v26 (IBM Corp, Summers, NY). Descriptive statistics are reported as 
mean±standard deviation for continuous variables and percentages and 
frequencies for categorical variables. Outliers were identified using boxplots 




among the following HEI-2015 variables: HEI-2015 Total Scores, Protein, and 
Refined Grains component scores. To explore differences between PwPD and 
caregivers, independent samples t-tests were used for all normally distributed 
continuous variables and Mann-Whitney U tests examined differences 
between non-normally distributed continuous variables. Finally, the percent 
and frequency of PwPD and caregivers who met >80% of adequacy and 
moderation HEI-2015 components scores were calculated. A p-value of <0.05 
indicated statistical significance. 
Qualitative Data Analyses. Qualitative data was analyzed using the 
framework analysis method46 and Colaizzi’s Strategy in Descriptive 
Phenomenology.47 The following steps were taken to analyze transcripts.  
Recordings were transcribed verbatim and DL checked transcripts for 
accuracy. Transcripts were analyzed by DL and a trained research assistant 
(KS). The analyses focused on five questions from the moderator guide 
related to diet and nutrition.  
Before coding individually, KS and DL read through all of the transcripts 
and developed a list of initial impressions and themes within three categories: 
Dietary Concerns Related to PD Sequelae, Other Nutrition Concerns, and 
Perceptions of Diet (Figure 1). Dietary concerns were coded deductively while 
themes that emerged from the transcripts were coded inductively and fell into 
the category of Other Nutrition Concerns or Perceptions of Diet. Both DL and 
KS coded one transcript from each batch independently and met to compare 




framework and agreed upon codes to use for analyzing the remaining 
transcripts. The transcripts were uploaded to NVivo12 (QSR International Pty 
Ltd, AU) and coded separately by DL and KS. An inter-coder reliability was 
calculated, with an agreement >93% achieved.48  
DL and KS compared codes and reconciled differences between codes, 
until a consensus was reached, and codes were finalized. To ensure 
information related to dietary intake was not overlooked in other sections of 
the transcripts, DL went through all of the transcripts and coded the remaining 
sections. KS reviewed the codes to verify coding structure, and added 
additional codes when needed, and DL and KS discussed differences in 
coding and collapsed themes. The larger research team and DL met to further 
collapse and finalize themes.  
Data Integration. The research team reviewed both data sets and 
considered the qualitatively-coded themes in conjunction with the findings from 
the statistical analyses of the HEI-2015 scores. Qualitative data was charted 
into framework matrices and reported as frequencies using NVivo12 to 
quantify codes within the over-arching category of Dietary Concerns Related 
to PD Sequelae. This frequency data derived from the qualitative themes and 
a side-by-side comparison of themes were compared with individual HEI-2015 
Scores for each participant. Data was interpreted and connections were 
explored between HEI-2015 scores and frequency of self-reported Dietary 








Twenty dyads were assessed. Participant characteristics are 
summarized in Table 1. All participants identified as Caucasian and one PwPD 
identified as Hispanic. Sixteen of the twenty dyads lived together. Ninety 
percent of PwPD were taking levodopa-containing medication, ranging from 3-
7 times per day.  
 To help describe our study population and support the research aims, 
Table 2 highlights diet assessment data of PwPD and caregivers. Both PwPD 
and caregivers had near optimal percent body fat and waist circumference 
though BMI scores indicated both groups were overweight. Dyads were 
consuming slightly below the acceptable macronutrient distribution range 
(AMDR) for carbohydrates, slightly above the AMDR range for fat and within 
the AMDR range for protein. People with PD consumed 0.9±0.4 g/kg body 
weight protein per day and caregivers consumed 0.9±0.2 g/kg body weight per 
day.  While dyads were below the dietary reference intake for most vitamins 
and minerals, the majority were taking supplements. There was no difference 
in nutrition assessment variables between PwPD and caregivers.  
Dietary Quality Among PwPD and Caregivers.  
Total HEI-2015 and component scores for PwPD and caregivers are 
summarized in Table 3.  Low HEI-2015 scores indicates poor diet quality 
consistent with the national average.49  Fifty-five percent of PwPD and 65% of 
caregivers had total HEI-2015 scores that translates to an F letter grade.42 




summarized in Figure 2 and highlights the number of PwPD and caregivesr 
who achieved >80 of maximum scores for total HEI-2015 scores and 
component scores.   
 
Qualitative Results: Self-Reported Nutrition Concerns  
 
Dietary Concerns Related to PD Sequelae.  There were 182 phrases 
coded into the category Dietary Concerns for PD Sequelae (Table 4). The 
major themes related to PD Sequelae are highlighted in Figure 1.  Phrases 
where dyads described how PD impacted mealtime and eating ability were 
coded as Mealtime Related Issues. The major areas discussed around these 
meal-time related issues included three-major sub-themes:  Chewing and 
Swallowing; The Time it Takes to Cook or Consume a Meal; and Physical 
Sequelae.  Phrases where participants reported cutting up their food smaller, 
modifying textures to consume foods, coughing during meals, or taking more 
effort to chew their food, were coded as Chewing and Swallowing.  
• “He has been advised to cut things into small pieces often, and to drink 
fluids as you eat” –CG17  
 
Many participants also described how physical changes related to PD 
impacted their ability to eat certain foods and mealtime. Phrases were coded 
as Physical Sequelae when dyads described how tremor and other physical 
changes impacted their ability to consume certain foods.  
• “Primarily, the tremor affects my ability to get soup or things on a fork 
up to my mouth” – PD2  
 
Another sub-theme within Mealtime Related Issues was the Time It Takes 




prepare a meal or consume a meal could diminish their appetite or impact 
meal enjoyment.  
• “I’m done and the dishes are already done, but I’m waiting for his dish” 
– CG14 
 
Phrases related to a Change in the Amount Eaten, Appetite, or Weight Status 
were coded when participants described an increase, decrease or no change 
in appetite, amount of foods consumed and/or change in weight status. Most 
of the phrases coded described a decrease in appetite. However, some 
participants did notice they were eating more than they used to.   
•  “My appetite is less than it used to be, there is no doubt about it.” – 
PD6 
• “I’ve always been able to eat a lot and consume the calories very well. 
Parkinson’s you just have to eat.” – PD17 
 
Only in four interviews did participants describe change in weight status. 
One participant reported an increase in weight due to the medications. Two 
participants reported that their weight decreased. Another reported that their 
weight stayed the same since being diagnosed.   
• “I’m kind of grateful you’re losing weight in that when and if you fall, I’m 
gonna have to help you get back up, and the more you weigh, you 
know I’m better off if you don’t weigh as much.” - CG14 to PD14  
 
Phrases where dyads described managing issues such as constipation, 
diarrhea, and nausea were coded as Gastrointestinal Issues; most of these 
phrases coded were constipation-related.  
• “A little bit of constipation…I try to eat a lot of salad lately, try to 
compensate a little.” – PD18  
 
• “I think for myself sometimes I tend to overcorrect, so then it’s you 
know, say my stool has been running loose, then I overcorrect, and 





Phrases where dyads discussed issues with spacing levodopa 
containing medication and high protein meals or where dyads described side-
effects of medication that impacted dietary intake were coded as Managing PD 
Treatment and Diet. 
• “I found online that milk is one of the worst proteins to have with my 
medications, so I have been spacing out having my milk more than an 
hour from when I take my meds. I used to mix the MiraLAX with milk, 
but now I will mix it with Gatorade… I noticed that my medication lasts 
45 minutes longer.” – PD01  
 
• “The first medication that I was on for Parkinson's increased my 
appetite and caused insomnia. And of course, if you are awake, you are 
going to pick on food items, so I wound up putting on some weight for 
about a year.” - PD7 
 
Phrases were coded as Taste and Smell when participants described how 
loss of taste and/or sense of smell impacted their food choices and ability to 
enjoy foods. Many reported a higher affinity for sweet tasting foods such as ice 
cream and desserts, while others reported trying to decrease their sugar 
intake.   
•  “I’ve come to love ice cream, I have it every single night almost, I didn’t 
used to do that…” - PD16 
 
• “I lost my sense of smell in 1992…way before my Parkinson’s 
diagnosis, yes, but I think they relate loss of smell to Parkinson’s. So, it 
took some of the enjoyment of food...”  - PD05  
 
Phrases where dyads described trying to increase their fluid intake or 
recognizing they needed more fluids in their diet were coded as Fluid and 
Thirst.  
•  “We’re trying to increase the amount of water weight that I drink” - 






Other Nutrition Concerns. Five themes emerged within the category of Other 
Nutrition Concerns (Figure 1). In total, 143 phrases were coded related to 
Other Nutrition Concerns.  Phrases around Understanding Nutrition Claims 
were coded in 19 out of 20 interviews. Phrases were coded as Understanding 
Nutrition Claims when dyads expressed a desire to better understand healthy 
eating, nutrition claims, nutrition for overall health, or nutrition claims for 
managing PD.  
• “As I spoke to you earlier, the difference between good cholesterol and 
bad cholesterol, so that I’m making better choices.” – PD19  
 
•  “Probably for my dad in particular it would be if for Parkinson's, do they 
recommend a higher protein, lower fat, lower carb diet? Or do they 
recommend complex carbs with protein? Maybe he could eat a 
healthier diet than he does.” – CG07 
 
Within the theme Managing Life were three sub-themes: Managing Other 
Conditions with PD, Managing PD and Life, and Managing Diet and Life.  
Besides managing Parkinson’s disease, many PwPD had other health 
conditions they were dealing with, including: musculoskeletal issues, weight 
management, endocrine issues, gastrointestinal issues, cardiovascular issues, 
and brain disorders.   
 
• “Well one thing we’ve learned, because he does have a tendency to 
[get] gout, there’s certain vegetables to avoid that will contribute to uric 
acid forming in the joints.” – CG17 
  
• “I sort of have breakfast, but don’t really have lunch, and then at dinner 
I eat a lot…I think it’s more my Concerta wears off, and then um, 
because it’s considered an appetite suppressant, and then I’m just 






Within the Managing Life theme was also the sub-theme, Managing PD and 
Life.  Participants described challenges with overcoming life events and 
challenges and managing PD.     
• “Well Parkinson’s definitely makes you more emotional. I’ve always 
been an emotional person. I cried when we got married.” – PD14  
 
A few participants described day-to-day and life events that could impact their 
dietary intake, such phrases were coded as Managing Diet and Life. One 
participant felt dealing with personal matters impacted their dietary choices but 
felt PD did not.  
• “People who don’t think you’re just going through a fad or trying to be 
effected by something, when really you’re just trying to eat healthy, 
especially for a medical condition, you know, ‘oh well she’s on one of 
those diets or she’s being one of those people’” – PD10 
 
• “I have been not watching what I eat over the past 18 months, but it 
does not have to do with Parkinson’s, it has to do with stress… stress 
eating - not feeling good and eating the wrong foods.” – PD20  
 
Many participants described how they were currently involved with 
complimentary care services to help manage PD. Phrases where participants 
described partaking in exercise programs, acupuncture, dietary changes, or 
support groups were coded as Alternative Practices or Medicine.   
 
• “There was a cleanse that was put out by Kripalu, the yoga center, it's 
like a 3 week cleanse to purge your body of various toxins, you know 
it’s hard, but once you get into it its really good, you feel really healthy 
and vibrant” –PD11 
 
• “My acupuncturist, who I respect and think is bright, tells me ‘don’t eat 
peanuts’ and I love peanuts…I asked her why she said something I 
didn’t understand, but I stopped eating peanuts, and same thing with 






When discussing food intake and dietary choices, many participants were 
not sure that their dietary intake changed as a result of having PD. Some did 
not feel having PD impacted their food intake, dietary choices or preferences.  
Several participants could not distinguish if changes they experienced with 
food were a result of having PD or just a natural part of the aging process.  
• “I generally felt better on the Keto diet because I lost a little weight, but, 
um, as far as Parkinson’s symptoms I’m not aware.” –PD02 
 
• “No, I don’t eat a lot, but I don’t know if that’s Parkinson’s or not. 
Indirectly it probably is, because I don’t have my smeller” –PD16 
 
The final theme related to the category Other Nutrition Concerns was 
Dietary Needs of Caregivers. Several interviews revealed caregivers had their 
own dietary concerns that may differ from the PwPD or were managing their 
own health conditions that required dietary modifications, including 
neurological conditions such as multiple sclerosis and essential tremor. Many 
caregivers were also the ones buying and preparing foods or impacted by their 
loved one’s dietary challenges.  
 
• “I feel really badly for [him] because he has got nothing to eat because 
just being in the kitchen thinking about food is awful but he's not 
wasting away, so...” -PD15  
 
• “I mean I call him almost every day ‘got any ideas for dinner?’, but I 
think for the most part it all falls on me. I think that he really does think 
that if he ate better, he might feel better, so again it’s on me.’’ –CG18  
 
Perceptions of Diet. In total 113 phrases were coded within the category 
Perceptions of Diet. Phrases coded as Perceptions of Diet fit into three sub-
themes (Figure 1). Of the 72 phrases coded as Perceived Usefulness of Diet 




dietary choices were useful for Managing PD, while 19.4% of phrases coded 
described how dyads were not sure or neutral regarding the role diet plays for 
managing PD. Only 6.9% of phrases coded described how participants 
thought a healthy diet was not useful for managing PD. As a result, there were 
mixed perceptions as to how useful diet can be for managing PD. The 
following quotes are examples of responses to the question, “How important is 
it to follow an eating plan for managing PD.” 
• “It’s very important, I don’t know if you would call it an eating plan, but 
it’s important to know what you are going to eat and when you are 
going to eat it and figure out how to back up from what time it is now 
and to dinner and when you should start taking your medicines and put 
it in proper order.”  -PD12 
 
• “I think more science needs to be done there, I think there needs to be 
some things that they find that [some foods] are especially good...some 
fruit that comes from Asia somewhere.” –CG16  
 
For the sub-theme, Perceived Usefulness of Diet for Managing Health, 
85% of phrases coded indicated participants found following a diet useful for 
managing overall health and only 15% of phrases coded indicated participants 
found following a diet to be useless for managing overall health.   
•  “I don’t count calories. I eat what I eat.” –PD04  
“But you need to! We need to be more cognizant of the caloric intake 
because it affects how much you weigh, and if you lost 15 pounds, your 
core would be much more manageable. As would mine be! …one isn’t 
independent as each other. So caloric intake does count! You just don’t 
think it does.” -CG04  
 
 A third theme within the category of Perceptions of Diet was Perception 
of Own Diet Quality. Of the 21 phrases coded, 76% of phrases coded 




of phrases coded were linked to participants who perceived they had poor diet 
quality. Only 2 interviews and 9.5% of the phrases coded reflected that 
participants recognized that their diet could be improved or that they were 
interested in making improvements in their diet quality; these phrases were 
coded as Neutral. 
•  “Only that I know that I should have more fruits and vegetables.”-PD15  
 
• “We need a healthier diet. We do eat like fish once a week at least, but 
we also eat like pizza, you know... But yeah I think we need to eat 
healthier, we definitely need to eat healthier. He tries to, he’s a lot better 
at it than I am.” –CG18  
 
  Integration of Quantitative and Qualitative Data  
 The frequency of themes coded within the category Dietary Concerns 
Related to PD Sequelae were compared with HEI-2015 scores to detect if any 
pattern between self-reported concerns and diet quality existed. Given the 
large variation between HEI-2015 scores and Self-Reported Nutrition 
Concerns Related to PD sequelae. Several PwPD reported a change in taste, 
including a preference for sweeter foods. However, about 50% of participants 
had high added sugar moderation scores, indicating that their diets are low in 
added sugar. Sodium scores indicate excess salt intake may be a concern for 
PwPD and caregivers. Higher salt intake may be attributed to change in taste 
as well as the intake of convenience and processed foods.  
Discussion  
This study is the first to examine PwPD’s and caregivers’ diet quality in 
conjunction with self-reported dietary concerns related to managing PD. 




as well as nutrition concerns regarding PD sequelae and their own nutrition 
literacy. Qualitative analyses revealed dyads also believe that a healthy diet 
may be important for managing PD and overall health.  However, there was no 
pattern between HEI-2015 scores and Nutrition Concerns Related to PD 
Sequelae. Findings from this study can be used to provide tailored nutrition 
counseling and inform nutrition interventions among PwPD and caregivers.  
This study adds to the body of literature of dietary quality and PD 
management by providing objective dietary quality data which is scarce. Our 
study supports the caregiver as an integral part of the care provided to PwPD 
and without including caregivers’ dietary management for PD may be 
incomplete. Total HEI-2015 scores of both PwPD and their caregivers was 
comparable to the average HEI-2015 scores for Americans of 59, or an F.50 
Compared to the national HEI-2015 component for Americans, dyads scores 
indicate PwPD and caregivers are doing a better including whole grains in 
their diets and limiting added sugar intake.50 Mean added sugar component 
scores were similar to American older adult scores.50 Dyads may need some 
education on how to incorporate protein and healthy fat into their diets as well 
as to minimize sodium intake.  
Few studies have examined diet quality and patterns among PwPD but 
nutrition status has been extensively examined. Past research shows that 
PwPD have compromised nutrition status and are at nutrition risk3,13,24. Our 
findings were similar to key findings from Cassani et al25, who found no 




between PwPD and controls; results also showed both groups could be 
making dietary choices that better adhere with the Mediterranean diet.  
Marczewska et al.26 examined daily intake among PwPD and their spouses 
and found no difference in average daily energy intake, but did find differences 
in individual food groups such as vegetable protein and carbohydrates.  Our 
study adds to this research by looking at over all dietary quality and adherence 
to the DGAs, rather than in terms of individual nutrients. 
Obtaining self-reported nutrition concerns of PwPD and their caregivers 
adds to the body of patient-centered care research. Dyads expressed dietary 
concerns related to PD sequelae, such as mealtime related issues, change in 
appetite, and gastrointestinal issues. Findings from our study indicate 
participants want to increase nutrition literacy, have pre-existing perceptions 
around nutrition intake, and are using complimentary care services. These 
findings expands upon previous research which has found PwPD and 
caregivers want to be involved in the communication and decision making of 
their care.51 Past research shows high levels of education and treatment of a 
movement disorder specialist were significantly related to PwPD using 
complementary health service.52 The majority of dyads in our study had at 
least a college degree and most PwPD were receiving treatment from a 
movement disorders specialist.  Young Shin et al.52 found exercise and 
vitamin supplements were most commonly reported forms of complimentary 
healthcare. Many of our participants reported in their medical history 




In addition to better understanding dietary quality and concerns among this 
population, our study expands upon previous research describing the day-to-
day challenges of navigating PD and sheds light onto how this may impact not 
only diet quality but overall health-related QOL. The emerging theme from our 
study, Managing Life, supports previous literature published by Smith and 
Shaw,37 which described the existential challenge shared by PwPD and their 
loved ones. Finally, exploring these self-reported nutrition concerns from this 
study may be able to help better understand the diet quality of participants in 
this study is warranted. 
The lack of pattern consistency between HEI-2015 scores and the number 
of self-reported nutrition concerns related to PD sequelae may indicate our 
participants may be in varying stages of the Transtheoretical Model.53 For 
instance, Dyad 16, the dyad with the highest HEI-2015 scores, also had the 
highest number of phrases coded within Self-Reported Nutrition Concerns 
Related to PD Sequelae (Table 4). This occurrence may indicate that this dyad 
was actively making dietary changes to minimize nutrition concerns and more 
cognizant of their dietary choices compared to other participants. The dyad 
with the second highest HEI-2015 scores, Dyad 4, had only two phrases 
coded within Self-Reported Nutrition Concerns Related to PD Sequelae. This 
suggests this dyad was actively managing their nutrition concerns.  Most 
dyads had HEI-2015 scores ranging from 43-70 and 9-12 phrases coded 
around nutrition concerns.  Findings suggest assessing dyads readiness to 




Self-reported perceptions and actual dietary patterns may vary due to 
alterations in perception that PwPD experience as part of the disease. These 
findings, combined with poor diet quality, suggest this population can benefit 
from nutrition education to improve diet quality and nutrition knowledge.  
Low adequacy and moderation HEI-2015 component scores may shed 
light on some of the self-reported nutrition concerns that came up during semi-
structured dyadic interviews. The sub-theme Mealtime Related Issues coded 
in dyadic interviews may account for low dietary scores and influence dietary 
choices and help to explain overall low HEI-2015 total and component scores 
among dyads. Our participants were not meeting maximum adequacy in areas 
of fruits, vegetables, and whole grains, sources of fiber which may help to 
reduce self-reported complains of constipation among our population. Future 
interventions should help PwPD obtain adequate fiber, manage dietary protein 
intake and reduce consumption of sodium and saturated fat.  Low dairy intake 
among PwPD may be a concern. The literature shows that osteoporosis and 
osteopenia can impact up to 91% of women and 61% of men with PwPD.54 
Most of our participants were taking supplements, including supplements to 
support bone health, which could be why nutrition for bone health did not 
appear as a self-reported nutrition concern. Understanding nutrition concerns 
among dyads may be a way to address nutrients of concern unique to PD and 
in turn help improve diet quality scores. Similar HEI-2015 scores between 
caregivers and PwPD indicate that caregivers can also benefit from nutrition 




Findings from this study can also help to inform digital nutrition 
interventions, which are lacking in this population. Tailored nutrition counseling 
by a registered dietitian that includes both the PwPD and caregiver could be 
beneficial for this population. Nutrition counseling can help to increase nutrition 
knowledge and promote dietary behavior change.55,56 Nutrition interventions 
should address the nutrition concerns discussed in semi-structured interviews 
among PwPD and caregivers as a way to help improve diet quality seek to 
help improve diet quality. Subsequently, including caregivers could optimize 
the health of the patient-caregiver dyad.27,28 In addition to managing PD, both 
PwPD and caregivers were dealing with other health conditions that may need 
dietary attention and can help reduce caregiver strain.  Couple-oriented 
interventions improve spousal coping strategies, promote disease related 
stress and anxiety management, increase self-efficacy, and help couples 
manage changes caused by PD.57 
Strengths and Limitations. This novel study had several strengths.  
Several measures were taken to ensure accuracy of the dietary intake 
information. To reduce recall bias, we used the multiple pass method, the gold 
standard for collecting dietary recall information.41 Enrolling both PwPD and 
caregivers also helped increase accuracy of dietary information. For example, 
several male participants, both PwPD and caregivers, needed assistance from 
their spouse to report dietary intake during 24-hour recalls. To measure diet 
quality, HEI-2015 was used, which is a validated, comprehensive measure of 




method study design collected both quantitative and qualitative data that 
provides an in-depth understanding of dyads’ diet quality and nutrition 
concerns that may help explain diet quality. The use of semi-structured dyadic 
interviews promotes interaction between participants to provide detailed 
information regarding their nutrition concerns and PD management.58 Finally, 
this study promotes the inclusion of PwPD and their caregiver as part of the 
healthcare team and the concept of patient-and caregiver-centered care for 
managing PD. 
Despite study strengths, this study has several limitations. Findings from 
our study are not generalizable to all PwPD. Most of our participants were 
educated and all of them identified as Caucasian. Cognitive status was an 
inclusion criterion to enroll in this study and as a result most of our participants 
had low reliance on caregivers and were able to perform activities of daily 
living with minimal assistance. However, research supports including 
caregivers early at disease onset and encourages caregivers to partner with 
healthcare providers to help cope with disease progression.59 A limitation of 
the HEI-2015 assessment measure is that it does not assess fluid intake. 
Many of our participants complained about a change in thirst, which could 
impact negatively impact hydration status. Cassani et al25 found that PwPD 
drank significantly less fluid compared to healthy controls. Finally, requests for 
personal health information, including disease stage, were sent to physicians’ 





Future Research.  
Concerns about low nutrition literacy in addition to poor diet quality among 
study participants may be explained by dyads’ limited access to nutrition 
education. During semi-structured interviews, when asked “Where do you get 
information about foods and diets for people with PD?” most dyads described 
getting information from support groups or attending one or two education 
sessions. Only one PwPD reported working with a dietitian overtime to 
manage nutrition and PD. Future research should explore barriers PwPD and 
caregivers have for accessing nutrition professionals. Future work should also 
explore ways to improve access to nutrition professionals through expanding 
other healthcare professionals’ knowledge of nutrition services as well as 
promote policy changes to expand insurance coverage for medical nutrition 
therapy among PwPD.  This is important since several participants reported 
obtaining dietary recommendations that were not evidenced-based or from 
non-nutrition experts.   
Conclusion 
This mixed-methods study focused on describing the diet quality and 
self-reported nutrition concerns of PwPD and their caregivers. Healthy Eating 
Index-2015 scores indicate PwPD and caregivers have low adherence to 
current dietary guidelines and present with dietary concerns related to PD. 
Poor diet quality and the self-reported nutrition concerns indicates dyads can 
benefit from nutrition education and support the inclusion of caregivers and 





Chapter 2 Tables and Figures  
 
Figure 1: Flow Chart of Qualitative Data by Major Categories and Sub-
Themes  
 









Figure 2: Frequency of PwPD and Caregivers with >80% Adequacy and 































Table 1: Descriptive Characteristics of PwPD and Caregivers  
 
Characteristics  PwPD Caregivers Range P 
Age (years) 69.7±9.2 66.4±13.0 39-89 0.4 
Gender n(%) 
      Male 





























Employment Status n(%) 
● Retired 
● Part Time 













Years Since Diagnosis  7.6(5.4) NA 0.33-18.0 NA 
T-MoCA 19.8±1.5 20.4±1.1 18-22 0.2 
Caregiver Relationship (%) 
● Spouse/Partner 
● Child  











Independent samples t-tests and chi square analyses  performed. A statistical significance was indicated 




















Table 2: Diet Assessment of PwPD and Caregivers  
 
Diet Assessment Variables  PwPD 
 (n=20) 
Caregivers 
(n=20) Range Anthropometrics 
Height (in)  66.1±3.3 65.1±3.8 57.5-70.7 
Weight (kg)  77.3±19.9 77.4±16.4 35.6-116.6 
BMI (kg/m2) 27.1±5.4 28.3±5.7 15.4-43.1 
% Body Fat (n=33)* 29.1±8.8 34.2±7.8 13-49 
Waist Circumference (in)  39.4±6.0 39.4±6.3 25.2-52.4 
Nutrient Intake     
Kcalorie Intake  1887.4±728.1 1752.7±465.8 908.8-3344.4 
% Calories from CHO 44.2±9.6 41.5±8.0 24.4-57.0 
% Calories from Fat 36.7±6.7 37.7±7.2 24.7-50.3 
%Calories from Protein 15.9±4.1 17.2±3.8 10.6-27.11 
% Calories from Sat Fat 12.8±3.1 13.3±2.8 6.6-18.5 
Analyses did not include dietary supplements; independent samples t-tests performed and a statistical 
significance was indicated at a  p-value of <0.05. Mann-Whitney test for non-normally distributed data ( 
g/kg protein; % calories from protein);  %BF n=16 PwPD and 17 CG (implantable devices such as DBS 
























Table 3: HEI-2015 Scores of PwPD and Caregivers  
 
HEI-2015 Scores  PwPD Caregivers Range 
Total Score (0-100) 58.3±12.4 58.1±10.6 37.7-83.4 
Adequacy Component:    
Total Fruit (0-5) 2.9±1.9 2.5±1.7 0.0-5.0 
Whole Fruit (0-5) 3.3±2.0 3.2±1.9 0.0-5.0 
Total Vegetables (0-5) 2.6±1.9 3.4±1.6 0.1-5.0 
Greens and Beans (0-5) 2.5±1.9 2.6±2.2 0.0-5.0 
Whole Grains (0-10) 4.8±3.4 5.0±3.1 0.0-10.0 
Dairy (0-10) 5.9±3.0 7.1±2.4 1.1-10.0 
Total Protein (0-5) 4.6±0.7 4.7±0.6 2.8-5.0 
Sea Food and Plant Protein (0-5) 3.6±1.9 2.9±2.2 0.0-5.0 
Fatty Acid Ratio (0-10) 3.9±2.9 3.0±2.3 0.0-10.0 
Moderation Component:    
Refined Grains (0-10) 7.0±3.1 8.0±2.6 0.0-10.0 
Sodium (0-10) 5.5±3.7 4.8±3.8 0.0-10.0 
Added Sugars (0-10) 7.6±2.5 7.4±2.6 1.2-10.0 
Saturated Fat (0-10) 4.1±3.4 3.6±2.8 0.0-10.0 
 Group differences ran using independent samples t-tests and Mann-Whitney U tests, p-value 

















Table 4: Number of Times Nutrition Concerns Related to Parkinson’s Disease 
Sequelae Were Coded During Dyadic Interviews: A Side-By-Side Comparison 










Dyad 1 9 65.7 43.7 
Dyad 2 4 44.9 41.8 
Dyad 3 1 63.1 62.8 
Dyad 4 2 83.0 78.7 
Dyad 5 9 45.1 51.8 
Dyad 6 11 46.6 70.3 
Dyad 7  10 48.6 43.7 
Dyad 8  7 54.5 54.3 
Dyad 9  7 54.3 54.5 
Dyad 10  11 62.9 63.1 
Dyad 11 11 63.1 62.9 
Dyad 12 12 59.8 54.6 
Dyad 13 11 59.3 56.6 
Dyad 14 19 70.7 61.0 
Dyad 15 13 46.1 57.2 
Dyad 16 21 81.4 83.4 
Dyad 17 10 47.0 57.5 
Dyad 18  9 60.5 51.1 
Dyad 19  5 71.0 59.3 
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In order to deliver tailored nutrition education via digital mediums for people 
with Parkinson’s disease (PwPD) and their information caregivers, this study 
examined the perception and acceptance of digital health for managing 
nutrition and health. Digital competence was also assessed.  Using a mixed-
methods design, qualitative data was collected through semi-structured, 
dyadic interviews and quantitative data through questionnaires from 20 dyads 
(20 PwPD and 20 caregivers). Data was collected in the Northeastern United 
States through home visits and phone interviews during the 2018-2019 
academic year. Interview transcripts were deductively coded using the 
framework analysis method. Phrases related to Acceptance of digital were 
sub-coded into Accept, Neutral or Reject.  Phrases related to perceptions of 
digital health were sub-coded into Perceived Usefulness, Perceived Ease of 
Use and Awareness of Digital Health. Quantitative data were analyzed using 
descriptives, independent samples t-tests and chi-square. To integrate this 




digital competence scores. A mean acceptance rate for digital health was 
calculated through examining the mean percent of phrases coded as Accept 
from interview transcripts. Twenty-five (62.5%) participants used the internet 
for at least 5 health-related purposes. The mean acceptance rate was 54.4%. 
Dyads rejected digital health devices if they did not see the added benefit. The 
majority of phrases coded revealed participants found digital health useful, but 
hard to use, and about half of the phrases coded suggest dyads needed 
education about existing digital health mediums. There was no difference in 
mean digital competence scores between PwPD and caregivers (28.6±12.6). 
Findings reveal dyads were accepting of and use technology, but not to its 
fullest potential. This may be attributed to perceiving technology as hard to 
use. This finding combined with digital competence scores, reveal education is 
warranted prior to providing a digital health intervention to deliver nutrition 
services.  
Key words: Parkinson’s disease, digital health, caregivers, nutrition 











What is known about this topic:  
• Increased disease burden with Parkinson’s disease progression 
compromises the health of the caregiver and the person with Parkinson’s   
• The healthcare plan often overlooks nutrition and the caregiver in 
managing Parkinson’s  
• Digital health is an effective healthcare delivery mechanism, but little is 
known about how Parkinson’s patients’ and caregivers’ perceptions of 
receiving nutrition and improving their own care 
 
What this paper adds:  
• Digital health and technology are convenient tools and provide Parkinson’s 
patients and caregivers with new evidence-based knowledge on 
Parkinson’s-related issues   
• Parkinson’s patients and caregivers are accepting of technology to manage 
nutrition, despite it being challenging.  
• The digital competence scores indicate some training will be needed prior 











Parkinson’s disease (PD) is an incurable, progressive 
neurodegenerative movement disorder that traditionally occurs in the second 
half of life (Fahn, 2003). Over 900,000 Americans are diagnosed with PD 
(Borlongan et al., 2013), and it costs the United States over $14 billion per 
year (Kowal, Dall, Chakrabarti, Storm, & Jain, 2013).  This cost is related to 
disease-related motor (e.g., postural instability, bradykinesia, muscle rigidity, 
resting tremors) and non-motor sequelae (e.g., cognitive decline, change in 
taste in smell, constipation). Sequelae resulting from PD, also compromise 
dietary intake and nutritional status (Barichella, Cereda, & Pezzoli, 2009), and 
warrant innovative nutrition care to help improve health outcomes (LoBuono et 
al., 2015). However, the unique nutrition services needed for PwPD are an 
under-recognized component of care (Vikdahl, Domellof, Forsgren, & Haglin, 
2015).  Additionally, PwPD can have limited access to all healthcare providers 
due to sequelae, age, and location, even with the presence of the caregiver 
(Dorsey et al., 2016). The increase in informal caregiver burden as the disease 
progresses is grossly under-estimated; the majority of informal caregivers 
spend up to 40 hours per week caring for a PwPD (Parkinson’s Australia Inc., 
2015).  As a result, an improved healthcare model that addresses nutrition and 
includes the caregiver is needed to facilitate PD management.  
Digital health describes technologies that enhance managing and 
tracking health status (Thomas & Bond, 2014), and include mediums such as 
videoconferencing, smart phones, internet applications, wearable devices, and 




health because a visual assessment is needed as part of on-going care by a 
team but PwPD can have limited mobility, visuospatial impairment, and 
decreased access to transportation (Achey et al., 2014). Digital health 
increases access to health and nutrition services (Meyer et al., 2019; Siddique 
et al., 2019; Stillerova, Liddle, Gustafsson, Lamont & Silburn, 2016; Ventura 
Marra, Shotwell, Nelson, & Malone, 2017), enhances quality of care (Espay et 
al, 2016), allows healthcare providers to obtain visual, objective and 
continuous data (Stamford, Schmidt, & Friedl, 2015), decreases healthcare 
inefficiencies, offers more personalized services and social support (Attard & 
Coulson, 2012; Shah et al., 2015), reduces burden and medical costs for 
PwPD (Dorsey et al. 2013), and offers caregiver support (Shah et al., 2015). 
People with PD and caregivers are receptive to using technology, especially if 
there is an added value, such as improving disease management (Ozanne et 
al. 2018; Schulz et al., 2016).  However, research has not directly examined 
the use of digital health for managing nutrition-related PD concerns 
In 2019, the World Health Organization published recommendations for 
implementing digital health interventions (World Health Organization, 2019). 
They recommend tracking a client’s health status and using videoconference 
to complement, rather than replace, in-person health services in a 
standardized protocol with infrastructure that promotes patient privacy.  To 
facilitate the adoption of mobile health technologies for PD management, the 
Movement Disorder Society Task Force on Technology proposes to identify 




mediums where the benefits exceed the burden for patients, and deliver a 
reliable intervention (Espay et al., 2019).  The development of these digital 
nutrition services should include the views, needs and preferences of informal 
caregivers, as they are confronted with the evolving roles, increased 
responsibilities, and planning for the trajectory of PD (Ducharme et al., 2009; 
Espay et al., 2019).   
This current study was part of a larger, cross-sectional study, which 
examined technology preferences and completed comprehensive nutrition 
assessments of PwPD and their informal caregivers (LoBuono et al., In 
Preparation). The purpose of this study was to examine PwPD’s and their 
caregivers’ perceptions and acceptance of digital health. This study also 
describes digital competence among PwPD and their caregivers.  
Methods             
   
Study Design  
 We used a mixed-methods, convergent design to compare and 
synthesize qualitative and quantitative data (Creswell and Plano Clark, 2018), 
and to fully capture dyads’ perception and acceptance of digital health. How 
these self-reported experiences may inform digital competence were also 
examined. A mixed-methods design was selected to allow for a better 
understanding of the experiences that dyads have in relation to digital health 




nutrition-related purposes (Espay et al., 2019; Creswell and Plano Clark, 
2018).    
Semi-structured, dyadic interviews and questionnaires were used to 
collect qualitative and quantitative data from PwPD (n=20) and their informal 
caregivers (n=20). The PwPD and their informal caregiver were interviewed 
together, but questionnaires related to digital competence and technology use 
were completed individually.  Ethical approval for this study was provided by 
the University of Rhode Island’s Institutional Review Board (HU1819-001).  
Theoretical Framework  
The structure of this mixed-method study and interpretation of results 
were based on two theories. The technology acceptance model (TAM) 
provides a basis for understanding external factors that influence ender users’ 
perceptions, attitudes, and intentions to use technology (Davis, Bagozzi, & 
Warshaw, 1989. This study concentrated on the early stages of the 
development of digital health nutrition services, in which PwPD and caregivers 
provided personal opinions and preferences to inform the creation of a user-
friendly, evidenced-based, digital nutrition service. The inclusion of informal 
caregivers is based on the emerging middle-range theory of transitions 
(Meleis, Sawyer, Im, Hilfinger, Messias, & Schumacher, 2000). A transition is 
the change from one state or condition to another, and includes life 
development stages, like progressing through a disease and becoming an 
informal caregiver. Collecting data from PwPD and caregivers provides a more 




of the caregiver evolves and the disease condition progresses, especially in 
relation to dietary management (Meleis et al., 2000).  
Sampling, Recruitment and Eligibility  
Study recruitment and data collection went from October 2018 through 
April 2019. Emails, flyers and announcements at support groups for PwPD 
and community centers were used to recruit participants. Prior to the first study 
visit, dyads completed an informational phone call about the study and were 
screened for eligibility.  Eligibility criteria were, both PwPD and their caregiver 
had to be community-dwelling, 18+ years old, and English-speaking, and both 
had to participate. All participants needed to score >18 on the Telephone 
Montreal Cognitive Assessment (T-MoCA), which is a cognitive screening tool 
(Castanho et al., 2014; Pendlebury et al., 2013). Transportation or prior 
technology use was not required to participate. Both PwPD and caregivers 
completed the informed consent process, and signed consent forms and each 
participant received a signed copy of the consent form.  
Twenty-five dyads expressed interest. Five dyads did not continue with 
the study due to scheduling conflicts or low T-MoCA scores. Eighteen dyads 
were eligible, enrolled and interviewed. Two of these dyads included couples 
who were both living with PD and identified as each other’s informal caregivers 
and were double counted as a PwPD and a caregiver.  As a result, 20 dyads 
were included in analyses. Dyads were from Rhode Island, Massachusetts, 
New York, and Connecticut.  We aimed to interview up to 20 dyads as 




saturation was reached (Boersma et al., 2016; Zizzo, Bell, Lafontaine, & 
Racine, 2017). Saturation was reached in this study after the fourteenth 
interview.  
Qualitative Data Collection and Analysis  
The 24-question moderator guide, informed by the previous literature and 
the research team was organized to capture three main domains: PD and Diet, 
Accessibility of Nutrition and Health Information, and Digital Health for PD. 
From these domains, participants’ acceptance and perception were assessed.  
A copy of the moderator guide is provided in Appendix N.  Prior to starting the 
study, interviews were piloted with two dyads and questions were modified 
based on participant feedback. Interviews were conducted in the participants’ 
homes (facilitated by DL) and were audio-recorded using a digital recorder. 
The mean interview length was 39 minutes (range 21-64 minutes).  
Operational definitions of terms (technology, digital health, smart phones, 
smart watches, apps, videoconferencing) were provided during interviews. 
Photo prompts were used to help describe different technological devices and 
digital health tools and this was particularly important for understanding 
acceptance of devices.  
 Qualitative data was analyzed using deductive and inductive reasoning.  
Transcripts were deductively-coded using the framework analysis method 
(Gale, Health, Cameron, Rashid, & Redwood, 2013), which is a seven-stage, 
systematic procedure that has been used previously in healthcare research 




were inductively-coded using Colaizzi’s Strategy in Descriptive 
Phenomenology (Shosha, 2012) to identify emerging themes; this 
interpretative approach draws an understanding of participants’ “lived 
experiences” of living with PD (Hycner, 1985).  
The following steps were taken to analyze the data.  Recordings were 
transcribed verbatim and DL checked transcripts for accuracy (stage 1). 
Transcripts were divided into three batches.  DL and a trained research 
assistant (KS) analyzed one batch at a time. Separately, DL and KS coded for 
the following overarching a priori themes related to digital health: perception 
(perceived usefulness, perceived ease of use, awareness of digital health, 
image of technology) and acceptance (accept, neutral, reject). Themes related 
to perception and acceptance were identified a-priori adopting components of 
TAM (Davis, Bagozzi, & Warshaw, 1989).  The model hypothesizes that 
perceived usefulness and perceived ease of use jointly determine acceptance, 
which can influence intention to use and actual behavioral use of technology 
(Davis, Bagozzi, & Warshaw, 1989). 
 Before coding individually, KS and DL read through an entire batch of 
transcripts and developed a list of initial impressions and themes and then 
coded a priori (stage 2). Both DL and KS coded one transcript from the batch 
independently and in duplicate (stage 3). The two researchers compared and 
reconciled coding, and there was a strong agreement between authors on the 
transcripts reviewed. During this discussion the two researchers developed a 




remaining transcripts (stage 4). The transcripts were uploaded to NVivo12 
(QSR International Pty Ltd, AU) and coded separately by DL and KS. An inter-
coder reliability was calculated and found acceptable (Bazeley and Jackson, 
2013; Saladaña, 2016), with an agreement >80% achieved for each 
overarching theme. DL and KS met to discuss coding differences and came to 
consensus. The research committee and DL met to collapse and finalize 
themes (stage 5). Data was then charted into framework matrices using 
NVivo12 to display codes within each theme (stage 6). The number of phrases 
coded within themes were summed to calculate frequencies and percentages.  
Data was interpreted, and connections related to digital competence and 
technological preferences of PwPD and their caregivers were made (stage 7). 
Although a priori themes helped to inform this framework, a phenomenological 
and iterative approach throughout each stage of the analyses was also taken 
to identify emerging themes that may impact technology use among this 
population. Both DL and KS contributed to the framework development with 
the advisement of the dissertation committee. 
Quantitative Data Collection and Analysis   
Both PwPD and caregivers completed demographics, medical history, 
dietary screening tool (Bailey et al., 2007), and digital competence (Measuring 
Digital Health Skills across the EU: EU Wide Indicators of Digital Competence, 
”European Commission, 2014) and technology use survey (“2015 Health 
Information National Trends Survey”, Kontos, Blake, Chou, & Prestin, 2014; 
National Cancer Institute, 2015; Nelson et al., 2004). The specific questions 




Questionnaires examining technology use and digital health use, combined 
with qualitative data, informed dyads’ acceptance of digital health. Questions 
related to where participants accessed health information and ease of 
obtaining health information was integrated with qualitative perception data.  
 To further describe the population, PwPD completed the 39-item  
Parkinson’s Disease Questionnaire was administered (PDQ-39, Jenkinson, 
Fitzpatrick, Peto, Greenhall, & Hyman, 1997) to asses health-related quality of 
life, and caregivers completed the Multidimensional Caregiver Strain Index 
(MCSI) to assess caregiver burden (Stull, 1996). Height and weight were 
collected, and body mass index was calculated.  
 Quantitative data was analyzed using SPSSv26 (IBM Corp. Summers, 
NY). All data were normally distributed. Categorical variables are represented 
as frequencies and percentages, and continuous variables are reported as 
mean and standard deviations. Independent sample t-tests examined 
differences between PwPD and caregivers for continuous variables. A chi-
square analysis explored differences for categorical variables. A p-value <0.05 
indicates statistical significance.   
Data Integration  
 Acceptance of digital health was analyzed by assessing current 
technology use and purpose, as well as digital health usage from 
questionnaires and through themes coded from qualitative interviews. 
Phrases/sentences related to acceptance were categorized as Accept, 
Neutral, or Reject. To calculate acceptance rate among qualitative interviews, 




totaled.  The total number of phrases coded as Accept were divided by the 
total number of phrases coded across the three acceptance categories to 
calculate acceptance rates among each dyad.  The percentages were 
averaged to calculate an Average Dyadic Acceptance Rate (n=20). Codes 
from the qualitative interviews were transformed into variables and reported as 
percent and frequencies. Side-by-side table displays of frequencies derived 
from perceptions and acceptance (qualitative data) and digital competence 
scores (quantitative data) were created and interpreted to better describe the 
population and readiness for a digital health intervention. A Pearson 
correlation was used to explore if there was an association between the 
percentage of phrases coded as Hard to Use and the Average Dyadic 
Acceptance Rate.  
Results 
Participant demographics are highlighted in Table 1. All participants 
identified as Caucasian and one PwPD identified as Hispanic. The majority of 
caregivers (85%) were spouses/partners, while two caregivers were children 
of PwPD and one was a friend; 80% of dyads lived together.  
Acceptance of Digital Health  
 All dyads had access to a laptop or desktop computer and internet 
connection at home. The majority of participants (n=17 PD and 19 CG) owned 
a smart phone and 60% (n=11 PD and 13 caregivers) owned a tablet. Five 
dyads reported owning an Alexa. One home owned an Amazon Firestick, 




regularly. Most participants (65%) did not own a smart watch (Apple Watch or 
FitBit), while 17.5% reported owning a smart watch but stopped using it and 
the remaining 17.5% were currently using a smart watch.   
 The reasons dyads used technology and the internet are provided in 
Tables 2a and 2b.  Twenty-five (62.5%) participants used the internet for at 
least five or more health related purposes such as looking for health 
information for themselves or someone else, looking for information to manage 
PD, and discussing health concerns with friends/family. Five participants 
reported not using any technology or do not use the internet for health-related 
purposes.  
There were 466 phrases/sentences coded from the interviews related to 
Acceptance of digital health and 52.1% of the phrases were coded as Accept. 
While 23.4% of phrases were coded as Neutral and 24.5% of phrases were 
coded as Reject. Phrases coded as Accept described the following: the 
various ways participants used technology in their everyday lives, how they 
used the internet to find information for managing PD, and/or participants’ 
interest in trying a form of digital health to manage health. The majority of 
participants reported going to the internet first to look up heath-related 
questions, especially for managing PD issues. Participants reported using 
digital health technologies such as patient portals, automated blood pressure 
cuffs, glucose meters, webinars, and apps to manage diet (e.g. Lose It and the 
Weight Watchers App) and track steps. Several participants reported setting 




PD02: “We’ve done the Weight Watchers app, which is very 
helpful...you can scan a product's label and it tells you how many points 
per serving” 
 
Those participants who had a high acceptance of technology reported 
how their enjoyment for using technology contributed to their desire to try 
digital health for managing nutrition and/or PD. For instance, when asked 
about what digital health products they would be interested in for managing 
food and eating, PD06 stated, “I am the type, if it is digital, I try it.”  When 
asked what makes technology and digital health useful, CG05 explained,  
“I enjoy using it, if you enjoy something you will use it, you can get all 
that information from so many resources there, I like apps” 
 
Phrases and responses to questions were coded as Neutral when 
dyads expressed moderate interest for using digital health or specific digital 
health mediums. For instance, when asked if they would like to try a certain 
digital health medium and why, some participants were only interested in 
trying the product if it would benefit their provider. Other participants were 
interested in trying some products, such as dietary applications and wearable 
devices, but predicted they would likely lose interest in these mediums over 
time. For example, when asked if interested in using a Bite Counter, a watch 
that tracks motion to count bites and estimate calories consumed, PD05 
stated:  
 “If you could tell me that the results would be useful to you, then I 





When another dyad was asked if they would be interested in taking pictures of 
meals and snacks for a nutrition professional to review, a caregiver 
responded:  
  
CG17: “If nutrition was an issue there might be a reason to do it… if the 
doctor recommended it.” 
 
Other participants said they felt they did not need certain digital health 
mediums at the moment but may want to take advantage of them in the future 
as PD progressed. For example, when asked if interested in using a wearable 
device to monitor gait changes, PD08 stated: 
 “I’m not at the place where I need that yet, I’d imagine down the road, 
maybe.” 
 
Finally, some participants discontinued their use of digital health 
mediums, such as wearable devices and dietary tracking apps. One 
participant stopped using FitBit (a wearable technology device that measures 
personal health data) due to physical limitations unrelated to PD, which 
decreased their ability to walk and no longer had many steps to track. This 
participant reflected,  
PD14: “Well when I first got my FitBit and I was kicking out 10,000 a 
day, and I kept getting all these messages about how good [I’m] 
doing…”  
 
Another participant stopped using his FitBit because it did not have enough 
technological features.  
PD12: “I just stopped using [FitBit] after a while …it didn’t have enough 
features, but I mean I did like that it kept track of how often I went up 





Phrases that were coded as Reject were typically due to certain digital 
health mediums or devices. However, some phrases coded were related to a 
rejection or skepticism of technology in general. For example, when asked if 
they were interested in using MyFitnessPal, an app to track dietary intake, one 
dyad stated:  
PD09: “I don’t think I’m at the risk of eating too much or eating the 
wrong things.” 
CG09: “I’m just not interested in knowing that much detail” 
 
When asked how they would like to receive health information, several 
participants reported preferring hardcopies of literature rather than information 
provided digitally.  
PD07: “I like reading the information, so rather than email or electronic 
form, I like to see a paper with the information on it. That way I can 
reference it any time I want.” 
 
Perceptions of Digital Health  
There were 189 phrases/sentences coded across the 20 dyadic 
interviews related to perceptions of digital health. Phrases related to 
perceptions were categorized as Perceived Usefulness, Perceived Ease of 
Use, and Awareness of Digital Health. Frequencies of phrases/sentences 
coded are summarized in Table 3. 
Perceived Usefulness. When examining dyadic data related to 
perceived usefulness, 50% of dyadic interviews mentioned digital health or 
technology as Useful. Many of these participants noted that technological 





PD06: “I think I will be able to stay driving until the day I die because of 
autonomous cars. I have no problem with it. I think we are very lucky for 
the age we are that it is happening now.” 
 
Other participants reported finding certain digital health technologies useful 
specifically for managing diet. For instance, when debating the usefulness of 
MyFitnessPal with her spouse, a caregiver stated:  
CG04: “We need to be more cognizant of the caloric intake because it 
affects how much you weigh, and if you lost 15 pounds, your core 
would be much more manageable.”  
 
Many participants, 50% (n=10PwPD, n=10caregivers) felt that it would be 
helpful to work with a nutrition professional to manage eating for PD. 
PD16: “Well I think it's always good to have access to [a dietitian] that you can 
ask questions to, but I don’t know how much they would be able to do for 
Parkinson’s.” 
 
Phrases were coded as Neutral for Perceived Usefulness when participants 
reported mixed feelings about the benefits of technology or if they were unsure 
if nutrition services could benefit PD. Supporting quotes from caregivers and 
PwPD are summarized below.  
CG17: “To me a computer is a tool… and I’m not going to sit in front of 
a screen, when I have other things to do.’’ 
 
PD10: I just type it in and whatever comes up I skim through, and some 
of it seems valuable and reliable, and some of it seems like a marketing 
scheme” 
 
Phrases that were coded as Useless when participants reported seeing little 
value or benefit from using technology. These participants may have also 
found nutrition interventions to be useless.  For example:  
PD04: “Some of [technology] is very useful but the majority of it is junk.”  
 






In addition to questions around technology, during interviews dyads were 
also asked to rate how important they felt it was to follow an eating plan for 
PD.  Forty-five percent of dyads agreed that it was important (n=10PwPD, 
n=8caregivers) to follow a healthy eating plan to manage PD, while 35% 
(n=6PwPD, n=8caregivers) reported: they were unsure, were neutral, or felt 
the question was not-applicable because they had not thought about the 
importance of healthy eating for PD.   
 
Perceived Ease of Use. When examining Perceived Ease of Use among 
participants, 70% of interviews contained phrases that were coded as Easy to 
Use, while 95% of interviews had phrases coded as Hard to Use. For those 
phrases/sentences coded as Easy to Use, participants often stated how 
technology helps them easily access health information. When asked if there 
was anything that prevents them from learning how to use a technological 
device or the internet, CG20 responded, “No, it makes life easier.”  
Participants described certain mediums as easier to use than others to access 
nutrition and health information. For instance, many found email and 
videoconferencing as an easy medium to receive nutrition information, and 
several felt that taking pictures of their meals to be reviewed by a dietitian 
would take little effortful and would be helpful.  
CG13: “I can certainly check an email easily. That’s probably the 
simplest, easiest way to get information” 
 
PD11: “I think it's easier to make an appointment, you have more 





Phrases/sentences were coded as Neutral Ease of Use when participants 
perceived digital health and technologies as neither difficult nor hard to use.  
Phases/sentences were also coded as Neutral Ease of Use when participants 
that were actively using technological devices but reported some annoyances 
or inconvenience when using the device. However, if these inconveniences did 
not deter participants from using the device or technological medium, the 
related phrase or sentence was also coded as Neutral Ease of Use. For 
instance, one participant summarized her experience with ordering her meal-
delivery subscription online:  
PD19: “[Sun Basket’s] a little bit time consuming, when [on the website], 
I feel I need time to go through it all, but I do it and it’s fine” 
 
Phrases/sentences related to accessing nutrition and health information were 
also often coded as Neutral Ease of Use. Many participants either had not 
thought to look for nutrition information specifically for PD or felt that finding 
nutrition information was easy, but interpreting this information was a 
challenge. For instance, when asked how easy or difficult is it to find 
information related to healthy eating, 55% (n=11PwPD, 11CG), said it was 
difficult or somewhat difficult. While 17.5% of participants responded neutral or 
felt the question was not applicable, with the rationale that they did not know 
nutrition was important or had not been looking for nutrition information prior to 
this study.  
CG01:”[It’s] easy to find, difficult to follow.”  




Phrases/sentences were coded as Hard to Use when participants expressed 
difficulty with using technology. Most phrases coded as Hard to Use were 
stated by the PwPD.  
PD09: “It’s [technology] become more complex I think, that bothers me 
too. I want it to be simpler like it used to be. it’s just become more 
complex and I just don’t l know how to do things now.” 
 
PD11: “… the cognitive limitations and challenges that come with 
Parkinson’s, you know you can’t always read something and 
immediately translate it into what it is you’re supposed to be doing… so 
sometimes that’s frustrating because if you don’t understand it you 
aren’t going to use it.” 
 
Some participants specifically stated understanding nutrition information could 
be a challenge and may impact their experience utilizing digital health to 
manage nutrition, 
CG12: “…I feel that nutrition is a particularly difficult topic because 
[there’s] so much conflicting information out there.” 
 
Awareness of Digital Health. Phases/sentences related to the theme 
Awareness of Digital Health were coded as Aware, Somewhat Aware and Not 
Aware. Phrases/sentences that showed dyads understood what digital health 
was, were coded as Aware. For instance, CG07 defined digital health as, 
 “I guess it would be … a broad term for categories that would have to 
do with your health and using technology to manage, look up 
information, to maintain your health, monitor your health.” 
 
 Phrases/sentences that revealed a limited understanding of digital health or 
provided an incomplete definition of digital health were coded as Neutral. For 
instance, PD04, defined digital health as, “I have no idea other than going 
online and getting some information, but I don’t see that as being a useful 




was were coded as Not Aware. For example, PD12 stated the term digital 
health “means not being married to your device continuously all day long.”  
Digital Competence.  
There was no difference in total digital competence scores among 
PwPD and caregivers, the mean score translates to about a 63.6% 
competence level (Table 1). Responses to individual questions form the digital 
competence questionnaire are summarized in Table 4; the majority of 
participants (>80%) felt comfortable finding information, reading or 
downloading news, and seeking health information. All caregivers and all but 
two PwPD felt comfortable sending emails. Most participants also felt 
comfortable buying goods online and internet banking. Participants may need 
some assistance with using social media and uploading self-created content. 
About half of the participants may need assistance with completing a videocall.  
Data Integration 
The Average Dyadic Acceptance Rate calculated from dyadic 
interviews was 54.4%. A side-by-side display of individual digital competence 
scores among PwPD and caregivers, the mean acceptance rate, and percent 
of phrases coded as Hard to Use were compared (Table 5). Overall, it appears 
that dyads with higher digital competence scores had higher acceptance rates 
for technology. However, these acceptance rates could be influenced by the 
fact that in several dyads, one person was much more comfortable using 




much higher digital competence score compared to their caregiver (62.2% v. 
17.8%), which may help explain an acceptance rate of 58% and 50% of 
phrases being coded as Hard to Use. Whereas within Dyad 05, both PwPD 
and the caregiver had high digital competence scores (91.1% and 97.8% 
respectively), and an acceptance rate of 80%. During this interview, 50% of 
phrases coded as hard to use.  There was a negative, significant association 
between the number of phrases coded as Hard to Use and the Average 
Dyadic Acceptance Rate (r=-0.522, p=0.018).  
Discussion  
This is the first study to analyze the perceptions and acceptance of 
digital health and digital competence among PwPD and their informal 
caregivers. It is also the first study aimed to obtain this data to help design a 
digital nutrition service for dyads. Findings from our study show, the majority of 
PwPD and their caregivers are currently using technology and have access to 
technological devices that can be equipped with digital health apps to facilitate 
delivery of nutrition services. Dyads find technology and digital health 
mediums useful, but hard to use. Digital competence scores and responses to 
individual questions provide insight to aspects of technology where PwPD and 
caregivers may need education and support.  Digital health may be a viable 
medium to increase access to nutrition information related to managing PD, 





Acceptance. An average dyadic acceptance rate of 54.4% calculated 
from qualitative phrases coded reveals dyads were interested in specific 
aspects of technology for assisting with managing PD and nutrition, but also 
disinterested in technological mediums where they did not see the added 
benefit. For instance, many dyads were not interested in tracking food or steps 
or using wearable devices, as they were not interested in knowing that much 
detail about their health. However, many dyads expressed interest in 
videoconferencing with a dietitian, receiving nutrition email updates or taking 
photos of their food to be reviewed by a dietitian. Participants were using 
technology to email, search the internet, pay bills, and shop online. Over 55% 
of dyads used social media and participated in videoconference and watched 
videos, indicating these tools may be viable mediums to bring nutrition into the 
home.  These findings show that a convenient, user-friendly digital health 
intervention that provides tailored nutrition information could be a way to 
improve access to care for this population.   
Findings from our study build upon previous research examining the 
acceptance of technology and digital health among PwPD and their 
caregivers.  Past research has found PwPD and caregivers are interested in 
using digital health for managing PD (Dorsey et al, 2016; Schulz et al, 2016). 
A recruitment webpage for a US-based randomized control trial utilizing virtual 
house calls for PwPD received 11,000 individual views worldwide (Dorsey et 
al, 2016). Ozanne et al (2017) found that PwPD saw the potential for wearable 




inconvenience of having to wear a sensor.  A study completed by Duroseau 
and colleagues (2016) examined acceptance among PwPD for using multiple 
electronic mediums to receive instructions and communicate with healthcare 
providers and found that older PwPD had a less favorable view of using 
technology to learn about their care plan and communicate with healthcare 
providers. Our studies expand upon previous research by specifically 
examining the acceptance of these technological mediums to receive nutrition 
information and interact with nutrition experts and includes the opinion of 
caregivers.   
Perceptions. Findings from qualitative analyses reveal that dyads 
perceive technology and digital health to be useful, but hard to use. Interviews 
revealed many of our participants, were also not aware of what the term digital 
health meant.  These perceptions expand upon previous research examining 
views of PwPD around digital health. In a study completed by Duroseau et al 
(2016), nearly 65% of PwPD reported they were willing to use electronic 
methods and 48% believed using technology to communicate with providers 
would help to better understand their care (Duroseau et al, 2016). When 
stratifying participants by age, those 65 and over were less likely to believe 
using technology to communicate with a healthcare provider would enhance 
their understanding of care; this is attributed to the fact that older patients may 
not be as comfortable with using technology (Duroseau et al, 2016).  This 




mediums among PwPD may vary based on patient demographics and that 
training older PwPD to use technology may be warranted.   
Digital Competence. Findings support the need for educational 
training of digital health mediums among PwPD and their informal caregivers 
before implementing a digital health intervention. The reported reasons dyads 
were using technology matched their responses to the individual questions on 
the digital competence questionnaire. For instance, most participants are 
comfortable with corresponding via email, searching for health information and 
services, and shopping online. However, installing new devices and using 
social networks may be problematic for some participants.  To help increase 
competence and perceived ease of use, future research could look to models 
such as Cyber Seniors®, an intergenerational program where college and high 
school students help older adults learn about technology (Rusnack & 
Cassady, 2014; Leedahl et al, 2018). Additionally, more information is needed 
about PwPD’s and caregivers’ knowledge of nutrition for managing PD and 
health literacy to ensure this population is accessing accurate and reliable 
nutrition information.  
Data Integration. There was a negative, significant association 
between the number of phrases coded as Hard to Use and the Average 
Dyadic Acceptance Rate. This relationship combined with the lack of 
awareness of digital health among dyads and how nutrition can help manage 
PD, may help explain why dyads rejected certain digital health mediums. 




the patient-caregiver dyad having a higher digital competence score than the 
other. This may account for the acceptance rate falling just above 50%. Future 
research should consider exploring ways to increase the acceptance rate 
among PwPD and caregivers, as well as educating dyads about how digital 
health can help enhance disease management. Research should also explore 
the facilitators and barriers for digital health adoption among dyads.    
Strengths and Limitations. Our study design promotes patient- and 
caregiver-centered care for managing PD and supports both as part of the 
healthcare team.  Additionally, the utilization of mixed-methods study design 
provides an in-depth understanding of dyads’ perception, acceptance and 
current level of digital competence. The use of semi-structured dyadic 
interviews is a strength, as dyadic interviews promote interaction between 
participants to help provide detailed information with regard to their experience 
on the topic of interest (Morgan, Eliot, Lowe, & Gorman, 2016). As a result, 
findings from this study can be incorporated in the TAM (Davis, Bagozzi, & 
Warshaw, 1989) and the emerging middle range theories of transition (Meleis 
et al, 2000).  
While this study is novel it is not without limitations. The majority of 
participants were educated, Caucasian and had access to technology. 
Additionally, our participants were all from the northeast region of the United 
States. As a result, findings may not be generalizable to PwPD in other 
regions of the country or from marginalized populations. Additionally, since 




participants did not fully rely on caregivers and were able to perform many 
day-to-day activities on their own. However, including caregivers early at 
disease diagnosis and encouraging caregivers to partner with healthcare 
providers can help reduce stress and family conflict (Roth, Fredman, & Haley, 
2015). Another limitation of this study is that the digital competence survey is 
not a validated tool, however items were adopted from the European Union 
Wide Indicators of Digital Competence, which is seen in the literature to create 
a digital competence framework (Görgényi Hegyes, Csapó, & Fekete Farkas, 
2017). Future research should explore validating this instrument among both 
the general population and the PD community. Additionally, similar survey 
questions around technology acceptance have been used to survey PwPD in 
previous research (Duroseau et al, 2016). A final study limitation is that 
disease stage was only obtained from some of the PwPD. Requests were sent 
to physician offices for personal health information, but we were not able to 
obtain this information for all 20 PwPD.  
Implications. Results from this study can be used to help design and 
implement an acceptable digital health service to assist PwPD and caregivers 
manage nutrition. For this service to be accepted among dyads the benefits of 
utilizing technology and healthy eating must be clearly communicated to end-
users. Training of the digital health service must be provided prior to 
implementing an intervention. Experts suggest when designing digital health 
interventions specifically for PwPD, developers should consider both PwPD 




support recommendations presented by Duroseau and colleagues (2016), who 
suggest services be tailored to meet the technological preferences of PwPD 
and exploration of these preferences through qualitative research. These 
remote services can help increase access to nutrition information among 
PwPD and caregivers and have the potential to improve health-related quality 
of life, disease and caregiver burden.  
Conclusion. This mixed-methods study focused on describing the 
acceptance and perceptions of digital health to manage nutrition for PwPD and 
their caregivers, as well as describe their level of digital competence. Results 
indicate mixed acceptance rates for technology and digital health mediums 
among dyads, possibly due to many participants perceiving digital health as 
useful, but hard to use. Digital competence scores suggest dyads participating 
in a digital health nutrition intervention will need some training prior to study 
participation. Findings from this study complement existing literature regarding 
digital health for managing PD and helps to better understand the opportunity 
to use digital health as an avenue to include nutrition and caregivers in the PD 
care plan. Future studies should explore digital health and technology as tools 
to provide evidenced-based nutrition and health knowledge to PwPD and 
caregivers. Prior to launching a digital health service to manage nutrition, 














Table 1: Participant Demographics  
 
Descriptive Variables  PwPD (n=20) Caregivers (n=20) Range 
Age (years) 69.7±9.2 66.4±13.0 39-89 
Gender n(%) 
      Male 










● HS Diploma/Some College  
● Technical Training/Trade 
School/Associates  














Employment Status n(%) 
● Retired 
● Part Time 












T-MoCA 19.8±1.5 20.4±1.1 18-22 
Years Since Diagnosis  7.6±5.4 NA 0.33-18.0 
Disease Burden (PDQ-39) 21.7±3.5 NA 3.12-50.01 
Caregiver Burden (MCSI) †  NA 12.6±8.2 0-26 
BMI (kg/m2) 27.09±5.4 28.3±5.7 15.4-43.1 
DST Scores  56.95±9.3 59.5±10.7 37-81 
Nutrition Risk n(%) 
● At Risk 
● Possible Risk 












Digital Competence  27.5±12.8 29.7±12.6 0-45 
 Data reported as n(%) for categorical variables and mean±sd for continuous variables; †n=19; 
Abbreviations: HS=high school, T-MoCA=Telephone Montreal Cognitive Assessment, BMI=body mass 













Table 2a: Distribution of Technological Purposes Among PwPD and 
Caregivers Reported in Frequencies and Percentages  





Email 18 (90) 20 (100) 
Social Media 10 (50) 12 (60) 
Videos (Youtube) 13 (65) 14 (70) 
Video Conference 11 (55) 8 (40) 
Search Internet 17 (85) 17 (85) 
E-banking/paying bills  14 (70) 17 (85) 
E-Shopping  15 (75) 16 (80) 
 
Table 2b: Description of Internet Use for managing Health Among PwPD and 






Look for health or medical information for 
yourself   15 (75) 18 (90) 0.197 
Looked for health or medical information for 
someone else  11 (55) 17 (85) 0.327 
Looked for information about managing 
Parkinson’s disease  13 (65) 14 (70) 0.053 
Participated in online forums or support 
groups for people with similar health or 
medical issue  
1 (5) 4 (20) 0.227 
Used a website to help you with your diet, 
weight or physical activity  7 (35) 8 (40) 0.052 
Looked for a healthcare provider  7 (35) 5 (25) -0.109 
Downloaded health information to a mobile 
device, such as an MP3 player, cell phone, 
tablet computer, or electronic book device  
8 (40) 4 (20) -0.218 
Shared health information on social media 
sites (Facebook, Twitter) 1 (5) 2 (10) 0.095 
Exchanged support about health concerns 
with family and friends  12 (60) 12 (60) 0.00 
Kept track of personal health information 
such as care received, test results, or 
upcoming medical appointments  
11 (55) 12 (60) 0.051 
Watched a health-related video on YouTube  10 (50) 6 (30) -0.204 
Values are reported as n(%). Chi Square Completed (looked for health info for someone else 





Table 3: Themes for Acceptance and Perception of Digital Health 
Summarized by Number of Phrases Coded, Percent of Comments, and 
Number of Dyads Mentioning Acceptance or Perception within Each Category    
    









Acceptance  466 - 20 
      Accept 243 54.4% 20 
      Neutral 109 23.4% 20 
      Reject 114 24.5% 19 
Perceived Usefulness 29 - 11 
      Useful 22 75.9% 10 
     Neutral 4 13.8% 4 
     Useless 3 10.3% 3 
Perceived Ease of Use 104 - 20 
      Easy to Use 22 21.2% 14 
     Neutral Ease of Use 12 11.5% 10 
     Hard to Use 70 67.3% 19 
Awareness of Digital Health  56 - 20 
      Aware 11 19.6% 8 
     Neutral Awareness 17 30.4% 13 

















Table 4: Those Participants Who Responded Slightly or Strongly Agree to 
Individual Digital Competence Questions Among PwPD and Caregivers 
Reported by Frequency (Percentage)  




Searching and finding information about goods and 
services 18(90) 18(90) 0.0 
Reading or downloading news/newspapers/news 
magazines 16(80) 17(85) 0.07 
Using copy/paste tools 13(65) 13(65) 0.0 
Seeking health information 17(85) 17(85) 0.0 
Sending/receiving emails 18(90) 20(100) 0.23 
Using videocalls, such as skype 11(55) 10(50) -0.05 
Participating in social networks 11(55) 12(60) 0.05 
Posting messages on social networks 9(45) 12(60) 0.15 
Uploading self-created content to any website to be 
shared 7(35) 7(35) 0.0 
Sharing talents and ideas with on social networks 6(30) 9(45) 0.16 
Sharing interests and ideas with those you know  13(65) 16(80) 0.17 
Connecting and installing new devices 12(60) 12(60) 0.0 
Internet banking 13(65) 14(70) 0.05 
Buying or ordering goods or services for private use 
(last 12 months) over the internet  16(80) 15(75) -0.06 
Making an appointment with a practitioner via a website  12(60) 14(70) 0.105 
Chi Square Analyses Completed to compare between group differences; phi co-efficient used 










Table 5: Data Integration: Side by Side Display of Digital Competence Scores 
(total scores(%)), Acceptance Rates Calculated From Semi-Structured 
Interviews 
 





Hard to Use 
(% phrases 
coded) 
Dyad 1 28 (62.2) 8 (17.8) 58.3 50.0 
Dyad 2 33 (73.3) 26  (57.8) 90.0 25.0 
Dyad 3 34 (75.6) 25 (55.6) 80 0.0 
Dyad 4 18 (40) 31 (68.9) 31.6 60.0 
Dyad 5  41 (91.1) 44 (97.8) 80.0 50.0 
Dyad 6 41 (91.1) 33 (73.3) 78.9 25.0 
Dyad 7  31 (68.9) 45 (100) 50.0 50.0 
Dyad 8  4 (8.9) 25 (55.6) 31.8 100 
Dyad 9  25 (55.6) 4 (8.9) 31.8 100 
Dyad 10  39 (86.7) 40 (88.9) 69.4 87.5 
Dyad 11 40 (88.9) 39 (86.7) 69.4 87.5 
Dyad 12  45 (100) 41(91.1) 51.7 55.6 
Dyad 13 16 (35.6) 29 (64.4) 25.0 50.0 
Dyad 14 32 (71.1) 7 (15.6) 48.1 75.0 
Dyad 15 21 (46.7) 31 (68.9) 39.3 80.0 
Dyad 16 23 (51.1) 35 (77.8) 48.4 50.0 
Dyad 17  16 (35.6) 14 (31.1) 31.8 75.0 
Dyad 18  0 (0) 42 (93.3) 44.8 83.3 
Dyad 19  19 (42.2) 39 (86.7) 57.1 100 
Dyad 20  44 (97.8) 36 (80) 69.2 66.7 
Digital Competence scores are reported for both PwPD and Caregivers and are reported as total 
score(percentage). Acceptance Rate reported which was calculated by dividing phrases coded as 
Accept by total number of phrases coded related to Accept, Neutral and Reject for each interview. 
Percent of phrases coded as hard to use in each interview were calculated by dividing phrases coded as 
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APPENDIX A: Review of the Literature  
I. What is Parkinson’s Disease  
Parkinson’s disease (PD) is an incurable, progressive 
neurodegenerative movement disorder that traditionally occurs in the second 
half of life.1 Over 900,000 Americans live with PD, approximately 60,000 new 
cases are diagnosed each year2,3, and the national economic burden of PD 
exceeds $14.4 billion.4  The life expectancy from PD onset of diagnosis to 
death is approximately 15 years.5,6 The number of people with PD (PwPD) 
living in the US is expected to double by 2030 due to the growing number of 
people over 65 and an increase in life expectancy for PwPD. As a result, 
researchers and clinicians have recently started investigating symptoms and 
clinical features of PwPD 20 years out.7  
The exact etiology of PD remains unknown but it is hypothesized to 
arise from an interaction between environmental and genetic factors resulting 
in degeneration of neurons.8 Parkinson’s disease results when there is a 
disruption of dopaminergic neurotransmission within the basal ganglia of the 
brain.9 Dopamine are neurotransmitters that control motor function and 
movement control, as well as reward-motivated beahavior.9  As a result of PD, 
dopaminergic neurons in the substantia nigra are decreased.  Within the 
residual dopaminergic neurons, Lewy bodies (deposits of alpha-synuclein) 
present.9 The basal ganglia, located in the forebrain, controls voluntary 
movement, procedural and habitual learning, eye movement, cognition and 




the mid-brain, plays a role in movement and reward.10 As PD progresses, 
problems extend beyond motor deficits and can impact nutrition, weight 
management, cognitive and physical functioning.  
The diagnosis and therefore the prevalence and incidence of PD varies 
by age, geographic location, race, and gender.11  Prevalence of PD increases 
with age, with the age of onset around 60 years old,8 and impacting 2.6% of 
Americans who are 85-89 years of age.8  Parkinson’s disease infrequently 
occurs under the age of 40 years old and early onset increases the probability 
genetics may play role.12 Rates of PD are highest in the Midwest and 
Northeast regions of the United States (US), with rates being up to 10 times 
higher than rates in the Western and Southern regions of the US.11 There is a 
higher occurrence of PD among males, with a male to female ratio of 3:2.12,13  
Whether or not PD is more prevalent among whites versus non-whites needs 
further exploration.11 Research regarding the prevalence of PD across race 
and ethnicity is consistent and inconclusive.11,14 
Parkinson’s disease can be characterized as idiopathic PD (primary 
parkinsonism) or non-idiopathic PD (secondary or atypical parkinsonism).9 It is 
estimated that up to 85% are diagnosed with idiopathic PD15 and respond well 
to dopaminergic medications. Those with non-idiopathic PD do not respond 
well to dopaminergic medications.9 Idiopathic PD can be characterized into 





Currently there is no cure for PD. Levodopa, a medication that 
produces dopamine in the central nervous system, is the most common 
medication used to control motor sequelae.17,18 Levodopa is cost-effective14 
and considered the most efficacious treatment because it improves motor 
function, quality of life (QOL), and reduces morbidity and mortality.15 An “on’’ 
state is when motor symptoms subside when levodopa is taken, and an “off 
state” is where levodopa wears off before the next dose and PD motor 
symptoms are present.  Off periods can result in functional disability and can 
be characterized by stiffness, slowness, tremor, as well as cognitive and mood 
changes.19 The negatives of levodopa treatment are: 1) causes motor-
symptoms which impact HRQOL and ability to perform activities of daily living 
(ADLs); and 2) over-time, patients build up a tolerance to levodopa and may 
require higher levodopa doses and eventually the medication loses 
effectiveness.20 
About 6.5 million informal caregivers provide substantial help for 
medical and dietary management for older adults living with disability.21 
Informal caregivers are any unpaid family member or friend who provides the 
majority of care.22  Almost 55% of caregivers for older adults assist with 
medication management23, and caregivers of PwPD likely play an integral role 
in managing food-drug interactions, given their role in managing dietary intake 
for PwPD.24 With an increase in life expectancy for PwPD but no cure for PD, 
the socioeconomic and personal burdens for PwPD and their informal 




medical spending.4,12,25 As the disease progresses, informal caregiver 
responsibility increases and caregivers will be play a central role in utilizing 
digital health to access care for their loved one with PD.26  
In general, caregivers spend 24+ hours per week caring for their loved 
one22, but caregivers of PwPD spend up to 40 hours per week performing 
care-related duties.27 Compared to the general population, caregivers for 
PwPD are more likely to have depression, anxiety, decreased health status28, 
and/or poorer QOL29, which is partly attributed to observing the physical and 
cognitive decline of their loved one with PD29.  Caregiver stress and burden 
can adversely affect caregiver’s psychosocial and physical functioning, which 
may compromise the care provided and the health of the patient-caregiver 
dyad.28,30.   Specific to neurodegenerative diseases, caregivers are confronted 
with evolving roles and responsibilities, and need to plan for the trajectory of 
PD.31 Couple-oriented interventions improve spousal coping strategies, 
minimize stress and anxiety, and increase self-efficacy to manage disease 
progression.32 
 
II. Disease Progression  
 
Parkinson’s disease-specific sequelae, conditions that result specifically 
from PD, impact motor and non-motor function. Disease sequelae can present 
20 years prior to diagnosis (Figure 1).33 Motor and non-motor sequelae can 
vary depending on the stage of PD. The Hoehn & Yahr (H&Y) scale is a five 
stage scale that  examines PD severity based primarily on ratings of motor 




2 the patient presents with bilateral symptoms. Those with stage 3 PD 
experience balance impairment but are still physically independent, while 
those in stage 4 exhibit severe disability but able to stand or walk unassisted. 
Stage 5 is the most advanced stage and the person needs a wheelchair or is 
bedridden unless assisted.  
Figure 1: “Clinical Symptoms and Time Course of Parkinson’s disease 
Progression”33  
 
The Unified Parkinson Disease Rating Scale (UPDRS) is a tool to 
monitor disease trajectory and inform treatment plans for PwPD. The rating 
scale assess motor and non-motor sequelae and consists of five sections: 1) 
Mentation, Behavior, and Mood, 2) Activities of Daily Living (ADL), 3) Motor 
Sections, 4) Modified Hoehn and Yahr Scale (H&Y), and 5) Schwab and 
England ADL scale. Higher UPDRS scores indicate more severe disability 




Older age at diagnosis and disease duration are independently 
associated with a higher prevalence of motor and non-motor sequelae that can 
result in disability.7 Due to its heterogenous and degenerative nature, research 
proposes to view PD as a complex syndrome, rather than a disease.36  As a 
result, a comprehensive clinical assessment including biomarkers to assess 
motor and non-motor symptoms of PD is warranted to better treat and 
attenuate PD progression.37  Tracking how disease sequelae impacts 
nutritional status overtime is also essential to provide adequate nutrition 
interventions.38  
a.  Motor Sequelae  
 
Motor sequelae can be caused as a result of PD or emerge as a side 
effect of PD medication.35 Levodopa-responsive motor sequelae include: 
dyskinesia (involuntary movement) and motor fluctuations including un-
predictable and sudden “off” stage, where levodopa medication suddenly 
stops working throughout the day.35 Non-levodopa-responsive motor 
symptoms include: tremors, hypomimia (poker face/lacking expression), 
rigidity, bradykinesia (slowness of movement) and hypokinesia (decreased 
movement), gait disturbances, freezing gait, balance issues, frequent falls, as 
well as dysphagia (difficulty swallowing) and speech difficulty. Decline in gait 
and balance as the disease progresses results in fall frequency.39,40 Since so 
many symptoms do not respond to levodopa treatment, the most effective 
form of medication for managing PD, an interdisciplinary care team is needed 




i. Physical Functioning  
Motor sequelae progress overtime and can compromise physical 
functioning.42,43 Resting tremor is usually the first and most visible symptom of 
PD and it  impacts one’s legs, jaw, tongue and/or hands. Up to 90% of PwPD 
experience resting tremor, joint stiffness and/or muscle rigidity44.  Resting 
tremor rarely cause disability among individuals since relief or diminution 
occurs during voluntary movement.44  Bradykinesia is one of the most 
disabling characteristics of PD, impacting up to 90% of PwPD.45 Bradykinesia 
is disabling as it cause freezing (i.e., sudden, short and transient inhibitions of 
movements) during other movements, such as walking, driving, talking, 
moving hands or writing.45 Freezing gait is one of the main risk factors for falls 
among PwPD.46 Nearly 68% of PwPD fall at least once per year47, compared 
to one third of community-dwelling adults over the age of 65.48,49 Bradykinesia 
can progress into akinesia or the inability to initiate or continue movement.50 
Akinesia can present as freezing gait (i.e., trouble initiating gait and or turning 
while walking), speech problems, and incapacity to perform smooth and rapid 
alternating finger movements.50  
Change in balance and gait lead to disability among PwPD, 
compromising ability to perform activities of daily living (ADLs), independence 
and QOL.  Balance and gait issues typically become more compromised as 
the disease progresses but can also impact physical functioning in earlier 
stages of disease. Parkinson’s disease gait is characterized by slower walking 




compared to healthy controls.51 Slowing of gait and worsening of motor 
sequelae over a time and this is a concern among PwPD as it can reduce 
functional independence, which in turn can decrease quality of life.52  
Research has also analyzed how physical functioning and ambulatory 
ability in PwPD changed overtime42,43. Cavanaugh et al42 conducted a 2-year, 
prospective longitudinal study, assessing the ambulatory decline and evolving 
components of disability among 17 PwPD and found the dose and intensity of 
ambulatory activity significantly decreased. At the same time, the daily dose of 
levodopa increased overtime.42 Findings from this study indicate natural 
ambulatory activity may be a strong indicator of physical decline, especially in 
early stages of disease51. Natural ambulatory activity is a subset of physical 
activity behaviors that entail stepping (walking, climbing stairs, mowing the 
lawn, jogging) and are used as a measurement strategy to assess physical 
activity, posture and movement.53 Findings from this support the need for 
ambulatory activity monitoring to be included in the PD plan. Research is 
needed to examine how ambulatory activity changes beyond two years.   
Another prospective, longitudinal study observed a significant decline in 
motor function and self-reported physical activity levels from year two to four in 
those living with early stage PD.43  Higher levels of physical activity among 
PwPD were significantly associated with ability to perform ADLs, slower 
progression of motor symptoms and cognitive decline.43 Physical disability and 
inability to perform ADLs can also decrease access to healthcare services that 




Finally, States et al.55 examined change in physical functioning after 
one, three and five years of attending an exercise program for PwPD.  Fifty-
nine percent of participants completed one year of the exercise program, while 
39% completed three years and 29% completed five years. Those participants 
that were categorized as consistent exercisers (PwPD who completed at least 
half of the exercise classes for at least one year) showed modest, but 
significant improvements in hand-grip strength, balance scores, and a six-
minute walk test.55 However, at years 3 and 5, no changes in these variables 
occurred,  indicating consistent exercise may help PwPD maintain their 
functional status despite living with a neurodegenerative disease. Findings 
from this study support the need for an interprofessional team to successfully 
implement a supportive community-based exercise program to support 
participation of PwPD overtime.  
Decline in mobility or ambulatory ability as PD progresses can not only 
increase risk for falls, but may also inhibit one’s ability to carry out general 
(bathing, dressing, eating, toileting, getting in and out of bed, mobility both 
inside and outside of the home56) and instrumental ADLs (laundry, preparing 
meals, shopping, banking, managing money56).57 As a result, PwPD may need 
assistance with buying, preparing, and consuming meals and snacks. 
Additionally, research has found a relationship between physical activity level 
and/or physical functioning with cognition and well-being measures such as 
QOL and depression among PwPD.58,59 Such findings support the need for an 




related QOL. However, more research is needed to understand how this 
relationship changes over the course of PD. Limited information also exists 
around the relationship between physical, cognitive, and swallowing functions, 
and their multi-faceted relationship with nutritional status in PwPD and how 
this interaction changes overtime.38   
ii. Swallow Function  
Similar to the decline in mobility, a decline in swallow function can 
hinder the ability to swallow medication60, decrease one’s ability to consume 
nutrient rich foods  and compromise nutritional status.61 Dysphagia is a 
condition where one experiences difficulty swallowing food and can occur 
anywhere between the oral cavity to the stomach;62 including difficulty initiating 
swallow and getting food stuck in the top or middle of the esophageus.62 
Oropharyngeal dysphagia, difficulty or inability to chew and mix food with 
saliva and move it to the back of the mouth with the tongue to the esophagus, 
is the most common form of dysphagia among PwPD.63  Dysphagia among 
PwPD can be caused by impaired cognitive processing, which can result in  
difficulty initiating swallowing as a resulting of hypometabolism in the 
supplementary motor area and dysfunction of the anterior cingulate cortex, 
causing impaired cognitive processing.64 It is estimated that up to 90% of 
PwPD will experience dysphagia throughout the course of their disease65, 
while prevalence of dysphagia only impacts 2-16% of the general population.66  
Symptoms of dysphagia include regurgitation, chest pain, aspiration, 




swallowing, heartburn.62,67 Regular swallow screenings are warranted among 
PwPD, rather than relying on self-reported concerns about swallowing among 
PwPD.68 
 In a cross-sectional study, Miller and colleagues68 examined the 
frequency of impaired swallowing via a 150mL timed swallow test, how 
impaired swallowing relates to disease progression and frequency of self-
reported swallowing issues among PwPD. 68 Results from this study found that 
23% of participants could not completely drink the full 150mL glass of water 
provided during the swallow evaluation and there was a moderate association 
between swallow function performance and UPDRS II (ADLs) and III (motor 
function) scores.68  Sixty-six percent of participants believed they did not have 
a swallowing problem but performed below average on the timed-swallow 
test.68  
To help manage dysphagia and reduce risk of choking, swallow 
maneuvers and exercises, postural adjustments, and modified textures (puree, 
mechanical, soft foods) and fluid consistencies (thin liquid, nectar and spoon-
thick) can be prescribed.69 For PwPD prescribed a dysphagia diet, nutrition 
guidance is needed to help meet adequate nutrition and hydration needs.70 
Caregivers may also have a significant role in helping PwPD adhere to a 
dysphagia diet, especially as the disease progresses and cognitive decline 
emerges.71 The risk of developing dysphagia coupled with nutrition risk 
present among PwPD warrants the need for ongoing nutrition and swallow 




dietitians.41   
Dysphagia can negatively impact dietary intake and increase nutrition 
risk. One study found that the majority of patients with dysphagia patients do 
not find mealtime enjoyable and 41% reported having anxiety or panic during 
meals.67 Since dysphagia can disrupt mealtime, diet quality and nutrition risk is 
a concern among PwpD.  Specifically, the amount consumed, and quality of 
the food consumed is compromised, which can impact body composition.  
Consequently, patients with dysphagia present with smaller calf and arm 
circumference, indicative of muscle wasting and under-nutrition.62 Difficulty 
swallowing among PwPD has been well-studied67, but the exact interaction 
between nutritional status and swallow functioning and how this changes 
overtime among PwPD has not been examined.  
 Matushima et al.72 conducted a cross-sectional study to assess the 
association between factors related to swallowing difficulty in 237 PwPD in 
Japan. This study also wanted to better understand behavior patterns behind 
the food types selected to cope with malnutrition and describe optimal 
characteristics of caregivers helping to manage swallowing difficulties their 
loved-one with PD is experiencing.  Findings from this study indicate severity 
of swallowing difficulties was associated with increased age and more 
advanced disease. Only 11 participants reported using care foods for 
managing dysphagia, which included home delivery meals adhering to 
dysphagia diets or a la carte pre-prepared foods designed for those with 




and none of these participants presented with a lower BMI. Dietary 
modifications to manage dysphagia, were more likely to occur when PwPD 
lived with an informal caregivers, particularly children.72 Findings indicate care 
foods may be effective in managing dysphagia and nutritional status but 
research assessing a larger sample of PwPD overtime is warranted.72 The 
issue of care foods and its impact on health-related quality of life (HRQOL) 
among PwPD is also warranted, as PwPD experience non-motor sequelae, 
such as depression and apathy.  
b. Non-Motor Sequelae  
 
Non-motor sequelae are being recognized as neglected aspects of PD, 
and effect up to 88% of PwPD.73 Non-motor sequelae include: change in 
mood (anxiety, depression, apathy), fatigue, pain, cognitive decline (dementia, 
memory, concentration attention), psychosis (hallucinations or delusions), 
excessive sweating, bladder urgency, dizziness, and/or orthostatic 
hypotension.7,74 Many non-motor sequelae among PwPD can impact dietary 
intake and nutritional status, and include: dysphagia, change in taste and 
smell, gastrointestinal issues (gastroparesis, constipation, acid reflux).61,75 
Dysphagia, while characterized as a motor symptom when assessing PD 
severity via the UPDRS is considered a mixed motor and non-motor 
symptom.74    
A cross-sectional study examining presence of non-motor symptoms 
among 89 PwPD self-reported a mean of 11 non-motor symptoms.76 Non-




with on/off states74, and are key causes of loss of independence and caregiver 
strain.77 In a prospective study, Duncan and colleagues78 evaluated impact of 
non-motor symptoms on HRQOL among newly diagnosed PwPD and found 
depression, anxiety, poor concentration, memory issues, insomnia and 
incomplete bowel emptying had the greatest impact on HRQOL.78  
Subsequently, screening and managing these non-motor symptoms should be 
prioritized early at diagnosis.78   
i. Parkinson’s Disease, Mood, and Mental Health 
 
Up to 50% of PwPD have anxiety, depression, and/or sleep 
disturbances.79,80 Apathy, depressed mood, and anhedonia (inability to feel 
pressure) are characteristics for clinical diagnosis of depression and are 
related the low levels of norepinephrine (hormone), dopamine and serotonin 
(neurotransmitters) among PwPD and associated with more severe motor 
sequelae.81  
Storch et al.74 examined the frequency and severity of nonmotor 
fluctuations among 100 PwPD, as well as the association of nonmotor and 
motor sequelae and found presence of fatigue, anxiety, depression, and pain 
is associated with poorer HRQOL independent if non-motor symptoms were 
present in the on or off state.74 Non-motor symptoms were more severe in the 
off state than the on state.74 Fatigue was the most frequently reported non-
motor symptom, impacting 88% of PwPD.74 The second most common non-
motor symptom reported was issues with concentrations/attention, reported by 




However, lack of energy may impact the ability to prepare and consume food, 
while decline in concentration can impact the way nutrition education is 
presented.  
Medication to treat psychiatric conditions can also impact well-being and 
physical functioning among PwPD.  Benzodiazepines, prescribed to treat 
anxiety, can impact cognition, alertness, and gait, and increase fall and 
fracture risk.82 However, selective serotonin reuptake inhibitors and 
norepinephrine reuptake inhibitors used to treat depressive symptoms among 
PwPD can improve depressive symptoms and freezing of gait but have little 
impact on feelings of apathy.83 Unfortunately, gastrointestinal events may be 
more common in PwPD managing depressive symptoms with SSRIs (nausea, 
diarrhea, abdominal stomach, vomiting) which can further impact dietary 
intake and quality.83   
In addition to non-motor sequelae, PwPD and their informal caregivers also 
experience stigma as a result of living with a progressive disease, which can 
further impact well-being. Maffoni et al.84 conducted a literature review of 
qualitative studies examining stigma among PwPD and caregivers and found 
stigmas included: disgrace, shame, embarrassment, feeling awkward, horrible, 
terrible or dishonorable.  Findings revealed that stigma presents as a complex, 
multi-faceted construct that is linked not only with the physical decline PwPD 
experience but also the undesirable self-image and loss of self-efficacy and 
independence that emerges from the progressive disease84;  many PwPD felt 




tasks.84 Stigma was also linked to relational and communication problems, 
where many PwPD attribute voice and articulation sequelae a contributor to 
stigma. It is important to recognize PwPD and their caregivers journey of living 
with PD to recognize their inner psychological needs to optimize care 
provided.84   
ii. Cognition, Mild Cognitive Impairment and Dementia in PD   
 
Cognitive dysfunction can occur early in diagnosis85,86, and eventually up to 
40% of PwPD present with dementia.79 Cognitive symptoms are strongly 
associated with increased economic burden and nursing home placement, as 
well as morbidity, disability, and compromised QOL for PwPD and their 
informal caregivers, increasing caregiver burden.87-89 Common cognitive 
issues that emerge among PwPD include impairments in executive function, 
working memory and attention.90 Kudlicka et al86 examined executive function 
impairment in those living with mild to moderate PD and found PwPD to more 
frequently have issues with attention control assessments than those 
assessing abstract thinking performance. Research indicates PwPD with mild 
cognitive impairment (MCI) are more likely to have issues with performing 
cognitive set-shifting tasks involved in decision making. 91 Among PwPD with 
mild cognitive impairment there is an increased presence of disability and 
physical impairment, which can impact QOL.25 Cognitive deficits among PwPD 
are predictive of the development of dementia and as a result longitudinal 
assessment and management of cognition in this population is warrant.90,92 




participants saw a significant decline in cognitive scores in both those with TD 
and PIGD.  However, findings from this study suggest, PIGD participants 
exhibited a larger magnitude of cognitive decline, particularly in the area of 
executive function and motor-cognitive skills. Despite these differences, this 
study found no difference in HRQOL or disease burden between PIGD and 
TD.92 However, future research needs to examine the longitudinal change of 
nutritional status presents as changes in cognition occur.  
In a mixed-methods study, Raein et al.88 interviewed dyads comprised of 
PwPD and their informal caregivers to determine subjective cognitive 
complaints. Findings from 22 dyads participating in focusing group identified 
subjective cognitive complaints across the following domains: memory, 
language and communication, attention and processing speed, executive 
functioning and episodic confusion/fluctuations in thinking ability.88 Dyads 
described subjective complaints that are not often objectively assessed when 
measuring cognitive status, such as fluctuations in cognitive abilities, lapses in 
prospective memory, and issues with recalling names, an issue distinct from 
an issues with general word-finding. 88 Those PwPD without dementia 
reported more subjective cognitive complaints compared to observed cognitive 
complaints reported by their informal caregiver.88 The top treatment priority 
among PwPD was related to language (recall, word finding, difficulty following 
instructions), while for informal caregivers the top treatment priority for PwPD 
were related to executive function (improving decision making abilities and a 




consider the unique aspects of cognitive decline in PwPD by examining both 
subjective and objective cognitive functions. Understanding cognitive deficits 
and self-reported cognitive concerns can help better design, develop and 
deliver effective nutrition education.  
iii. Sensory and Perception Changes  
People with PD experience sensory changes and reduced insight, which 
can impact decision making, cognition, physical functioning, swallowing ability 
and food intake. Such changes include increased saliva production, drooling, 
change in the ability to taste and smell, altered time and vision perceptions, 
deficits in perception of loudness, failure to  identity emotion and prosody, and 
inability to change or shift sets quickly.93-96 More than 50% of PwPD report 
issues with drooling97 and approximately a quarter of PwPD experience issues 
with frequent drooling97; people with PD are five times more likely to 
experience issues with drooling than healthy controls. Drooling frequency is 
associated with disease severity.97 Speech language pathologists are critical 
for the care team in helping PwPD manage drooling.  Changes in tactical 
function, thermal, nociceptive (perception or pain), and proprioceptive 
(perception of self-movement and body position) sensations also occur among 
PwPD.96     
These sensory changes among PwD are either pure disorders of 
conscious perception or disorders of sensorimotor integration (“the use of 
sensory information to guide movement”).96  Disorders of conscious 




sensorimotor integration occurs when there is an alteration in the interaction 
between sensory input and motor output.96  Despite normal cognitive 
functioning, PwPD have a decreased sensitivity to visual sensory and 
cognitive stimuli, which implies alterations to the visual cortical and subcortical 
areas, along with possible impacts on the retina.98 It is also speculated that 
dopaminergic treatments worsen sensory impairments (e.g. postural 
instability),  by disrupting the primary somatosensory cortex, found in the 
postcentral gyrus of the brain.99 As a result, how PwPD perceive situations, 
their own health status and dietary intake,  as well as process nutrition and 
health education may be impacted. Multiple modalities and repetition to 
educate PwPD may be warranted.100  
Cognitive-linguistic changes can impact QOL and day-to-day functioning of 
PwPD. While nearly 75% of PwPD experience a speech disorder at some 
stage in the disease, PwPD have an impaired perception of their own speech 
loudness as well as impaired perception of verbal emotions when interacting 
with others.94 It is proposed that altered perception of own speech loudness is 
due to the inconsistency between perceived level of effort and produced vocal 
loudness.101 Meanwhile, inability to detect verbal emotion may be due to 
compromised working memory, executive function, and acoustic 
processing.94,102  As a result, on-going monitoring cognitive status among 
PwPD is vital. This information is also important for health professionals 
providing ancillary services and education to PwPD to design and implement 




In addition to lack of insight about perceived loudness and interpretation of 
emotional parody, PwPD also can have challenges with shifting tasks and 
perception of time. 93,95 When examining the change in muscle responses 
when provided a cue to complete two different tasks, PwPD needed to perform 
the original task several additional times before switching to the new task. 95   
Those PwPD taking levodopa did not see improvements in their ability to 
change tasks quickly.95 Findings of this study should be taken into account 
when designing nutrition education and assessment programs for PwPD. 
Temporal information processing is another sensorimotor integration process 
altered among PwPD and may explain some PD symptoms, such as poor time 
perception.84 Research has found PwPD tend to underestimate time, and it is 
proposed dopamine deficit may cause a delay in the body’s internal clock. 
Distortion of time is a concern among PwPD as time perception is fundamental 
for the relationship between humans and their environment. As a result, how 
PwPD perceive their surroundings and experiences may be altered. How 
alterations of perceptions among PwPD impact nutrition assessment, dietary 
recalls and nutrition education has not been explored. Changes in perception 
also warrant the inclusion of caregivers to provide insight on the diets of their 
loved one living with PD.  
 
III. PD Management   
a. Treatment Options for Managing PD  




Dopamine Agonists. Dopamine agonists, while less effective and 
potent than levodopa,  are usually used as the initial medication for PD.9 
Compared to levodopa, they are associated with a lower risk of motor 
fluctuations and dyskinesia for the first five years of treatment.9,103  Dopamine 
agonists bind to dopamine receptors to mimic the neurotransmitter 
dopamine.104  However, overtime levodopa is usually used in conjunction with 
dopamine agonists to control advancing symptoms.9  Those on dopamine 
agonists are more likely to experience non-motor side effects compared to 
those on levodopa (Figure 2).105 Nutritional side effects of dopamine agonists 
include weight gain and compulsive behaviors, such as excessive spending 
and eating, which can impact health-related QOL among PwPD.9,61  
 
Figure 2: Incidence of adverse effects in Parkinson’s disease for trials of 
Dopamine Agonists (with and without levodopa) versus Levodopa Alone105 
 
Levodopa Containing Medications.  Levodopa is the most effective 
medication for treating PD motor sequelae, because it improves function, QOL 




converted to dopamine in the brain and is administered to increase striatal 
dopamine levels.18 It’s tolerability and efficacy was improved by combining 
levodopa with dopa-decarboxylase inhibitor  (carbidopa-levodopa).18 While 
levodopa is the gold standard for managing PD motor sequelae, overtime 
PwPD can build a tolerance to levodopa and the medication can become 
ineffective. The response time where levodopa is effective and motor sequelae 
is minimized is known as the “on” time. The “off” time is the period before the 
next levodopa dose is consumed and motor sequelae are present.  Figure 3 
highlights the change in levodopa response over the progression of PD.18,106 
Those with early stage PD seem to have a prolonged response to levodopa 
containing medication with longer “on” times and shorter “off” periods. As the 
disease progresses, the short half-life of levodopa and increase tolerance, 
medication duration of action and motor benefit wears off quicker before the 
next dose is scheduled. In advanced PD, adverse effects of levodopa, such as 
dyskinesias during the “on” time emerge and levodopa becomes ineffective. 
As a result, PwPD have to take levodopa more frequently and often at higher 
doses.18 To optimize the effectiveness of levodopa, levodopa containing 
medications are not usually prescribed in the early stages of PD and 
introduced later as motor sequelae become more pronounced. Levodopa also 
competes with absorption with neutral amino acids found in animal protein, 
and if consumed with high protein meals the medication is less effective. 
People with PD taking levodopa-containing medication are encouraged to wait 




levodopa containing medication.61 As a result, working with a Registered 
Dietitian (RD) to manage medication and nutrient timing is essential to prolong 
the effectiveness of levodopa-containing medication.41 
Figure 3: Change in Levodopa Response Over the Course of PD18,106 
 
Other Pharmacologic Treatments for PD. Anticholinergic agents and 
MAO-B Inhibitors can also be prescribed to treat PD but are less common due 
to their adverse effects or ineffectiveness. Side effects of anticholinergic 
agents include confusion, impaired memory, constipation, blurred vision, 
urinary retention, dry mouth and glaucoma.9 MAO-B Inhibitors, while produce 
less side effects, are ineffective when used alone to manage PD.  Side effects 
of MAO-B Inhibitors include insomnia, nausea, anorexia, hallucination, and 
potential interaction with medications such as selective serotonin reuptake 
inhibitors and meperidine. Many PwPD receive a combination of medications 
to manage PD which may have side-effects that impact, dietary intake, 
medication-interactions and health-related quality of life. These side-effects 
can impact adherence to medication and working closely with a neurologist, 




Pharmacologic Adherence. People with PD taking anti-parkinson 
medication often need to take a steady level of medications throughout the 
day. As PD advances medication management becomes more complex and 
PwPD may have to take anti-parkinson medication every 2-3 hours. However, 
with advanced disease, motor and cognitive deterioration may make adhering 
to such complex medication treatment too difficult for PwPD on their own, 
resulting in greater amount of time, effort and family support needed to 
manage medications regiments.107,108 In the US it is estimated that 27.3-67% 
of PwPD have poor adherence to anti-parkinson medication management.108-
111  
In an exploratory, qualitative study, Shin et al108 interviewed 16 PwPD 
and five informal caregivers to better understand challenges to anti-parkinson 
medication adherence and strategies used by PwPD and caregivers to 
overcome these challenges. Challenges among participants included 
medication responses, cost of medication, or forgetting to take medications.108  
Those who described medication response as a reason for missing doses was 
because they did not notice any difference or effects after taking their anti-
parkinson medication.108  Several participants also noted that the cost of 
medication was a burden, despite coverage from their insurance company. 
Participants also had a concern about protein and levodopa interaction, 
describing uncertainty about the time they were supposed to wait to consume 
a high protein meal after taking medication and difficulty scheduling daily 




their medication at the prescribed time because they forgot.108   Strategies 
used by PwPD and caregivers to facilitate medication adherence included 
seeking  knowledge about the medication, seeking advice from family and 
friends, using pillboxes to keep track of medications or using alarms and 
smartphones to set reminders to take their medication.108 Findings from this 
study can help inform medication adherence interventions among PwPD to 
minimize food-drug interactions and optimize medication effectiveness. In 
addition to using smart phones for medication adherence, digital health 
technologies, such as cloud technologies are being used internationally to 
promote medication safety and adherence in aged societies.112  Such findings 
advocate or exploration of how cloud technologies and digital health may 
support medication safety and adherence among PwPD.112    
ii. Deep Brain Stimulation  
Deep brain stimulation (DBS) is an established and effective treatment 
strategy for those living with advanced PD.113 This surgical procedure involve 
implanting a device that delivers small electric shocks to areas of the brain. In 
PwPD the target areas of the brain include the subthalamamic nucleus (STN) 
or the globus pallidus pars interna (GPi).113 Deep brain stimulation can 
effectively help manage motor fluctuations and dyskinesias. Findings found 
the motor benefits from DBS were sustained over 36 months and longer 
longitudinal evaluation is warranted.113  When targeting STN specifically, there 
is a significant reduction oral medication required among PwPD.113 However, 




significant extent as stimulation to the Gpi.113 Research suggests veterans 
with PD who received DBS compared to those who received usual care have 
longer survival rates.114 Stroupe and colleagues115 compared the healthcare 
utilization and costs of veterans with PD who received DBS compared to those 
who did not over five-years and found average healthcare costs for veterans 
who received DBS were $77,131 higher ($162,489 vs $85,358). However, 
when excluding costs for DBS procedures and complications, there was no 
significant difference in average total healthcare costs between veterans that 
received DBS and those who did not.115 When assessing the economic value 
of DBS, a cost benefit analyses should be taken into consideration, including 
the survival benefits of DBS.114,115   In addition to medication and surgical 
treatment for managing PD, ancillary services can help curtail disease 
progression.  
b. Ancillary Services for Managing PD  
 
Rehabilitative and complimentary medicine programs are being promoted 
to compliment pharmacological and DBS treatment.41 This includes physical 
therapy and speech therapy, occupational and exercise regiments.41 Lee 
Silverman Voice Therapy Big (LSVT BIG Therapy) consists of five tasks 
focusing on large trunk and extremity functional movements,116 and requires 
PwPD to attend four sessions per week for four weeks.117 The therapy 
improves physical functioning  among PwPD and helps manage PD related 
feelings of fatigue and depression.118 Exercise programs help prevent falls, 




perform ADL.119 Exercise programs that can benefit physical functioning and 
overall health of PwPD include: treadmill120 and resistance training121, Tai 
Chi122, dancing123, biking124 and boxing.125 
 Visits with a speech language pathologist (SLP) are also a vital part of 
the PD treatment plan, as the SLP can evaluate, diagnose and treat 
swallowing and cognitive-linguistic issues that develop among PwPD.126  The 
SLP is also vital  in prescribing appropriate modified textured and fluid 
consistencies to help reduce risk of choking and aspiration pneumonia. An 
SLP can also provide swallowing exercises to strengthen muscles related to 
swallowing and improve QOL.127 The SLP can also treat speech and voice 
disorders that emerge from PD, which include mono-pitch, reduced loudness, 
slowed and slurred speech or inaccurate articulation.128  Lee Silver Voice 
Treatment LOUD (LSVT LOUD) is an effective form of speech therapy for 
managing speech disordered related to PD.128  The treatment requires PwPD 
to attend one-on-one sessions four days a week for four weeks.128   The one-
hour sessions have been found to increase vocal loudness and functional 
communication among PwPD. Both LSVT Loud and BIG require tone ups and 
to keep up with the exercises in between the 4-week sessions.129 For PwPD to 
have added benefits of such programs, high frequency and repetition is 
needed and this can be time consuming for PwPD and their informal 
caregivers and prevent PwPD from accessing an interdisciplinary treatment 






c. The International Classification of Functioning, Disability and 
Health  
 
The International classification of Functioning, Disability and Health (ICF) is 
framework approved by the World Health Organization to describe and classify 
functioning and disability among adults and children living with health-related 
conditions.130  The ICF can be used with the International Classification of 
Disease and Related Health Problems (ICD) to provide a comprehensive 
picture of a person’s health. Health is defined by the World Health 
Organization as “the complete physical, mental and social functioning of a 
person and not merely the absence of disease.130”   With this proposed 
definition, ICF is an essential component.130 The framework can be used to in 
interprofessional practice, to promote person-centered care and to establish a 
common language across disciplines, including for those working with 
PwPD.130,131   
The ICF framework is broken down into two major components: 1. 
Functioning and Disability and 2. Contextual Factors. Figure 4 has been 
adopted to capture the major components when working with PD.130 
Functioning and disability factors include: body functions and structures, 
activity and participation.130 Body functions and structure describe the actual 
physical and psychological status of the person. While activity and 
participation describes their ability to function and participate in desired 
activities. Functional status includes mobility, communication, interpersonal 




acquisition and application.130   Contextual factors include environmental 
factors and personal factors. Environmental factors are those factors that can 
influence one’s health that are not within the person’s control (family, 
government policies, cultural beliefs and work). Personal factors (race, gender, 
age, education level and coping styles) may influence how a person manages 
their disability and activities they participate in. 130 The domains within each 
factor are highlighted in Figure 5.  











 Vojciechowski and colleagues131 completed a literature review to 
describe and quantify the development use of IFC and portray the different 
components of IFC that have been used in PD. Only four studies have 
examined the relationship between IFC and PD. Questionnaires and 
assessments administered among PwPD and their relationship between ICF 
domains are summarized in Figure 6.131 Findings from this review concluded 
more research is needed to better examine the association between the ICF 
and PD. 131  Additionally, ICF and its relationship to PD outcomes following a 
health intervention is also warranted.131 Adoption of the ICF for PD and 
understanding the relationship between ICF and PwPD outcomes, can help 
better track changes among PwPD and provide a universal language between 
the healthcare team, and promotes  PwPD and their caregivers at the center 
of the careteam.130  
Figure 6: Questionnaires and Function Tests Related to the ICF Domains and 
PD131 
 
Abbreviations: Mini-BESTest=balance, evaluation systems test; MoCA=Montreal 
cognitive assessment; GDS=geriatric depression scale; FTSST=five times sit to stand 






Components of the ICF model cover aspects of health-related QOL and 
allows for interaction between domains as a result ICF can serve as a 
predictor for health-related QOL and health status.58 The model is encouraged 
to be used by physical therapists among PwPD to guide daily functioning and 
identify specific needs.58 How ICF can be used across other help 
professionals, such as RDs, for the treatment plan of PwPD and impact 
health-related QOL needs further explanation. In a prospective, two-year 
study, Cavanaugh et al examined clinical measures associated with 
ambulatory activity decline among PwPD. The clinical measures assessed fit 
into the major domains of the ICF model (Figure 7). Findings from this study 
showed the potential to use ICF model to track long-term ambulatory function 
among PwPD. Utilization of this model assessing and tracking PD progression 
over longer periods of time is warranted.  







d. Care Model for Managing PD  
Worsening of disease sequelae overtime, combined with declining 
nutritional status negatively impact QOL132, which can further compromise 
ability to perform ADL, making PwPD more reliant on caregiver.133,134 Due to 
this increase reliance, caregivers are essential to healthcare and can partner 
with healthcare providers to more effectively implement treatment and promote 
adherence of PD treatment.70,135 Including caregivers in interventions can 
address some of the nutritional concerns PwPD face, allowing caregivers to 
help maintain the health of PwPD and their own health.41,70 Interdisciplinary 
care is recommended for managing PD, but nutritional care and inclusion of 
informal caregivers is often overlooked; Figure 8 has been modified to include 
informal caregivers and nutrition services in interdisciplinary PwPD care.136 



































In a mixed-methods study, Kessler and colleagues137 surveyed 57 
PwPD and 30 caregivers and interviewed 13 PwPD, six caregivers, and six 
healthcare providers to develop an integrated care program for managing PD.  
The development of these program advocates for a collaborative approach, 
integrating PD and caregivers as an active part of managing PD. The 
collaboration calls for self-management, support and communication with and 
between healthcare providers. To create this tertiary PD clinic, co-design was 
utilized, which included viewpoints of key stakeholders, including PwPD and 
caregivers. Promoting self-management of care provides PD dyads with the 
skills and confidence needed to manage a chronic health condition on a day to 
day basis. People with PD and caregivers wanted more support with goal-
setting to promote self-management, follow up with healthcare providers and 
access to services to better manage PD. Both PwPD and caregivers 
expressed satisfaction when they were able to make decisions collaboratively 
with their health care providers. Findings from this study should be considered 
when designing healthcare services for PD dyads to promote access to 
comprehensive care.   
 
e. Resource Availability  
 
Since many PwPD have limited access to healthcare due to disease 
sequelae, age and location138,139, an improved model to address healthcare 
access and need is critical.138,139  People with PD experience cognitive and 
physical decline that can impact mobility and driving ability, which in turn can 




if there is a higher occurrence of PD among rural vs urban populations, 
research has found a link between occupational exposures and increased 
incidence of PD. These occupations that appear to have an increased 
occurrence of PD include agriculture, working with pesticides, and heavy 
metals.140 Those PwPD living in rural areas are especially at increased risk for 
inadequate access to treatment.  
 According to the current interdisciplinary care model, PwPD should see a 
neurologist 2-4 times a year141, and physical therapists and speech language 
pathologists up to 4 times a week for certain treatments.54,142 This can be 
burdensome for PwPD and their caregivers, due to limited access to 
transportation and compromised physical mobility. 50 Up to 40% of Medicare 
beneficiaries with PD do not seek care from a neurologist within the first four 
years after diagnosis.138  Additionally, while physical and speech therapies 
exist to help manage PD sequelae, there are no recommendations for routine 
appointments with allied health professionals, including speech-language 
pathologists, physical and occupational therapists, exercise physiologists 
and/or registered dietitians (RDs).41 Monitoring how PwPD change across the 
domains of nutrition, cognitive-linguistic and physical functioning can help 
better understand health needs of PwPD.38 Inclusion of allied health 
professionals can help attenuate burden of disease sequelae, improve QOL 
and may lower healthcare costs.143  
Due to limited mobility, visuospatial impairment, decreased access to 




are excellent candidates for digital health.26,139  However, nutritional services 
via digital health are not utilized in this population and the individualized 
nutrition care needed by PwPD is also an under-recognized component of 
care.144 Monitoring the nutritional status of PwPD and caregivers can help 
better understand nutritional needs and provide effective digital health nutrition 
services. Tracking how PwPD change overtime can also help monitor and 
track treatment efficacy provided across disciplines and further promote 
interprofessional practice to manage PD.   
I. Theoretical Framework:  Technology Acceptance Model  
 
Obtaining PwPD preferences and opinions regarding features of 
technology to manage health can help to inform the creation of a user-friendly, 
evidenced-based digital health service.145 Formative analysis has been used 
to effectively employ digital health technologies for older adults146,147, and in 
the development of dyadic interventions for PwPD.148 Understanding PD 
dyads preferences for technology to manage and track nutrition health can be 
incorporated into the technology acceptance model (TAM).149   
 The TAM was created to explain computer usage behavior across a 
broad range of  user populations and end-user technologies.149 The model 
seeks to provide a basis for understanding external factors that influence 
internal beliefs, attitudes and intentions to use technology (Figure 9).149    
External factors can directly impact perceived usefulness and perceived ease 
of use related to various computing technologies. The model hypothesizes that 




which can influence intention to use and actual behavior use of technology.149 
The TAM has also been modified to specifically examine technology 
acceptance among older adults, known as the Senior Technology Acceptance 
Model (STAM). The external factors STAM examines specifically relate to 
aging populations that may impact technology use and attitudes toward 
technology.150  These external factors include: self-efficacy to learn 
technology, anxiety toward technology, facilitating conditions, self-reported 
health conditions, cognitive ability, social relationships, attitude to life and 
satisfaction and physical functioning.150 External factors that impact PD dyads 
to use technology are important to understand to ensure usability and 
utilization of digital health for managing PD.150  As a result,  including PwPD 
and caregivers in the formative stages of research can facilitate the creation of 
user-friendly digital health nutrition services.145 
 










II. Digital Health  
 
 
A. Overview of Digital Health  
 
Improvement in the current healthcare model for PwPD is needed to 
effectively meet patient needs.54,138 Digital health describes technologies that 
better manage and track health.151  Additionally, as technology adoption 
increases, eight in ten (113 million internet users) seek health information 
online.152 Specifically, 64% of adults living with one or more chronic diseases 
seek health information from online sources.153 Most US adults (77%) report 
owning a smart phone device.154  Recent efforts have been made to develop 
and use digital health to assess, monitor, and provide therapeutic treatments 
for PwPD.26,155 Such efforts can increase access to care and promote 
efficiencies in providing care.156  
More than 40% of PwPD are over the age of 65, and most PwPD living 
in rural areas will not see a neurologist after diagnosis.138 Forty-percent of 
Medicare beneficiaries with PD do not seek care from a neurologist within the 
first four years after diagnosis.138  In addition to visits with neurologists 2-4 
times per year141, multidisciplinary care models, including visits with physical 
therapists and speech language pathologists, are encouraged and 
effective.157,158 Some of these treatments require sessions four times per 
week142 which can be a challenge for those with limited access to 
transportation and compromised physical mobility, thus becoming burdensome 
for PwPD and caregivers.54 Disease stage is associated with driving safety, 




to immobility, limited means of transportation, and ongoing multidisciplinary 
care, PwPD are excellent candidates for digital health.139  
Digital health serves as a gateway to efficacious and convenient health 
information and treatment.156 Digital health increases access to health 
services, decreases healthcare inefficiencies, offers more personalized 
services, and reduces burden and medical costs for those living with 
neurological disorders, including PD.156  Technological advancements such as 
cloud computing, sensors/wearable devices, mobile and video 
communications160,161, and social networks151 increase access and quality of 
care for PwPD.26  
In addition to usability and increasing access to care, digital health 
adoption can help minimize healthcare costs. In 2012, the Veterans Health 
Administration served 150,000+ telehealth beneficiaries, and estimated an 
annual savings of $6,500 per user; a billion dollar savings system-wide.162  
People with PD that have utilized digital health services have saved on miles 
traveled and commute time to healthcare providers.156 Specifically, PwPD 
saved 100 miles of travel and three hours of time compared to in person visits. 
156  Patients and clients are interested in utilizing digital health, and high 
patient satisfaction is reported by those PwPD who have utilized digital 
health.156,163 
A. PwPD Viewpoints on Digital Health  
Interests and opinions of digital health among PwPD and their 




randomized control trial utilizing virtual house calls for PwPD received 11,000 
individual views worldwide.164 Caregivers are also receptive and willing to pay 
for technologies that monitor and support care recipients.165 Specifically, 20% 
of informal caregivers were willing to pay for kitchen (e.g., technologies that 
assist with meal preparation and washing dishes)  and self-care activities (e.g., 
technology to help the care recipient getting in and out of bed, dressing, 
eating, bathing, or toileting).165  Of those caregivers willing to pay for such 
technologies, these caregivers reported willingness to pay 50 dollars per 
month for monitoring technologies and 70 dollars per month for technologies 
that both monitor and provide assistance to the care recipient.165  Findings 
indicate that a combination of private pay and government subsidy may 
promote development and adoption of these technologies among informal 
caregivers.165   Experts suggest when designing digital health interventions 
specifically for PwPD, designed and developers should consider caregiver 
views, needs and preferences.166   
A large cohort study measured the proportion of PwPD interested in 
telehealth (i.e., interactive videoconferencing with a healthcare provider) and 
identified predictors of patient interest to use telehealth. Among PwPD who 
currently use telehealth services, 85% chose to continue utilizing the 
service.167 The five patients who discontinued telehealth were treated with 
deep brain simulation (DBS), who required trained professional to be present 
during the visit due too the lack of training/experience of the nurse/technician 




Approximately 65% of participants who continued to use telehealth reported 
they wanted a combination of in person and remote services.167  Of those 
PwPD who had never used telehealth before, 53% were interested in using 
the services, believing utilization of the service could result in significant cost 
savings.167  Others interested in telehealth were in the early stages of PD and 
believed physical examinations by a physician were not necessary at every 
appointment, so telehealth could serve as check-ins with their physician.167  
In contrast to these findings summarized above, a cross-sectional 
survey assessing PwPD views on using different electronic mediums for 
communicating and exchanging information with healthcare providers, found 
PwPD may have a less favorable views around technology for communicating 
with health providers.168  Nearly 65% of PwPD reported they would be willing 
to use electronic methods and 48% indicated that using technology to 
communicate with providers would help PwPD better understand their care. 
People with PD were asked which forms of technology would help with care. 
Of the modalities suggested, ~15% supported electronic forms at check-in for 
medical visits and 40% stated they would like a summary of care/home 
instructions emailed to them. Of the participants surveyed, ~35% noted they 
would like the ability to communicate with healthcare providers through email 
and 33% indicated they would like video education about services offered to 
PwPD.168 When stratifying participants by age, those over 65 and over were 
less likely to believe using technology to communicate with a health provider 




had a lower odds of being willing to use electronic methods and believing that 
technology would result in better understanding of medical needs or their 
healthcare providers better understanding their medical needs.168  Findings 
from this study indicate optimal communication mediums among PwPD may 
vary on patient demographics and that training older PwPD to use technology 
may be warranted. Qualitative interviews are needed to better understand 
technology choices and preferences of PwPD.  Additionally, research that has 
implemented digital technology among PwPD shows implementation can be 
advantageous to PwPD and their informal caregivers, including reduced 
burden and timed saved, which further promotes digital health as a efficacious 
medium for delivering healthcare services.169  
B. Efficacy of Digital Heath for Managing Parkinson’s  
Digital health, such as telemedicine, has been used successfully in a 
variety of populations that have evaluated usability (Figure 10).170 A review of 
138 studies was conducted, eight included end-users with neurodegenerative 
diseases, including PD.170 People with PD have used telehealth for visits with 
specialty physicians and multidisciplinary care providers, such as physical 
therapy, speech therapy and mental healthcare.142,156 Digital health mediums 
used for managing PD include wearable devices171, telehealth142,163, and 
online communities.172  Telehealth, or interactive videoconferencing, provide 
healthcare providers visual cues of patients, which makes the visit more 
objective139,173. Wearable devices collect continuous data to provide a more 




unlike subjective data or cross-sectional assessments.171,174 Telehealth can 
also provide social support and reduce burden and cost for PwPD and 
caregivers.175,176  For example, speech therapy for PwPD via telehealth saved 
each caregiver 48 actual hours involved in a speech therapy visit, 92 hours of 
work time (time taken off from work), and over $1000.169  In addition to 
economic benefits and reduced participation burden, telehealth increases 
access to health information, provides effective quality of care, and influences 
individuals to make healthy lifestyle choices.177,178 Telehealth is believed to 
motivate patients to increase access to care, achieve greater control over 
disease management, and serves as an effective medium for healthcare 
management in older adults.179-181 
Figure 10: Medical conditions and telemedicine170   
 
  
Online communities are another form of digital health may empower PwPD 
to be more active participants in their own care.172  Online health communities 
are a form of communication technology that allow patients to interact with 




caregivers. These communities also allow patients to track their health 
information and become involved in research.182  
1. Telehealth  
There have been successful telehealth interventions in PwPD across 
various disciplines.  Dorsey et al.156  conducted a 7-month, trial in which PwPD 
were randomly assigned to receive specialty care from a neurologist in-person 
or home via telehealth and found telehealth to be as effective as in person-
care. Study findings indicate feasibility of telehealth for specialty visits, with a 
93% completion rate of visits.156 Constantinescu et al.142 conducted an 
intervention where PwPD were randomized to receive voice treatment therapy 
via videoconference or in person and found that both groups saw an increase 
in acoustic measures and reported high patient satisfaction. Findings from this 
study confirmed the efficacy, validity and reliability of videoconference for 
voice treatment.142 Additionally, there was no difference between quality of life 
scores and motor scores between groups.156 Another randomized trial found 
telerehabilitation could effectively assess ADLs and hand function compared 
to an in-person assessment.183 Whether a comprehensive nutrition 
assessment can also be conducted via telemedicine has yet to be explored.  
Two studies support using telemedicine as part of patient care but not 
in place of in-person care. Sekimoto et al.184 conducted a randomized 
crossover pilot study of telemedicine via iPads using Facetime. During the 
telemedicine visit, clinicians performed perform a structured interview, 




Findings from this study indicate telemedicine service could be used in 
conjunction with in-person visits, as no difference in quality of life was reported 
between groups and PwPD in the telemedicine group reported high 
satisfaction. Finally, Wilkinson et al.163 examined if telehealth delivered in the 
home and at a satellite clinic compared to those receiving usual-care and 
found no difference in patient satisfaction or clinical outcomes between 
groups. Those in the telehealth group saw a significant decrease in travel time, 
but compared to the usual-care groups the satellite arm had significantly lower 
proportion of “no-shows’’/cancellations.163 Findings reiterate telehealth can 
enhance usual care health services and can benefit patients who face barriers 
to receive in-person care regularly.185 
2. Devices, Wearables, & Sensors  
Over the last decade, advancements in sensors and wearable 
technologies have been made, allowing these innovative mediums to gain 
popularity to complete and compliment evaluations of PwPD.186 Devices such 
as Kinesia™ and Parkinson’s KinetiGraph (PKG™) can help detect 
bradykinesia, record resting and postural tremors, and differentiate patterns of 
bradykinesia and dyskinesia  in the “on” and “off states.”186 Other wearables, 
such as accelerometers, gyroscopes (device used for measuring or 
maintaining orientation and angular velocity), and magnetometers (a non-
invasive device that monitors heat function), can be integrated in garments or 
accessories.187  These accessories can also be used in conjunction with web-




People with PD report added value of wearable devices. Ozanne et 
al.187 conducted focus groups among PwPD and found that participants saw 
the potential for wearable sensors to improve treatment, and believed the 
benefits outweighed the inconvenience of wearing sensors. When examining 
facilitators and barriers to utilizing sensors, participants indicated that user-
friendly and a simple design interface would promote usability, as well as  
receiving interactive information from providers.187  However, participants were 
concerned about unclear information, inconclusive recordings and  had 
concerns about protecting personal health information and integrity. In order to 
encourage use of sensors, findings indicate PwPD need to feel well-informed 
and find added value when using sensors.187 Wearables also need to be easy 
to use, have an attractive design and be efficacious for improving disease 
management.187  Findings further support the use of digital health to help 
manage track Parkinson’s disease.  
Devices, such as smart phones or iPads are becoming popular 
mediums to deliver health services to PwPD. mHealth, or “the use of mobile 
and wireless devices to improve health outcomes, healthcare services and 
research,” has been effectively used in PD management. One study found 
peer coaching through mHealth can promote physical activity among PwPD 
and is safe, feasible and acceptable among participants.188  Both peer 
coaches and PwPD were satisfied or very satisfied with the program and all 
PwPD participating saw an increase average steps per day.188 These findings 




to increase physical activity and promote other healthy lifestyle patterns 
among PwPD. In a pilot study, Arrora and colleagues189 demonstrated the 
ability of consumer-grade smart phones to accurately differentiate PwPD from 
age-matched controls through effectively measuring symptoms. Findings from 
this study reveal the potential for mHealth to evaluate disease severity.189   
The integration of wearable technology with smart devices can enable 
remote monitoring of PwPD and provide clinicians, caregivers and patients 
with real-time feedback.26  Patel et al.190 found that combining wearable 
sensors with a web-based application for home monitoring PwPD can provide 
reliable quantitative information that can inform clinical decisions.  The system 
these researchers developed includes 8 accelerometers on the upper and 
lower limbs which is relayed to a mobile device or computer. The system 
promotes patient-clinician interaction through video-conferencing or real time 
access to the sensor data. 190 The proposed system can successfully gather 
data from PwPD to inform symptom severity and motor fluctuations in between 
medication doses. Findings from this work indicate that this home monitoring 
system has the potential to simplify the process of monitoring medication 
effectiveness.190  
3. Online Health Communities  
Online support groups via forums, blogs and social media are becoming 
popular sources for health information.191  Over 50% of American adults living 
with a chronic disease have looked online for health information.192  It is 




communities and that 43% of internet users are involved in online groups to 
help manage career, medical conditions or parenting.152  Approximately, 12%  
internet using adults with one or more  chronic health conditions (e.g., cancer, 
fibromyalgia, non-specified chronic pain conditions, diabetes, Addison’s 
disease, bipolar disorder, celiac disease, trigeminal neuralgia, Parkinson’s 
disease, systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjögren’s 
syndrome, schizophrenia, cystic fibrosis, and  cerebral palsy) maintain a blog 
and 28% read blogs about their condition written by others (Figure 11).192 A 
2019 report examining social media use among Americans revealed 68% of 
Americans between 50-64 years of age, and 46% 65+ report using 
Facebook.193   






Online discussion forums are one of the most popular ways people 
interact with each other online. In a discussion forum, one person writes a 
message/post that can be answered by other members, which forms a 
conversation thread.194 Attard et al.191 examined positive and negative aspects 
of online PD supports groups through analyzing forum posts from four different 
support groups; membership within each group ranging from 1000 to 100,000. 
Benefits of peer communication appeared to be: exchange of knowledge 
between participants, formation of friendships and the development of support 
systems to cope with living with PD. The results revealed that participation in 
forums allowed patients to share experiences and knowledge, form friendships 
and help each other cope with the challenges of living with PD.191 
While less frequently reported, there were some drawbacks to 
participating in online, peer-to-peer communication through forum posts.191 
First, there are a lack of replies or lag time in between replies,191 which can 
hinder the experience.   Findings revealed that tremors and cognitive 
impairments can hinder engagement in forum posting among PwPD. For 
instance, tremors would hinder one’s their ability to answer posts when 
desired.191 Another barrier of online forum posting is that many PwPD did not 
want share personal information, as a result personal connections could not 
be formed between participants.  For some participants, online support was 
not enough, and they felt lonely in their offline environment. Finally, 
misunderstanding and disagreements occurred on the forums due to lack of 




offer PwPD emotional support and foster knowledge but should be used 
alongside  traditional forms of support.191 Additionally, health professionals 
should partake in these online support groups through monitoring or facilitating 
posts to ensure the accuracy of information exchanged.191 Health 
professionals may also help guide PwPD using such online communities to 
reputable websites and publications.191 Roles of healthcare professionals in 
online communities is becoming especially important with the rise of online 
blogs.  
Illness blogs are a type of online blog, where patients freely describe 
their experience managing their condition overtime.195  Readers have an 
opportunity to respond to blog posts, and as readers become more involved in 
the blog, a community is created.195 Shapira and colleagues195 completed a 
thematic analysis of 78 illness blog authors with PD to explore medical illness 
concerns blog authors had and found these authors typically discussed 
diagnosis and symptoms, treatment, coping mechanisms and providing 
information to their readers about PD. Treatments discussed included: 
medication, exercise, supplements, nutrition, complimentary therapies and 
surgeries. Only three authors blogged about nutritional modifications for PD, 
which included experimenting with diets to optimize medication management, 
trying vegan diets, fasting, and lowering sugar and protein intake.195 The 
reason that so few PwPD discussed diet in blog posts could be because 
nutrition is often excluded from the PD care plan.41 However, findings from this 




health concerns and medical and nutrition issues raised by PwPD online and 
in a non-medical setting.195  
Personal online health communities have also been developed to 
promote online communication between PwPD and their healthcare 
providers.172  Visser et al.172 conducted semi-structured interviews and 
observed the use of online health communities among PwPD for over a year. 
Patients could communicate with their provider through diary entries or virtual 
meetings/postings. Providers did not receive notifications when the PwPD 
posted a diary entry but did with the virtual meeting post. Participants could 
also update a stored list of health problems and upload health documents. 
 Three major themes that emerged from these analyses were: “number 
of postings,” “coming across as a complainer,” and “hesitating about legitimacy 
of knowledge.” In regard to “the number of postings,” many PwPD expressed 
concerns about burdening their healthcare providers with too many questions 
and limited their number of postings to only concerns that needed immediate 
attention from their provider. However, PwPD found the diary section of the 
online health community to be less disruptive to healthcare providers and 
shared more information in their section of the community.172  The PwPD also 
felt obligated to report and update symptoms, but did not want to come across 
as a complainer, so refrained from expressing emotions or feelings regarding 
PD sequelae.172  The use of online communities can change the power-
dynamics between the provider and PwPD, especially when the provider can 




symptoms from the PwPD.172  Many PwPD believed the provider still 
possessed the greatest amount expertise about their condition, despite the 
change in delivery of care.172   As a result, PwPD presented their knowledge 
and interpretation of their symptoms as an opinion and were hesitant to make 
claims about their condition.  
Findings from this study reveal even though online communities are 
innovative mediums to deliver healthcare services they have not met the 
expectation of creating more pro-active patients or changing the power 
processes between provider and patient and pre-existing norms regarding 
patient-provider dynamics persist. Future health communities need to focus on 
creating a two-way exchange between provider and patient, where healthcare 
providers share additional resources for managing PD to help PwPD gain 
more knowledge about the disease.  More research also needs to assess 
digital health to manage the nutritional status and diet intake for PwPD or their 
caregivers. This is because PwPD are likely at nutrition risk and as nutrition 
concerns increase as PD progresses, caregiver responsibility to manage diet 
increases, but nutrition is often excluded from the treatment plan of managing 
PD.41  
A. Efficacy of Digital Health for Managing Nutrition  
Research has not directly examined the use of digital health for 
managing nutrition and PD, but success with digital health for PD, as well as 
digital health’s ability to help manage nutrition in other populations196,197, 




health services can increase fruit and vegetable consumption196,197, decrease 
fat intake198, self-efficacy to make healthy dietary choices197, and promote 
sustainable dietary changes.198 Tailored digital nutrition interventions 
addressing participants’ environment and learning preferences improved diet 
quality more than providing generic nutrition information through online 
modules (n=1349).199  
Mobile devices can help track dietary intake.200,201 Using mobile 
applications (e.g., Lose It! and MyFitnessPal) to track food intake can provide 
instant feedback about all calories and nutrients consumed. Dietary self-
monitoring however takes time and effort and technological advances such as 
Remote Food Photography Method are being developed to improve the ease 
of self-tracking dietary intake.200 Through the Remote Food Photography 
Method users submit photos pre and after consuming food to researchers and 
researchers perform semiautomatic computer analysis to determine the 
nutritional value of those foods.200 Neriah and Gelibeter201 conducted a 
retrospective cohort study to determine the effectiveness of using photography 
to track food intake via a smartphone weight loss application. Compared to the 
traditional weight loss app group the group with the photography feature lost 
significantly more weight and tracked their food for a longer duration. Weight 
loss in the photography group was mediated by the duration of app use and 
number of logged days in the program.  
Telenutrition is another solution for PwPD and can help to increase 




delivery of medical nutrition therapy (MNT) by a registered dietitian using 
interactive electronic information and telecommunication technology (e.g. 
videoconferencing).202  A randomized controlled trial assessing the feasibility 
of telenutrition weight loss intervention in middle-aged and older men with 
cardiovascular risk factors, found telenutrition services demonstrated patient 
satisfaction as well as good adherence and retention rates.203  During this 12-
week intervention, men were randomized to either the intervention group  or 
enhanced usual care group. The intervention group received three medical 
nutrition therapy sessions from a registered dietitian at week one, five, and 
nine to nine nutrition coaching sessions at weeks 2-4, 6-8 and 10-12.203 The 
MNT sessions included individualized nutrition assessment, education and 
counseling sessions. The coaching sessions were patient-led discussions 
around topics such as, self-monitoring weekly weight, goal setting, and 
overcoming barriers to dietary adherence. The enhanced usual care group did 
not receive nutrition coaching in between their in-person sessions at weeks 
one, six and 12.203  
Both groups lost a significant amount of weight and there was no 
difference in the amount of weight loss in between groups. Both groups saw 
an improvement in total fruit (p=0.05), whole grains (p=0.004), and fatty acid 
ratio scores (p=0.002). Participants lowered refined grain (p=0.04), sodium 
(p=0.01), added sugars (p=0.01) and saturated fat scores (p=0.002) healthy 
eating index (HEI) component scores. However, the intervention groups saw a 




beans (p=0.013). Findings from this study show promise for PwPD, as there is 
a higher occurrence of PD among men than women.12,13 More information is 
also needed to determine how digital health nutrition interventions may impact 
caregivers and reduce caregiver burden, as caregivers are involved in 
managing dietary intake for PwPD.24  
B. Efficacy of Digital Health for Informal Caregivers  
Technology, including digital health can support caregivers and 
promote better coping.204 More than 30 million US adults provide home 
caregiving and approximately 80% of these caregivers seek health information 
online.205,206 Caregivers believe that technology can help provide more 
efficient, effective and safer care and reduce stress when delivering care.204 
Nearly 75% of caregivers stated they would be willing to pay for access to a 
website for a complex care matter and 85% believe insurance should pay for 
access to such websites.207  While digital health has been used to manage 
chronic disease more information is needed to understand the impact of 
telehealth interventions can have on informal caregivers and how digital health 
can offer support and address informal caregivers’ health needs.204  
Chi and Demiris204 conducted a systematic review assessing of 65 
studies that included informal caregivers and utilized digital health 
technologies to provide education, consultations, psychosocial therapy, social 
support, data collection and monitoring systems, or deliver clinical services.  
The most common medium used by studies reviewed was videoconferencing.  




outcomes, such as psychological health, satisfaction and comfort with digital 
health, caregiving knowledge and skill, and social support.204  Nearly a quarter 
of the studies reviewed, were conducted among caregivers living in remote or 
rural areas and brought significant improvements in caregivers’ QOL and 
psychological well-being. Findings from this review conclude telehealth can 
provide acceptable care and save travel costs for caregivers of patients who 
need long-term care and monitoring, such as PwPD.204 
Several studies have specifically examined digital health interventions 
delivered for caregivers of PwPD.176,208 These studies specifically looked at 
virtual support groups and their impact on coping with caregiving 
responsibilities, disease burden and QOL.176,208  In a study conducted by 
Marziali et al.208, caregivers of persons with Alzheimer’s, Stroke or PD met 
weekly for 10 weeks via videoconference in small groups lead by a support 
group leader. At the end of 10 weeks and six-month follow up, 90% of 
participants reported a positive experience and found the group helped with 
coping with the stresses of caregiving.  Findings revealed virtual support 
groups were comparable to in-person groups. In a small pilot study, caregiver 
tele-support groups was a feasible option and showed promise to potentially 
improve depression scores and decrease caregiver burden.176 Whether 
nutrition assessment and nutrition interventions can also be delivered to 
caregivers of PwPD warrants exploration.   
 




Poor nutritional status is an imbalance of energy and/or nutrient intake, 
resulting in suboptimal body weight and composition, function, and/or clinical 
outcomes, which can eventually lead to malnutrition in the forms of over- and 
under- nnutrition.209,210 Assessing the nutritional status of PwPD includes the 
traditional examination of dietary intake, anthropometrics, and biochemical and 
clinical measures,209,210 as well as a focus on possible food-drug interactions, 
duration of medications and history of depression and anxiety.70 A cross-
sectional study, examining nutritional intake of PwPD for nutritional and protein 
risk, found that nearly 63% of PwPD would be categorized as with malnutrition 
or at risk for malnutrition, ~53% exhibited weight loss in the last three months 
but presented with elevated waist circumference.211 
A. Dietary Intake and Diet Quality 
 
Disease sequalae, physiological factors and treatments for PD can 
compromise dietary intake and quality.61  Disease stage and side -effects from 
medication or surgery can impact dietary choices by impacting appetite and 
the ability to consume food.212 Other factors that related to PD that can impact 
dietary choices include:  nausea, delayed gastric motility, dehydration, 
constipation, change in taste and smell, and dysphagia.61   Complaints relate 
to change in taste and smell are among the most frequently reported from 
PwPD. One study found 26% of PwPD complained of taste/smell issues, 
compared to only 7% of controls.213 How change in taste and smell impact 




decline and depression, common among PwPD, can also compromise food 
intake by impacting mealtime and appetite214  
Dysphagia can also impact mealtime and the amount consumed as it 
results in change in dietary choices and avoidance of certain foods, which can 
impact weight status. Those with dysphagia are more likely to experience 
unintentional weight loss, especially PwPD avoiding solid foods due to 
swallowing issues.214  A longitudinal prospective study, examining dietary 
intake, weight, and swallow function among, found that PwPD with weight loss 
were more likely to avoid solid foods due to swallowing difficulties compared to 
controls.214   Those PwPD who experienced weight loss also consumed less 
vegetables, fresh fruit, meat on sandwiches and drinks without energy at the 
first evaluation.214 However, whether this weight loss was associated with 
swallowing difficulties was not  explored. Avoidance of solid food and fluid can 
result in nutritional imbalances and hydration. Variability in weight and 
nutritional status is a concern because it can impact diet quality as well as 
physical functioning, which can lead to muscle wasting and difficulties in 
performing ADL.215  
Though low dietary quality scores are associated with chronic disease 
such as cardiovascular disease216, few studies have examined diet quality and 
intake in PwPD.  LoBuono et al.38 found low dietary quality scores among a 
small cohort of PwPD. Cassani and colleagues217, further examined dietary 
intake among PwPD and healthy controls, specifically regarding the 




vegetables, cereals and baked items, as well as more sweets and 
dressings.217 Those with PD also consumed less fish and alcohol and drank 
significantly less water, coffee or milk, 217 and as a result, consumed 
significantly less fluid overall.217 Overall PwPD had higher intake of calories, 
iron, zinc, folate, and vitamins A ,and  C, however PwPD  also had significantly 
lower BMIs compared to controls (26.2±4.9 vs. 28.5±6.4 kg/m2, p<0.001).217 
Dysphagia was self-reported among 12% which resulted in a significant 
decrease in fluid intake and preference for more vicious foods, but did not 
impact adherence to the Mediterranean Diet. There are two major areas of 
significance with these findings. First, the difference in dietary intake between 
PwPD nad control warrants a similar exploration between PwPD and their 
informal caregivers. Also, a prospective, longitudinal examination of how 
dietary intake and quality relate to disease progression.217   
Protein intake among PwPD is also a concern for those taking 
levodopa. Dietary protein and levodopa compete for absorption and transport 
across the gut, blood-brain barrier, and peripheral nervous system.218  It is 
advised to wait 30 to 60 minutes between taking levodopa and eating a high 
protein meal.211  Participants taking levodopa exceeded daily protein 
recommendations, consuming 1.4±0.6 per day, rather than the 0.8 
grams/kg/day. 211 Seventy-five percent of PwPD ingested levodopa with 
food.211  Findings highlight the need for nutrition education on protein timing 






B. Impact on Weight and Body Composition 
 
Weight and nutritional status in PwPD varies during disease progression 
(Figure 12)61 and can adversely affect body composition, cognitive and 
physical functioning144,214,219, QOL and health outcomes.220 A decade before 
diagnosis, an average 5.2 pound weight loss is reported, despite increased 
energy intake.221 Much of this weight loss is attributed to the increase in 
energy expenditure caused by untreated motor symptoms.221 Once treatment 
is initiated symptoms are minimized, and weight gain is observed61,222,223   
 
 




Weight status changes throughout the course of PD (Figure 12), at the 
beginning of treatment for PD excess weight is a problem, but as the disease 




can result in overnutrition224 caused by excessive oral intake and/or 
inadequate activity.225 One study found a majority of PwPD and their spouses 
are overweight or obese226, indicating the need for early nutrition intervention 
for PwPD and caregivers to reduce chronic disease risk.227  Side effects from 
some PD medications, such as dopamine agonists, can increase impulsivity, 
lead to overeating and result in weight again.227 Additionally, treatments can 
reduce dyskinesia, which can decrease energy expended and result in weight 
gain.61 Furthermore, anxiety and depression are common in PwPD and 
prescribed medications can cause weight gain.228,229 Following the 
implantation of deep brain stimulation (DBS), a mean weight gain of 3.1 to 9.3 
kg within three months has been reported, and typically curtails about a year 
after implantation. 227,230 Weight gain among PwPD first receiving DBS is 
attributed to reduced energy expenditure since dyskinesias are reduced after 
DBS.168 Being overweight increases risk of developing sarcopenic-obesity, 
higher body fat and decreased muscle strength that can exacerbate a 
deterioration in physical function.215 
Due to disease-related decline in mobility, it is speculated the age-related 
loss of skeletal muscle mass and muscle strength231  are prevalent in PwPD 
and impact the ability to perform ADLs, increase fall and fracture risk, and 
compromise QOL.232 People with PD  often weigh less than healthy controls, 
but have similar amounts of abdominal fat20 and a higher proportion of visceral 
to subcutaneous fat233, excess visceral fat is linked with increased risk for 




cognitive impairment234, and changes in body fat distribution may be attributed 
to changes in macronutrient distribution.234 Conversely, other research 
indicates PwPD have a higher fat-free mass and possibly a more favorable 
body composition compared to healthy controls.235,236  Inconsistent findings 
related to diet and body composition warrants a deeper understanding of 
chronic disease in PwPD, such as cardiometabolic.237 
 A study assessing weight stability of PwPD over one year found a 
significant amount of muscle converted to fat.224 However there was no 
association between nutritional variables (BMI, weight, Seniors in the 
Community: Risk Evaluation for Eating and Nutrition version II questionnaire, 
mid-upper arm circumference, hand grip strength, triceps skin-fold)  of interest 
and motor and non-motor features of PD. Findings from this study warrant 
longer observational studies to track nutrition outcome variables overtime to 
better understand the relationship between nutrition outcome variables and 
motor and non-motor sequelae. Findings from this study also indicate 
malnutrition should be screened regularly among PwPD to help identify those 
at risk of muscle loss and decrease mobility, and that nutrition professionals 
should be included in the care plan of PD.  
As PD progresses, levodopa tolerance develops, sequelae worsen, and 
weight loss and under-nutrition are common.61  Undernutrition results from 
inadequate intake to meet energy expenditure.225 Up to 25.5% of PwPD are 
malnourished and up to 26.5% are at risk for malnutrition.70,220,238 After PD 




body weight. One study found, despite increased energy intake, the average 
weight loss in PwPD (n=174) was 7.7 pounds 8 years following diagnosis.239  
Significant weight loss is experienced among both men and women.240 
Unintentional weight loss can be caused by a variety of factors.70 Mobility 
limitations make it challenging to buy, prepare, and cook food,61 and PwPD 
may exhibit dysphagia and gastrointestinal problems, which can diminish 
appetite.212 Higher levodopa dosages are associated with a lower BMI,229 
which is associated with compromised motor and non-motor function.219 
Weight loss among PwPD is negatively associated with cognition, suggesting 
an association between cognition and nutritional status.214 Weight loss is also 
exhibited among PwPD experiencing dementia or visual hallucinations. 241  
Whether PwPD experience Despite under- or over-nutrition, malnutrition in 
PwPD is under-treated.144,242 The variability in weight status, cognition, and 
physical functioning warrants innovative nutrition care to improve health 
outcomes.38 Caregivers should be part of/included when making 
care/treatment plans for PwPD whose responsibilities increase as PD 
advances25, in turn compromising the health of the caregivers.29 Fluctuations 
in nutrition and weight status compromises body composition and can impact 
cognitive and physical functioning.144,214,219 A decrease in fat-free mass and an 
increase in fat mass is a natural part of aging and can accelerate decline in 
physical function215, however the added effect PD has on age-related muscle 
loss is unclear.144,235 How this fat free mass increase impacts cardiometabolic 




C. Cardiometabolic Risk in PD 
 
Inconsistent research exists regarding cardiometabolic risk among 
PwPD. In a small cross sectional study, six of seven participants had at least 
one sub-optimal cardiometabolic lab value and two PwPD were on statin-
lowering drugs.38  Chahine et al243 examined vascular risk factors (diabetes, 
hypertension, obesity) among early PD and found an association between the 
presence of vascular risk and concentration of white matter hyperintensities 
(WMH). Greater presence of WMH was predictive of decline in verbal memory 
two years later.243 Cardiometabolic and vascular risk factors are associated 
with cognitive decline.244 Research needs to exam how vascular risk factors 
can impact cognition beyond two years needs to be assessed.  
Previous research suggests a cardiometabolic protective effect of PD 
and theorizes that optimal HDL-C levels among PwPD may explain this 
theory.237  In a larger cross-sectional study (n=150), despite excess visceral 
fat or poor nutritional status, longer PD duration was associated with optimal 
high-density lipoprotein (HDL) cholesterol levels, indicating possible 
cardiometabolic protective properties of PD.237 Cereda et al236 also 
investigated the cardiometabolic status among PD and found compared to 
healthy controls, PwPD exhibited a lower percentage of body fat and more-
optimal glucose levels and lipid profiles. However, there was no difference in 
waist circumference between PwPD and healthy controls.236  Wei et al245 
performed a retrospective study comparing serum lipid and lipoprotein levels 




hemorrhage (n=140) and with an acute cerebral infarction (n=140); findings 
revealed PwPD had reduced serum levels of triglycerides, apolipoprotein B 
and very low density lipoprotein (VLDL) cholesterol.245  Further research is 
needed to explore the relationship between nutrition and the changes of lipids 
and lipoproteins among PwPD.245 Additionally, how this protective 
cardiometabolic profile may impact health outcomes overtimes warrants 
further investigation.236  
D. Nutrition Recommendations  
Protein, water, fiber, vitamin D, and omega-3 fatty acids are nutrients of 
concern for PwPD due to sequelae and medications.61 Over-time, patients with 
higher dietary protein intake may require higher levodopa doses and 
eventually the medication loses effectiveness.20 Common gastrointestinal 
sequelae include delayed gastric emptying and constipation and warrant the 
need to manage daily water and fiber intake.246 Reported low vitamin D status 
in PwPD can impact bone health and increase risk of fracture with disease-
related physical decline.247  Since PwPD are at increased risk for falls, helping 
this population to optimize bone health to prevent fracture is essential.41 In 
addition to neuroprotective effects52, omega-3 fatty acid can improve 
depressive symptoms in PwPD.248 
Formal, comprehensive dietary guidelines for PwPD have not been 
established.249This is partly due to the heterogeneity of PD and the need for 
individualized recommendations. There are multiple dietary recommendations 




and can be confusing for PwPD and their caregivers. Diets adequate in fiber 
and probiotics are proposed for early phase PD to improve gastrointestinal 
issues, increase absorption of levodopa250  and promote optimal cognitive 
function.61,222 Planted-based, vegetarian, or Mediterranean diets are proposed 
for early-phase PD prior to the introduction of levodopa containing medications  
because they are adequate in fiber and pre- and probiotics. These specific 
diets can improve gastrointestinal issues, increase absorption of 
levodopa20,61,251 and promote optimal cognitive function.61,222 
 National organizations for PD provide dietary suggestions which 
include: 25-35 grams of fiber per day,252 up to 70 fluid ounces of water252, and 
encourage consumption of nuts, tuna, salmon and dark green leafy vegetables 
to promote cognitive health.253 These organizations also advise to monitor 
vitamin D status.253 Supplementing with vitamin E and omega-3 may also be 
beneficial.  A trial found co-supplementing with 400 IU of Vitamin and 1000 
mg/day of omega-3 fatty acid from flax seed oil significantly improved overall 
PD clinical outcome scores, total antioxidant capacity, insulin metabolism. 
glutathione concentrations, and high-sensitivity C-reactive protein levels.254 
Guidelines for managing dietary protein intake with levodopa also exist 
and must be based on the frequency and timing of taking levodopa. As a 
result, there is confusion among PwPD and their caregiver on how to optimize 
medication timing and dietary protein intake.108 Recommendations include: 1) 
a low protein diet; 2) a protein redistribution diet; 3)  allowing thirty minutes to 




protein diet restricts protein intake to <0.8g/kg of ideal weight/day.256  A protein 
redistribution diet recommends consuming the  recommended dietary 
allowance (RDA) of 0.8g/kg of protein/day to ensure adequate protein intake, 
but requires the majority of dietary protein to be consumed at dinner to reduce 
daytime motor symptoms and minimize interaction between medication and 
protein.251 Cereda et al251 completed a systematic review examining the 
effectiveness of the low protein and protein redistribution diets, and found 
evidence supports the safety and efficacy of a protein redistribution diet.   
Among PwPD there seems to be low adherence to protein the 
redistribution diet and low protein diets due to low palpability and acceptability 
as well as logistic difficulties for adopting the diet.223 As a result, waiting an 30 
minutes to two hours for meals is encouraged by most PD organizations.223 
More research is needed to understand long-term effects of the protein 
redistribution diet on nutritional status and to help participants find them more 
appealing and less burdensome.223 Increasing access to nutrition information 
through innovative mediums such as  digital health will allow PwPD and 
caregivers to work with dietitians, pharmacists and physicians to manage 
medication side-effects and interactions.  
E. Nutrition and Quality of Life  
 Nutritional status is an important component of QOL and should be 
incorporated in the care PwPD257, but is often an under-recognized component 
of care for PwPD.144 Under-nourished PwPD receiving general nutrition 




improvement in emotional overall well-being.20 Many PwPD and their 
caregivers experience decline in psychosocial health, and support groups  and 
group education can alleviate these feelings through promoting interactions 
with other PwPD and caregivers.75,258,259 Health promotion programs designed 
for PwPD increase overall wellbeing but also foster feelings of enjoyment and 
sense of social self.260  Access to transportation due to disease sequelae can 
be a barrier and increases caregiver burden.261 The observed variability in 
weight status, cognition, and physical functioning may warrant innovative 
nutrition care38, and should also include informal caregivers whose 
responsibilities increase as PD advances.25 
III. Emerging Middle Range Theory of Transitions  
Including caregivers in formative research targets elements of the 
emerging middle-range theory of transitions (Figure 13).262  A transition 
represents change from one state or condition to another, and includes life 
development stages, such becoming an informal caregiver. The theory 
promotes the exploration and understanding health and illness transition 
experiences, through understanding facilitators and barriers to a successful 
transition, and assessing the outcomes of successful transitions.148,262 
Successful outcomes examined include: increase knowledge and skills that 
promote self-efficacy, coping, and satisfactory relationships with family, friends 
and formal services.262  The theory posits itself on helping informal caregivers 
to acquire new skills and knowledge to cope with situations related to 




a central role in successful role transition.262  The theory has been 
incorporated previously to guide the development of dyadic interventions for 
PD148 and Alzheimer’ disease.263   
Figure 13: Schematic of the Emerging Middle Range Theory of Transitions262    
 
Research and services are beginning to identify the need for informal 
caregivers to help manage long-term conditions such as PD.137,264,265 
Development of more comprehensive approaches to help PwPD and their 
caregivers adapt to changes they experience as a consequence of a long-term 
condition are warranted.265,266 Caregivers of PwPD are often faced with 
restricted work and social activities, increased worry and uncertainty about the 
future, loss of income, and feelings of guilt, frustration and/or grief.267,268 
Consequently, PD caregivers are at risk for compromised psychosocial 
outcomes, which include poor QOL, emotional and financial strain, sleep 




motor sequelae  among PwPD (e.g., depression, cognitive impairment) and 
depression among caregivers are predictive of caregiver burden.267 While 
social support may be a protective feature in minimizing caregiver burden.267  
Whether caregiver burden is associated with poorer nutrition status for 
caregivers or their loved one with PwPD has yet to be explored.  
  As a result, future programs and services for PwPD should incorporate 
the preferences and needs of informal caregivers as their responsibility tends 
to increase as the disease progresses.266 Comprehensive, interdisciplinary 
services can help both PwPD and caregivers better cope and adjust with living 
with PD and improve QOL.265 Including PwPD and caregivers will be 
especially beneficial in digital health interventions and nutrition services as 
caregivers will likely have an active role in managing both of these as PD 
progresses and reliance on caregivers increase.  Qualitative dyadic research 
among PwPD and caregivers, show concerns about keeping both parts of the 
dyad healthy.148 As a result, how the inclusion of caregivers can help promote 
healthy dietary patterns among PD Caregivers warrants exploration.  
IV. Inclusion of Caregivers  
Up to 6.5 million family caregivers provide substantial help, including 
coordination of care, medication management, and personal care for older 
adults living with disability.21One quarter of informal caregivers provide nearly 
45 hours of care per week for their loved with PD,22 and over a quarter spend 
more than 75 hours per week providing care.269 Additionally, caregivers 




physicians 40-70% of the time.270 Compared to matched control caregivers, 
caregivers of PwPD exhibit higher direct and indirect costs consistently over 
five-years.271 When examining income progression over five-years, caregivers 
of PwPD also exhibited a higher cumulative income loss (Figure 14).271 
Figure 14: Cumulative Income Loss for PD caregivers versus matched 
controls271 
 
  In addition to economic disadvantage, PD caregivers also experience 
stress and burden for caring with their loved one with PD.29 Male PD 
caregivers have decreased access to informal caregiving resources, despite 
reporting less strain than female caregivers.272  Women with PD receiving care 
from a male informal caregiver are more likely to use, formal, paid 
caregivers.272   Caregiving is a fundamental and valuable part of PD treatment 
but limited research has been conducted on caregiving patterns and needs for 
caring for a loved one with PD.272  In particular,  dietary concerns, nutritionals 
status, and  how technology can enhance dietary management caregiving has 




innovative mediums are necessary to increase access to caregiving and 
reduce disparities among PwPD.272  
Caregivers experience primary stressors and secondary role strains as a 
result of providing care for their loved one.56 Primary stressors include both 
subjective and objective difficulties directly related to providing care.273 
Examples of objective primary stressors include care tasks and the degree of 
impairment of the care recipient.273 Subjective primary stressors are the 
caregivers’ emotional and psychological response to objective stressors. 273 
Primary stressors can negatively impact caregivers’ physical and mental 
health.274 Secondary role strains are when hardships experienced in roles and 
activities that originate from primary stressors proliferate to other life areas.273 
An example of secondary role strain is decreased participation in non-care 
activities or reluctance to partake in activities due to the time, energy and 
resources required to providing care.275 Older caregivers and those providing 
help with ADLs and healthcare management (e.g. scheduling appointments) 
are more likely to decrease participation in non-care activities.56  
Caregiver activity restriction is also associated with poor health outcomes 
for the caregiver, such as reduced sleep quality and high blood pressure.276,277 
Compared with matched controls caregivers, PD caregivers had higher rates 
of comorbidities, such as headache, gastroesophageal reflux disease,  
hypertension, and irritable bowel syndrome.271 Many of these diseases require 
dietary modifications to minimize and manage symptoms and suggest 




the nutritional status and nutrition needs of PD caregivers. Additionally, given 
the later-onset of PD, most caregivers are older adults and have their own 
medical conditions.259 
Informal caregivers for PwPD are at increased risk for poorer QOL, which 
is partly attributed to observing disease-related physical and cognitive decline 
in their loved ones.29 Informal caregivers are typically responsible for 
performing the majority of ADL, including buying and preparing food, and 
transportation.22 Caregiving stress can also resonate adverse consequences 
on the patient-caregiver dyad, compromising the care provided, as well as 
negatively impacting relations with the larger-family system.56  
Studies have examined the lived experience of living with PD, needs and 
preferences of PD-Caregiver Dyads related to managing Parkinson’s disease. 
278 Smith and Shaw279exained the lived experience of both the PwPD and their 
caregiver within a family unit and found partners share the impact of PD, were 
learning to live in a new way to adopt to disease progression and felt a sense 
of belonging from support groups. Additional research can help identify 
services required to facilitate the process of learning to live with PD,279 such 
research should include how nutritional management can help facilitate this 
process. How dyads experience related to food and access nutrition 
information has yet to be explore. 
Habermann & Shin278 conducted a descriptive qualitative study among 
caregiver and PwPD to explore how dyads discuss needs, concerns and 




communication with healthcare providers and had concerns with choking, falls, 
voice production, financial strain and the future of disease progression.278 
Increasing access to nutrition services can help address some of these 
concerns; nutrition professionals can provide education on optimizing dietary 
intake when modifying textures and calculating nutrition support needs to 
accommodate swallowing issues, as well as optimize dietary intake to promote 
a healthy body composition to prevent fall risk.  
Educating caregivers early at disease diagnosis and encouraging 
caregivers to partner with healthcare providers can reduce stress and family 
conflict.135 Couple-oriented interventions improve spousal coping strategies, 
promote disease related stress and anxiety management, increase self-
efficacy (one’s belief in his/her capability to perform, organize, or execute a 
task or succeed in a situation280), and help couples manage changes caused 
by PD.32 Innovative mediums, such as digital health via video, web-based, 
telephone-based and remote-monitoring can have a significant improvement 
on caregiver outcomes.204 The use of technology can enhance caregiving 
experience and facilitate shared decision making, where patients and 
caregivers are actively involved in the care process and participate in the 
decision making processes.204  
V. Conclusion 
 Due to limited mobility, transportation access, need for visual assessment 
and ongoing interdisciplinary care, PwPD are excellent candidates for digital 




Understanding how the nutritional status of PwPD change overtime can help 
health care professionals better understand the nutritional needs of PwPD and 
provide effective nutrition services via digital health. Therefore, the purpose of 
this mixed-methods project is to: 1.) Understand how the nutritional status of 
PwPD changes overtime; 2.) examine the perceptions, acceptance, 
facilitators, and barriers for adopting digital health to improve the nutritional 
health of PwPD and their informal caregivers; 3.) understand the nutritional 
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EXTENDED METHODOLOGY  
Overview   
 The completed studies are part two major studies / projects at the 
University of Rhode Island. Project 1 is part of a 5-year longitudinal study 
examining the change in nutrition, physical function, cognition and swallowing 
among those living with neurological disorders and neurotypical participants. 
Project 2 is a formative, mixed-methods analysis, assessing people with 
Parkinson’s disease (PwPD) and their informal caregivers. The specific aims 
for this dissertation, the chapters of the dissertation they are addressed in and 
the corresponding study project are summarized in Table 1.  Enclosed is the 
methodology for both projects and their aspects that address the specific aims.  
Table 1: Specific Aims, Corresponding Chapter and Project Number  
Overarching and Specific Aims   Chapter # Project # 
Aim 1: To assess the nutrition risk of PwPD overtime. 
• Track the nutritional status of PwPD overtime  
• Examine how disease sequelae may influence nutritional 
status. 
1 1 
Aim 2: Evaluate the nutritional status in PwPD and their 
caregivers 
• Evaluate the diet quality among PwPD and their informal 
caregivers;  
• Describe the self-reported nutrition concerns among PwPD 
and their informal caregivers;  
• Explore if the nutrition concerns match the dietary quality of 
PwPD and informal caregivers. 
2 2 
Aim 3: Examine PwPD’s and their caregivers’ perceptions and 
acceptance of digital health 3 2 
Aim 4: Describe digital competence among PwPD and their 






Project 1 Design and Methodology (Aim 1, Chapter 1)  
This is an ancillary study of a five-year observational, longitudinal study 
assessing the nutritional, cardio-metabolic, cognitive and physical function 
status of PwPD, acquired brain injury (ABI) and neurotypical participants 
(Longitudinal Study of Communication, Nutrition and Physical Activity, IRB 
HU1314-006). Participants come to URI’s Speech and Hearing Clinic located 
at the Kingston Campus and are assessed every six months for five years. 
Participants are enrolled in the study on a rolling basis. Potential participants 
aged 18-85 years are recruited via brochures and word-of-mouth; one-year 
post-PD or -ABI diagnosis. The time commitment for participants is three 
hours per evaluation for a total of 30 hours for the five years. Written data 
were stored in a locked file cabinet in the Department of Communicative 
Disorders. Prior to their first assessments, participants went through the 
informed consent process (Appendix C).   
For Chapter 1, those PwPD who completed an assessment their 
baseline year, year 2 and year 4 were included in this study. These 
participants completed their assessments from Fall 2013 through Spring 2019.  
Table 2 summarizes the research timeline for chapter 1. Table 3 summarizes 








Table 2: Specific Aim 1 Study Timeline 
 
 
Table 3: Assessment Protocols by Domain  
 
Assessment Domain  Assessment Tool  
Nutrition  The Dietary Screening Tool (DST)*1  
Cardiometabolic  Lipid profiles and blood pressure* 
Anthropometric Height, weight, body mass index (BMI), percent body fat* 
Physical Functioning  Short Physical performance Battery (SPPB)2 
Swallowing Swallowing Quality of Life Survey (SWAL-QOL)
3; 
Timed Swallow Test4 
Cognition  Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)5 
Medical History  Past Medical History Questionnaire  
*Assessments used to for Aim1 
 
Data Collection  
Nutritional Assessment Measures 
 Within the nutrition assessment, the dietary screening tool was used to 
assess nutrition risk, and biochemical, clinical, and anthropometric data were 
obtained   Participants completed the dietary screening tool (DST, Appendix 
D), a 25-item questionnaire validated and used to identify dietary patterns and 
nutritional risk in older adults.1,6  A total of 105 points can be achieved. Scores 
can be categorized as: at risk (<60), possible risk (60-75), and not at nutrition 
risk (>75).The eight component scores from the DST were also examined, 
which include: whole fruit and juice (15 points), vegetables (15 points), whole 
grains (15 points), lean protein (10 points), processed meats (10 points), dairy 













IRB X X      
Recruit X       
Assessment Visits X X X X X   
Data Entry X X X X X   
Data Analysis     X X  




(10 points), added fats, sugars and sweets (25 points), and supplements (5 
points). We determined participants who achieved >80% for each DST 
component score.  
Biochemical and Clinical Data (Appendix E).  Serum total cholesterol, 
low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, 
triacylglycerol, and glucose will be obtained using a finger stick (Cholestech® 
LDX system, Hayward, CA) after a 12-hour fast. Blood pressure will be 
measured using automatic blood pressure machine (Omron Healthcare Inc., 
Bannockburin, IL).  
Anthropometrics.  Height was measured using a stadiometer (Seca, 
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged. 
Measures were repeated if obtained height was not within 0.2 cm of each 
other. Weight was obtained using a calibrated electronic scale (Healthometer 
752KL, Jarden Consumer Solutions, Boca Raton, FL) to the closest 0.1 kg. 
Weight measurements were taken in duplicate and averaged.  The average 
height and weight value were used to calculate body mass index (BMI, kg of 
body weight/height in meters2). A BMI between 28 and 23 was considered 
within an optimal range, aligning with older adults.7  
Other measures  
The measures described below were collected at each assessment visit 
and analyzed to help better understand and explore factors that may influence 




Physical Functioning. The SPPB (Appendix F) assessed participants’ 
global physical functioning and includes gait speed, standing balance tests, 
and five repeated chair stands.2 Scores <10 indicated mobility disability.2  
Cognitive Evaluation.  To measure attention, language, memory, 
constructional and visual-spatial abilities, the RBANS (Appendix G) will be 
used.5 The test includes 12 subtests that can be completed in 30 minutes. A 
score <80 indicates cognitive impairment may be present.  
Swallowing Evaluation. The SWAL-QOL (Appendix H) is a 44-item survey 
that takes10 minutes to complete. Participants rate factors about 10 quality of 
life concepts related to swallowing.3 A timed swallow test (ml/s) is 
administered to assess strength, coordination, range of movement, and timing 
of movement of swallowing muscles in those with neurological disorders 
(Appendix I).4 The number of swallows and the time it takes to swallow the 
water are counted. 
Medical History. A medical history questionnaire (Appendix J) is used to 
identify health-related conditions and takes ten minutes to complete. 
Statistical Analysis. Data was analyzed in SPSSv26. Categorical 
variables were represented as numbers and percentages and continuous 
variables were reported as mean±standard deviations. Data was assessed for 
normality and non-normally distributed data was transformed for analyses but 
original mean±standard deviations were reported. To assess changes in 
nutritional risk via DST scores, a repeated measures analysis of covariance 




adjustment was made for multiple comparisons. Analyses were 2-tailed and a 
p<0.05 will indicate statistical significance Paired sample t-tests were also 
conducted among outcome variables from baseline to year 2, year 2 to year 4 
and baseline to year 4 were also conducted. Analyses were 2-tailed and a 
p<0.05 will indicate statistical significance. Participants were then individually 
analyzed for suboptimal scores across each outcome variable and the 
frequency of sub-optimal scores were reported.  
Project 2 (Chapters 2 & 3, Aims 2-4)  
Project 2 Overview  
Chapters 2and 3 were from a descriptive, cross-sectional study collected 
qualitative and quantitative data from PwPD (n=20) and their informal 
caregivers (n=20) via dyadic semi-structured interviews (n=20), 
questionnaires, and anthropometric assessment. The project was approved by 
the Institutional Review Board (HU1819-001, Telenutrition and Parkinson’s 
disease). The purpose of project 2 was to examine the perception and 
acceptance of digital health technologies in PwPD and their caregivers, as well 
as understand facilitators and barriers for digital health adoption for the 
nutrition care process. This study also evaluated the nutritional status and 
digital competence in PwPD and caregivers. A concurrent mixed-method 
design8 was used to assess the nutritional status and nutrition concerns of 
PwPD and their informal caregivers. This mixed-methods design was chosen 
to gain a more complete understanding of nutritional needs of PwPD and 




qualitative data.8  Data was collected over four assessments completed 
between November 2018 and April 2019. A summary of activities that 
occurred in each session is provided in Table 4. Sessions 1, 3, and 4 were 
conducted by phone, while Session 2 was conducted in the participants’ 
home. The study timeline is summarized in Table 5.  














Table 5: Description and Timeline of Evaluations for Project 2  
 
 
Assessment 1 was an informational phone call during which 
participants were screened for eligibility and informed about the study protocol.  
At the beginning of Assessment 2, the study protocol was reviewed and both 
PwPD and their informal caregiver completed the informed consent process. 
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2nd 24-hour Dietary Recall 60 minutes 




Assessment 2 was an in-person home visit, which consisted of a timed-
swallow screening, questionnaires, and a semi-structured, dyadic interview. 
Assessments 3 and 4 were phone calls during which participants completed 
two 24-hour recalls.  
Theoretical Framework. This mixed-methods study targeted elements of the 
emerging middle-range theory of transitions.9 A transition represents change 
from one state or condition to another, and includes life development stages, 
such becoming an informal caregiver. Research shows helping informal 
caregivers acquire new skills to cope with situations related to caregiving, and 
creating feelings of informal support for caregivers, plays a central role in 
successful role transition.9 Acquisition of subjective and objective data from 
PwPD and caregivers was collected to help better understand the transition 
dyads face as the patient-caregiver relationship changes, and the role of the 
caregiver evolves9, especially in relation to dietary management. The 
approach has been used to provide tailored health interventions for those with 
neurodegenerative diseases and their caregivers.10,11  
This study concentrated on the early stages of digital health nutrition 
services, in which PwPD and caregivers provided personal opinions and 
preferences to inform the creation of an user-friendly, evidenced-based, digital 
health service.12  Formative analysis has been used to effectively employ 
digital health technologies for older adults13,14, and in the development of 
dyadic interventions for PwPD.10 Findings from the proposed study can be 




Inclusion Criteria. Both the PwPD and their informal caregiver were 
required to participate and needed to be community-dwelling, English 
speaking, and ≥18 years old. Participants also needed to score >18 on the 
Telephone Montreal Cognitive Assessment (T-MoCA), a cognitive screening 
tool, that was administered during Assessment 1.16,17  A list of inclusion criteria 
for both PwPD and caregivers are summarized in Table 6.  
Table 6: Inclusion Criteria for Project 2 (Specific Aims 2-4)  
 
 
Recruitment and Data Saturation. Recruitment occurred following 
study approval by URI’s Institutional Review Board (HU1819-001). Emails, 
flyers (Appendix K), announcements at support groups, word of mouth and 
current statewide collaborations and contacts were used to recruit participants. 
Participants were recruited from support groups throughout New England, 
New York and New Jersey via announcements and flyers at community 
centers, via healthcare providers, the American Parkinson’s Disease 
Association website, and through popular press coverage from the University. 
Twenty-five dyads expressed interest. Five dyads did not continue with 
the study due to scheduling conflicts or low T-MoCA scores. Eighteen dyads 
were eligible, enrolled and interviewed. Two of these dyads included couples 
who were both living with PD and identified as each other’s informal caregivers 
and were double counted as a PwPD and a caregiver.  As a result, 20 dyads 
PwPD Informal Caregiver 
18+ years old  18+ years old  
English Speaking English Speaking 
Cognitive Function <18 on t-MoCA Cognitive Function <18 on t-MoCA 




were included in analyses. Dyads were from Rhode Island, Massachusetts, 
New York, and Connecticut.  We aimed to interview up to 20 dyads as 
previous research among PwPD and caregivers indicates this is where data 
saturation is reached.18,19 Saturation was reached after the fourteenth 
interview.  
Incentive Structure.  Dyads who complete all 4 sessions will receive 
tailored dietary recommendations based on individual assessments, and a 
chance to win a wearable device to monitor health. Emerging themes and 
general findings from interviews related will be provided 
Informed Consent Process. Potential participants will receive an 
informational phone call (session 1) to review the study purpose and 
requirements. Consent was provided or declined from the PwPD and their 
informal caregiver at the beginning of the in-person evaluations (session 2). 
Both the caregiver and the PwPD were consented. Interested and eligible 
dyads were enrolled in the study. (Appendix L & M). Enrolled dyads will 
complete a demographic and medical history questionnaire, then the semi-
structured interview. During the informed consent, there was a request 
authorization for disclosure of protected health information from primary care 
physicians or neurologists for PwPD, which included: PD stage, date of 
diagnosis, current medications and treatment. Permission to request personal 
health information from PwPD’s neurologist was also obtained (Appendix X), 





Collection and Analyses of Qualitative and Quantitative Data  
Qualitative Assessment and Analysis.  
 Semi-structured Dyadic Interviews. A 24-question moderator guide, 
informed by the previous literature and the research team was organized to 
capture three main domains: PD and Diet, Accessibility of Nutrition and Health 
Information, and Digital Health for PD. From these domains, participants’ 
acceptance and perception were assessed.  A copy of the moderator guide is 
provided in Appendix L.  The moderator guide included three key sections of 
the moderator’s script: 1.) PD and Diet, 2.) Accessibility of Nutrition and Health 
Information, 3.) Digital Health for PD. Prior to starting the study, interviews 
were piloted with two dyads and questions were modified based on participant 
feedback. Interviews were conducted in the participants’ homes (facilitated by 
DL) and were audio-recorded using a digital recorder. The mean interview 
duration was 39 minutes (range 21-64 minutes). During interviews, 
participants were provided operational definitions of terms (technology, digital 
health, smart phones, smart watches, apps, videoconferencing). Photo 
prompts were used to help describe different technological devices and digital 
health tools and this was particularly important for understanding acceptance 
of devices.  
Qualitative analyses related to digital health specific aims (Aim 3):  
 Qualitative data was analyzed using deductive and inductive reasoning.  
Transcripts were deductively-coded using the framework analysis method20, a 




were inductively-coded using Colaizzi’s Strategy in Descriptive 
Phenomenology21; this interpretative approach draws an understanding of 
participants’ “lived experiences”.22   
The following steps were taken to analyze the data related to 
perception and acceptance of digital health, facilitators and barriers and 
identified features for a digital health service.  Recordings were transcribed 
verbatim and DL checked transcripts for accuracy (stage 1). Transcripts were 
divided into three batches.  DL and a trained research assistant (KS) analyzed 
one batch at a time. Separately, DL and KS coded for the following a priori 
themes related to digital health: perception (perceived usefulness, perceived 
ease of use, awareness of digital health, image of technology) and acceptance 
(accept, neutral, reject). These a-prior themes adopts components of the 
technology acceptance model (TAM).15  
 Before coding individually, KS and DL read through an entire batch of 
transcripts, met to discuss initial impressions, developed a list of initial themes 
and then coded a-priori (stage 2). Both DL and KS coded one transcript from 
the batch independently and in duplicate (stage 3). The two researchers 
compared and reconciled coding, and there was a strong agreement between 
authors on the transcripts reviewed. During this discussion the two 
researchers developed a working analytical framework and agreed upon which 
codes to use on the remaining transcripts (stage 4). The transcripts were 
uploaded to NVivo12 (QSR International Pty Ltd, AU) and coded separately by 




with an agreement >80% achieved for each overarching theme across each 
batch. DL and KS met to reconcile coding differences. The research 
committee and DL met to collapse and finalize themes (stage 5). Data was 
then charted into framework matrices using NVivo12 to display codes within 
each theme (stage 6). Data was interpreted, and connections related to digital 
competence and technological preferences of PwPD and their caregivers were 
made (stage 7). Although a priori themes helped to inform this framework, a 
phenomenological and iterative approach throughout each stage of the 
analyses was also taken to identify emerging themes that may impact 
technology use among this population. Both DL and KS contributed to the 
framework development with the advisement of the dissertation committee. 
Qualitative Analyses Related to Nutrition (Aim 2):  
The two coders (DL and KS)  took a similar approach to analyze the 
interviews for nutrition concerns.  Before coding individually, KS and DL read 
through all of the transcripts and developed a list of initial impressions and 
themes, which fell under three categories: Dietary Concerns Related to PD 
Sequelae, Other Nutrition Concerns and Perceptions of Diet. Both DL and KS 
coded one transcript from each batch independently and met to compare and 
reconcile coding. At this point DL and KS created a working analytical 
framework and agreed upon codes to use for analyzing the remaining 
transcripts. The transcripts were uploaded to NVivo12 (QSR International Pty 
Ltd, AU) and coded separately by DL and KS. An inter-coder reliability was 




DL and KS compared codes between each batch and reconciled 
differences between codes, until a consensus was reached. Codes were then 
finalized. To ensure information related to dietary intake was not overlooked in 
other sections of the transcripts, DL went through all of the transcripts and 
coded the remaining sections. KS reviewed these codes to verify coding 
structure, added additional codes when needed and DL and KS discussed 
differences in coding and collapsed themes. The larger research team and DL 
met to further collapse and finalize themes.  
Quantitative Data Collection and Analyses.  
The following assessments will be completed and analyzed for both 
PwPD and their informal caregiver, unless otherwise noted. 
Dietary Data. Nutrition Risk and Diet Quality. 
Within the nutrition assessment, the dietary screening tool was used to 
assess nutrition risk, and biochemical, clinical, and anthropometric data were 
obtained   Participants completed the dietary screening tool (DST, Appendix 
D), a 25-item questionnaire validated and used to identify dietary patterns and 
nutritional risk in older adults.1,6   
Both PwPD and caregivers completed two 24-hour recalls via telephone 
(sessions 3 and 4). These recalls included one weekend and week day,  and 
were conducted using the gold-standard, multiple-pass interview method 
(Appendix O).24 Participants received a food amounts booklet to estimate and 
report accurate portion sizes. Twenty-four-hour recalls were entered into 




Minnesota, Minneapolis, MN) and analyzed for total energy, food group and 
nutrient intake. The NDSR data was assessed for diet quality using the 
Healthy Eating Index (HEI)-2015 scoring metric.25 Total scores can range from 
1-100; the higher the score, the better the diet quality. Mean scores from the 
two days were used. Outputs from NDSR were used to calculate HEI-2015 
component scores (whole grains, whole fruits, total fruits, vegetable, greens 
and beans, dairy, total proteins, seafood, plant protein and seafood, refined 
grains, sodium, added sugars, and saturated fat) derived using USDA SAS 
codes.26 Component scores help to provide insight into types of food 
consumed and nutrients of interest for future interventions.  
Anthropometrics. Height was measured using a stadiometer (Seca, 
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged. 
Measures were repeated if obtained height was not within 0.2 cm of each 
other. Weight was obtained using a calibrated electronic scale (Tanita HD351, 
Japan) to the closest 0.1 kg. Weight measurements were taken in duplicate 
and averaged.  The average height and weight value were used to calculate 
body mass index (BMI, kg of body weight/height in meters2). A BMI between 
28 and 23 was considered within an optimal range, aligning with older adults.7  
The bioelectrical impedance analysis (InBody, Korea) device27, 
assessed body composition28,29, and has been used with PwPD.30 The 
analysis takes five minutes to complete. Body composition was not be 
obtained for participants with implantable medical devices.  Guidelines 




body fat31, with values of <32% for women and <25% for men considered 
acceptable.31  Standardized protocol was used to measure waist 
circumference with Gulick anthropometric tape (Fabrication Enterprises Inc. 
White Plains, NY).32  Waist circumference was measured in the horizontal 
plane at the superior border of the iliac crest. Measurements were taken in 
duplicate and averaged.  
Digital Competence and Technology Use. In addition to digital health 
data gathered during semi-structured interviews, questions related to 
technology competence, technology use and digital health use will be 
gathered through two questionnaires. Questions will be adopted from 
“Measuring Digital Health Skills across the EU: EU Wide Indicators of Digital 
Competence,” (Appendix P)33 which assessed use and level of comfort using 
various aspects of technology via 15 questions/statements.33 For each 
statement, participants responded strongly disagree, slightly disagree, slightly 
agree or strongly agree. We also collected data regarding device use, 
frequently and purposes of device use.  
 Digital health was assessed using questions from the “2015 Health 
Information National Trends Survey”, Section B (Appendix Q), which contains 
11 yes/no questions, as well as questions describing technology use and how 
health information is accessed.34-36 Questions from this questionnaire also 
asked participants where they go first to search for health information, rate the 
amount of effort it took to find the information and the describe the confidence 




caregivers to rate the level of trust they had for obtaining nutrition and health 
information from an array of sources, including doctors, other health 
professions, family and friends, organizations and online blogs.  
Other Measures. Assessment tools measured cognition, anthropometrics, 
disease related QOL, caregiver burden, swallowing function, medical history, 
and demographics. These variables were used to help describe participants. 
Cognitive Status. Cognitive status was assessed using the T-MoCA 
(Appendix R).16,17 The test takes about 10 minutes to complete and is 
validated in community-dwelling adults with mild cognitive impairment.17 It 
includes eight subtests assessing digit span, attention, calculation, repetition, 
verbal fluency, abstraction, recall and orientation.16  Participant who have less 
than 12 years or less of formal education will receive one point toward their 
total score.  Scores <18 out of a possible 22 points indicate mild cognitive 
impairment. 
Swallowing Function. A timed swallow test (ml/s) was administered to 
assess swallowing muscles in those with neurological disorders.4 Specifically, 
it assesses: strength, coordination, range of movement and timing of 
movement of swallowing muscles (Appendix I). The Eating Assessment Tool 
(EAT-10)37, a validated 10-item questionnaire, screened for self-reported 
swallowing difficulties (Appendix S). Scores on the EAT-10 range from 0-40; 
higher scores indicate a swallowing problem. 
Disease Related Quality of Life. The 39-item Parkinson’s Disease 




related quality of life of PwPD (Appendix T).38,39 The questionnaire contains 
eight sub-scales (mobility, emotional well-being, stigma, social support, 
cognitions, communication and bodily discomfort), which were used to 
calculate global health-related quality of life. Each item scores from 0 (never) 
to 4 (always), with the highest possible score of 156, and higher scores 
indicate worse quality of life.38,39 Results are reported using an index 
percentage (0%=no disability and 100%=maximum disability).   
Caregiver Burden. The Multidimensional Caregiver Strain Index (MCSI) 
assessed caregiver burden.40 This 18-item tool collected subjective 
information from informal caregivers across six domains: physical strain, social 
constraints, financial strain, time constraints, interpersonal strain, and elder 
demanding/manipulative. Response to individual questions are reported on a 
0 (never) to 4 (a great deal) scale. Scores range from 0-64 points and are 
reported as an index percentage130; higher scores indicate higher caregiver 
strain130.  The scale has been previously used successfully in the PD 
population131. 
Medical History and Demographics. To identify health-related conditions 
and past medical history, a non-validated medical history questionnaire was 
used. Topics covered included: questions related to neurological, endocrine 
and cardiovascular and gastrointestinal health. Demographics (age, gender, 
race/ethnicity, employment status) were collected.  Health information and 
demographic information was obtained from both PwPD and their caregivers 




Quantitative Statistical Analyses. Quantitative data was analyzed using 
SPSS v26 (IBM Corp, Summers, NY). Descriptive statistics are reported as 
mean±standard deviation for continuous variables and percentages and 
frequencies for categorical variables. Data was examined for outliers, and 
outliers were found among the following HEI-2015 variables: HEI-2015 Total 
Scores, Protein, and Refined Grains component scores. Independent t-tests 
explored differences between PwPD and caregivers for all normally distributed 
continuous variables. A Mann-Whitney U test examined group differences 
between non-normally distributed continuous variables. A chi-square analysis 
explored differences for categorical variables. A p-value of <0.05 indicated 
statistical significance. Finally, the percent and frequency of PwPD and 
caregivers who met >80% of adequacy and moderation HEI-2015 components 
scores were calculated.  
 
Data Integration. 
Manuscript 2: The research team reviewed both data sets and 
considered the themes coded from the qualitative research in conjunction with 
the findings from the statistical analyses of the HEI-2015 scores. Qualitative 
data was mapped into framework matrices and reported as frequencies using 
NVivo12 to quantify codes within the over-arching category of Dietary 
Concerns Related to PD Sequelae. This frequency data stemmed from the 
qualitative themes and a side-by-side comparison of themes were compared 




consistent patterns between HEI-2015 scores and frequency of self-reported 
Dietary Concerns Related to PD sequelae from PwPD and their caregivers 
were made. 
Manuscript 3: Acceptance of digital health was analyzed by assessing 
current technology use and purpose from questionnaires and through themes 
coded from qualitative interviews. Phrases/sentences from qualitative 
interviews related to acceptance were categorized as Accept, Neutral or 
Reject. To calculate average acceptance rate among qualitative interviews, 
the number of phrases coded as Accept, Neutral or Reject were counted and 
totaled.  The total number of phrases coded as Accept were divided by the 
total number of phrases coded across the three acceptance categories to 
calculate acceptance rates among each dyad. The percentages were 
averaged to calculate an average acceptance rate (n=20). Codes from the 
qualitative interviews were transformed into variables and reported as percent 
and frequencies. Side-by-side table displays of frequencies derived from 
perceptions and acceptance (qualitative data) and digital competence scores 
(quantitative data) were created and interpreted to better describe the 
population and readiness for a digital health intervention. A Pearson 
correlation was used to explore if there was an association between the 
percentage of phrases coded as hard to use and the mean average 
acceptance rates.   




Partial funding for Project 1 came from the URI Spark Grant and 
Enhancement for Graduate Research Award. There was no funding for Project 
2. Data collection for Project 1 took place in Independence Square in the URI 
Speech and Hearing Clinic. Data for Project 2 was collected through phone 
calls and home visits. Department equipment included: stadiometer, bio-
electric impedance scale, electronic scale, cholestech analyzers, portable 
automatic blood pressure machines, and measuring tape. Data was analyzed 
using software found on the lab computers in the Lipid Metabolism Lab, 
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APPENDIX C: Longitudinal Study Consent Form (Study 1)  
 
Longitudinal Study of Communication, Nutrition and Physical Activity 
Leslie A. Mahler, PhD, Principal Investigator 
Ingrid Lofgren, PhD, co-Investigator 
Matthew Delmonico, PhD, co-Investigator 
 
CONSENT FORM FOR RESEARCH: Participant 
Version 5: May 24, 2016 
 
The University of Rhode Island 
Department of Communicative Disorders 
25 W Independence Square, Suite I 
Kingston, RI 02881 
 
Purpose of the Consent: 
You have been invited to take part in a research project described below.  The purpose 
of the consent form you are about to read is to provide you with details about the 
research study and to inform you of your rights if you agree to participate in the study.  
Your participation is completely up to you.  The researcher will explain the project to 
you in detail.  You should feel free to ask questions.  If you have more questions later 
you can call, Dr. Leslie Mahler, the person mainly responsible for this study, at 401-
874-2490.  You may also contact Dr. Ingrid Lofgren at 401-874-5706 or Dr. Matthew 
Delmonico at 401-874-5440, who are co-Investigators on the study.  You must be at 
least 18 years old and speak English to be in this research project. 
 
Description of the project: 
This is a research project designed to look at communication, nutrition, and physical 
activity characteristics of adults who have a stroke, traumatic brain injury or Parkinson 
disease and healthy adults with no known neurological disorder or head injury to be a 
control group.  All evaluations will be conducted at one of two University of Rhode 
Island locations; in Independence Square on the Kingston Campus at 25 West 
Independence Way, Kingston or in Independence Square at 500 Prospect Street in 
Pawtucket.   
 
You are being asked to be in this study because we want to determine the long-term 
impact of neurological disorders on communication, nutrition, and physical activity. 
We are looking for 200 people who have a stroke, traumatic brain injury or Parkinson 
disease to participate in this project.  Participation in this study is entirely your choice. 
 
If you decide to take part in this study, you should understand that the evaluations are 
investigational and you may not experience any benefit from participation.  
Participation may also involve additional risks as listed in the Potential Risks and 




included in the study before you decide whether you want to take part in the study.  
You may also quit the study at any time. 
What will be done:  
 
If you agree to take part in this study, you will be asked to complete up to 11 
evaluations over five years.  Evaluations will take place every six months.  The 
evaluations will include a variety of tasks such as reading sentences and describing a 
picture, an assessment of how your muscles move, a cognitive screening, an interview, 
a clinical swallowing evaluation, and questionnaires regarding swallowing, diet and 
physical activity.  The total time for each evaluation will be approximately 3½ hours.  
All evaluations will be conducted in a quiet private room at one of the University of 
Rhode Island Speech and Hearing Clinic locations (Kingston or Pawtucket). 
 
With your permission, we will request health information from your physician about 
the following specific items only: 
• Date of diagnosis 
• Current medications 
• Imaging information about where the brain damage is located (if 
appropriate) 
• Stage of Parkinson disease (if applicable) 
You will sign a separate form to indicate whether you give your permission to release 
this health information for the study.  This information will not be requested for 
healthy adults enrolled in the study 
 
Potential risks and discomforts: 
There are minimal foreseeable risks associated with these evaluations. There have 
been no reported adverse affects from clinical evaluation of speech and swallowing.  
There may be some unknown or unanticipated risks, but every precaution will be 
taken to ensure your personal safety.  Even though experienced personnel will obtain 
the blood samples from a finger prick, there is a chance of discomfort and minor 
bruising from the finger stick.  For physical function testing there is a risk of muscle 
soreness or other muscle injury as well as skeletal injury but we will minimize these 
risks by using standard safety practices. 
 
Purpose and benefits of the study: 
The purpose of this study is to describe communication, nutrition, and physical 
activity behaviors over time to see how they change and affect quality of life.   The 
information obtained is important because it will help us to understand how to provide 
services to meet the needs of people with neurological diagnoses.  This is an 
investigational study and there is no guaranteed benefit to your communication or 
nutrition or physical function as a result of participation in this research study.  You 
will receive personal health information such as your height and weight, physical 




and triglycerides.  In addition, you will receive information about your thinking skills 
and language skills and dietary choices. 
 
Drugs, devices or instruments to be used: 
Drugs will not be used in this study. The equipment for the evaluations include: 
microphone, sound level meter, tongue blade, a digital tuner, tape recorder, and video 
cameras. All equipment used to collect cognitive-linguistic and physical function data 
is considered non-invasive. A lancet and capillary tube will be used to obtain the blood 
sample from a finger prick and the sample will be analyzed on a small portable 
machine that is on a table. 
  
Cost to participant: 




Your part in this study is confidential.  Your individual privacy will be maintained in 
all published and written data resulting from this study.  No names of participants will 
be published or included in written data resulting from this study.  Results of this 
study may be used for purposes of research, educational lectures, and/or professional 
presentations.  When you are entered into the study you will be assigned a code that 
does not include any identifying information.  For example, the first participant will be 
coded as Long01.  The code number will be used on all response forms and in the 
analysis of the data.   
 
Dr. Mahler and her research team will have sole access to all contact information and 
evaluation results containing your name.  This information will be kept in a locked 
filing cabinet in a locked office.  However, the U.S. Department of Health and Human 
Services, and the University of Rhode Island Institutional Review Board have the right 
to inspect all of your records relating to this research for the purpose of verifying data.  
Because of the need to release information to these parties, absolute confidentiality 
cannot be guaranteed.  Following completion of this project, contact information will 
be destroyed for those participants who wish, for any reason, not to be contacted in the 
future.  All other information will be archived and kept in a locked filing cabinet with 
the study results at the University of Rhode Island.  All research data will be retained 
for a minimum of three years following completion of the study and then will be 
destroyed.  Research data will be located in a locked filing cabinet in the principal 
investigator’s locked office. 
 
Cognitive-linguistic evaluations will be audio and video recorded to allow for data 
analyses.  At times these recordings can be useful for teaching students or 
professionals about the disorders of people with a neurological diagnosis such as 
yours.  Please indicate by signing below whether you give your permission to use your 
samples for lectures and presentations.  Audio and/or videotapes may be used for 
teaching for up to 3 years after completion of the study.  If you agree, you will never 




permission to use audio and/or video samples in lectures has no impact on your 
participation in the study. 
 
_____________________Yes, I give permission to use audio samples in lectures and  
presentations. 
 
_____________________Yes, I give permission to use video samples in lectures and  
presentations. 
 




______________________No, I do not want video samples used except for research 
analysis. 
 
In case there is any injury to you during the study: 
If this study causes you any injury, you should immediately contact Dr. Leslie Mahler 
at (401) 874-2490 or contact the University of Rhode Island Speech and Hearing 
Clinic at (401) 874-5969.  You may also call the office of the Vice President for 
Research Integrity, 70 Lower College Road, University of Rhode Island, Kingston, RI 
at (401) 874-4328.  If you are injured during an evaluation or during treatment every 
effort will be made to get you medical attention but you will be responsible for paying 
for the medical treatment needed. 
 
Decision to quit at any time: 
The decision to take part in this study is up to you.  You do not have to participate.  If 
you decide to take part in the study, you may quit and stop participating in this study 
at any time. You have the right to refuse to answer any question(s) or participate in 
any procedure for any reason.  Deciding not to participate will have no effect on your 
potential to receive services from a speech-language pathologist.  If you wish to quit, 
simply inform Leslie Mahler at 874-2490 of your decision.  If you wish to pursue an 
alternative treatment instead of completing the study you will be provided with 
information on how to obtain those services. 
 
Rights and complaints: 
If you are not satisfied with the way this study is performed, you may discuss your 
complaints with Dr. Leslie Mahler (lmahler@uri.edu; 401-874-2490), Dr. Ingrid 
Lofgren (ingridlofgren@uri.edu, 401-874-5706), or Dr. Matthew Delmonico 
(delmonico@uri.edu; 401-874-5440), or you may contact the office of the Vice 
President for Research for concerns or any questions about your rights as a research 
subject at: 70 Lower College Road, University of Rhode Island, Kingston, RI at (401) 






Your authorization means that you have read this paper and know the purpose of the 
study and the possible risks and benefits.  It also means you know that being in this 
study is voluntary and you choose to be in this study.  You can also withdraw at any 
time.  Your questions have been answered.  Your signature on this form means that 
you understand the information and you agree to participate in this study.  
 
________________________  ________________________ 
Signature of Participant   Signature of Researcher 
 
_________________________  ________________________ 
Participant Typed/printed Name  Researcher Typed/printed name 
 
__________________________  _______________________ 
Date      Date 
 
 
________________________  ________________________ 
Signature of Guardian    Signature of Researcher 
 
_________________________  ________________________ 
Guardian Typed/printed Name  Researcher Typed/printed name 
 
__________________________  _______________________ 
Date      Date 
 




































































































































APPENDIX J: Past Medical History  
 
INTERVIEW 
Longitudinal Study of Communication, Nutrition and Physical Activity 
Leslie Mahler, PhD, CCC-SLP, Principal Investigator 
Ingrid Lofgren, PhD, co-Investigator 
Matthew Delmonico, PhD, co-Investigator 
Version 1: 7-3-13 
 
Participant Name:_________________________   Initials: ___  ___  ___  
ID#:  ______________  
Name of Interviewer:_____________________________                    
Date:_________________  
Emergency contact name and address & phone:     
                  
 _______________________________________ 
                  
 _______________________________________ 
               
DIRECTIONS:   Read the following questions out loud to each prospective volunteer 
and record the answers. Any answers that require clarification should be written in 
the space below the question or on the back of the sheet.  Indicate whether any 
follow-up is necessary or if any referrals are appropriate. 
 
What is your neurological diagnosis? __________________________ 
When were you diagnosed? _________________________________ 















What is your diet like? 
___________________________________________________________ 
What is your physical activity like? 
_________________________________________________ 
Does your speech sound clear to other people? 
_________________________________________ 
 If not, how does it sound? 
___________________________________________________ 
Can you think of the words that you want to say? 
______________________________________ 
If you do have trouble, how often does it happen? 
__________________________________ 
Are you experiencing any symptoms of a swallowing disorder? 
_____________________________ 




















How many hours of speaking do you do in a day? 
____________________________________ 




Do you pronounce your words clearly? 
____________________________________________ 
Do people ask you to repeat yourself? 
______________________________________________ 
Do people have a hard time understanding you? 
______________________________________ 









Has your neurological diagnosis caused you to talk less? 
________________________________ 






Do you have any difficulty with swallowing? 
___________________________________ 
Do you cough during mealtimes? _____________________ 
If yes, do you cough more with water or solid food? 
_________________________________   
Do you have difficulty making the food go down (need to swallow twice)? 
____________ 
Does it take you longer to finish a meal than before your neurological diagnosis? 
________________ 
Have you experienced any unintentional recent weight loss? _____________ 
Have you ever been diagnosed with pneumonia? ____________ If yes, when? 
_____________ 
Have you changed your diet since your neurological diagnosis? 
___________________ 
If yes, what did you modify? ___________________________________ 
 
Musculoskeletal system: 
Has your doctor ever told you that you have:  (circle all that apply) 
• Osteoarthritis or degenerative arthritis                                                                
• Rheumatoid arthritis                                                                                            




• Ankylosing Spondylitis                                                                                       
• Unknown or other type of arthritis                                                                      
• Any other disease of joint or muscle: 
• Comments:         
  
Cardiovascular system: 
• Has any family member had a heart attack prior to the age of 55?          
o If so, how are they related to you?                     
• Have you ever had frequent cramping in your legs while resting?                      
o If yes, is it a current problem?        _____________________________                                     
• Have you ever had pain or cramping in your legs while walking?                         
o If yes, is it a current problem?     ________________________________                                      
  
•  If yes, is this pain relieved by rest or by discontinuing walking? 
• Have you ever been told that you have high blood pressure 
o If yes, what was the date of onset? ____________________ 
o Were you given any medications?       ______________                                                      
• Did a doctor ever tell you that you had a heart problem?                                      
o If yes: What was the date of onset? _______________________ 
• What did the doctor call it? _________________________________ 
o Were you given any medications?   ____________________________  
•   Do you have any history of high cholesterol in your blood as evidenced by  a 
previous blood lipid tests?
 ________________________________________________________ 
Comments:   ______________________   
  
Endocrine system: 






_   
• If yes to diabetes, which type? Type 1 or Type 2   
  
  Date of onset- _________________________ 
            Are/were you on any medication, or is it diet controlled? 
_________________________ 
Neurological system: 
• Do you have any significant problems with your memory? (circle all that apply) 
o When answering the telephone, do you recall what you were doing 
before it rang?           
o Can you give the directions to your house/apartment?  
o Can you keep appointments without a reminder? 
o Can you remember what clothes you wore yesterday?                     
• Any problems with vision other than corrective lens changes?         
            
o If yes, which of the following conditions- Blindness, temporary loss    




Do you have and of the following?: (circle all that apply) 
• Vertigo (a feeling of spinning, or unsteadiness)                
• Seizure or convulsions?    
• Migraine or severe headaches?                         
• Paralysis of arm or leg?                                     
• A head injury with loss of consciousness?     
• Pain, numbness or tingling in your limbs?             




• Do you have pain in any part of body including headaches while exercising?
                                
• Have you been told that you have a peripheral neuropathy?                 
  
• Tremors?                                    
• Problems with walking? If yes, 
o Do you fall frequently?                       
o Is your walking problem related to pain, weakness or loss of balance?  
                         
• Have you ever had an operation on skull or brain?         
        
• Have you ever had meningitis or Brain fever?         
        
Comments:          
Previous Treatment 
Have you had previous speech or swallow treatment, occupational therapy or 
physical therapy? __________________________________________ 




Was it beneficial? 
_____________________________________________________________ 








Are you employed? 
___________________________________________________________ 
Type of employment 
__________________________________________________________ 





Have you noticed any difficulty with your memory? 
_____________________________ 
Have you experienced any changes in your mood? 
_______________________________ 
Is it difficult for you to pay attention long enough to finish a task? 
___________________ 
Do you have any difficulty reading? ____________________________________ 
Do you have any difficulty writing? ___________________________________ 
Do you have any other health problems or conditions that would affect 

























The University of Rhode Island’s Lipid Lab is looking for people with 
Parkinson’s disease and their caregivers (18 years+) to participate in a 
research study to 
collect information related to diet, access to health information and technology 
use. The total time 




 Dr. Ingrid Lofgren, Department of Nutrition and Food Sciences, is the principal 
investigator for this study. We are asking you to display our recruitment flyer in 
your office, meeting area and/or lobby to help us recruit participants for this 
study. The flyer is attached to this email. If you know of any participants who 
are interested, please direct them to our 
recruitment flyer with our contact information.  
 
Thank you for your time and support. If you have any questions regarding the 
study 
please feel free to contact us. 
 
Sincerely, 
Dara LoBuono MS RD LDN 
PhD Student  
Department of Nutrition and Food Sciences  
























APPENDIX L: Parkinson's and Telenutrition  



























APPENDIX M: Parkinson's and Telenutrition  
































APPENDX N: Moderator Guide for Semi-Structured Dyadic Interviews  
 
Moderator Guide and Script  
Script: Hello my name is Dara LoBuono. I am a PhD student at the University of Rhode 
Island in the Department of Nutrition and Food Sciences. Today we will discuss how 
you get health information, how you would like to get health information and what 
would help you get this information more easily. Remember, there are no right or 
wrong answers, so please answer questions as best as you can.  As a reminder, I will 
be recording our discussion and taking notes for research purposes. Before we begin, 
do you have any questions?  
 
Transition: Great! Let’s get started. The first few questions will be about Parkinson’s 
disease and what you eat.  
PD and Diet   
1. Do you make different food choices as a result of having PD?  Please explain.   
a. Probes: Sugar intake? Fluid Intake? Types of food you eat?  
b. Prompt: In what ways is eating more difficult for you as a result of 
Parkinson’s disease?  
 
Follow up: How does Parkinson’s disease impact the amount you eat?   
c. Probes: Changes due to: Taste and smell?  Constipation? Appetite? Time it 
takes to cook a meal or limited time to cook meals?  
 
2. What food choices or diet modifications help you manage the symptoms of your 
Parkinson’s disease? Why or why not?  
a. Probes: Changing textures to minimize difficulty chewing and swallowing? 
Eating certain foods to manage constipation?   
 
 
Transition: Now we will discuss your ability to get nutrition and health information 
and ways that may help you increase access to these services.  
 
Accessibility of Nutrition and Health Information   
3. How does having Parkinson’s disease influence your ability to get health 
information? (Are you able to find the health information you need for managing 
Parkinson’s?)  
 
4. How do you access health information for managing Parkinson’s disease?  
 
5. Where do you get information about foods and diets for people with Parkinson’s 
disease?  










7. How would you like to receive information about food and eating?   
a. Probes: At visits with a healthcare provider, pamphlets, the internet, support 
groups 
 
b. Follow up: How often?  
 
 
Transition: Thank you for that information. Now we are going to explore information 
related technology* for managing Parkinson’s disease. For the purposes of this 
interview, technology will be defined as: tools that support independent living, social 
interaction and assist in managing and providing care. Examples include computers 
and internet. When responding to these questions, please think about forms of 
technology that either of you may use or be interested in using.   
 
Digital Health for PD:  
8. What forms of technology do you currently use and for what purpose?  
a. Probes: computers, tablets, internet, e-mail, smart phones*, smart-watches* 
*Smart phones – a cell phone that also includes internet access, 
camera, email access, and storage. (Example: iPhone, Pixel, Android)  
* Smart watches – a wristwatch that can also perform tasks similar to 
a smart phone or computer. (Example: Apple Watch)  
 
9. What does the term digital health* mean to you?  
Transition: So, for the purpose of this study, digital health is a broad term used to 
describe technologies that better manage and track health.   
 
10. What digital health products do you currently use?  
a. Probes: Apps* for medication management, devices to monitor 
gait/speech/blood pressure, videoconferencing* 
*Apps – also known as mobile or computer applications are programs 
designed to perform a function, task or activity that can benefit the 
user 
*Videoconferencing – is a technology that allows two or more people 
to communicate from different locations through video and audio 
signals. Like talking on the phone, but you can see the person 
(Example: Facetime, Skype) 
 
 
11. What (additional) digital health products would you be willing to try and why?  





i. Wearable device to Monitor Gait/Speech à sensors (ankle 
bracelet or sock) that measure your stride length and time. 
Information collected can determine if you are shuffling or 
taking short steps and can provide information about disease 
progression.  
ii. wearables such as fit bits and apple watches are devices that 
can track steps taken, heart rate, calories burned and sleep 




12. What digital health products would you be willing to try to help manage food and 
eating for Parkinson’s disease and why?   
 
13. The following scenarios are possible ways digital health can be used to make 
information Tell me if you would be interested in learning more about utilizing 
the following example of digital health and explain why.   
a. Using videoconferencing to have nutrition counseling sessions from home.   
b. Wearing a watch at meals and snacks that counts your bites*.  
Bite Counter - a watch that tracks wrist motion to count bites and estimate 
calories while you eat. It provides real-time feedback on amount consumed. 
c. Taking pictures of meals and snacks for a nutrition professional to review.  
d. A website that allows you to post questions to nutrition professionals and 
other people living with Parkinson’s disease and their caregivers about 
nutrition.  
e. Using phone applications and websites to track the food you eat. (example: 
MyFitness Pal, Lose it,  
 
14. What makes technology and digital health useful for you?  
 
15. What makes it difficult for you to use digital health (more)?  
 
16. What else should I know about how digital health could help you with your eating 
to optimize your management of Parkinson disease? 
Transition: Thank you for answering all of my questions. We have a few more 
questions related to the information we discussed today. I will read you the 
question/statement and the possible responses. Please select one choice that most 
closely aligns with your response.  
Quantitative Questions.  




1. Unimportant 2. Somewhat Important 3. Neutral 4. Important 5. Very 
important. 
 
                                                                                                
Unimportant Somewhat 
Important 




18. Which of these is your main source of knowledge about your disease? (Please 
Pick one).  
1. Healthcare 
2. Patients organizations 
3. Found myself online 
4. Other patients 
5. Family, relatives, and friends 
6. Other sources.  
 
19. Have you been able to find the knowledge you need about your disease?  
 
                                                                                                
Not at all Rarely Some of the 
time 





20. How strongly do you agree or disagree that it is important to follow an eating 
plan for managing PD?  
 
 







21. How easy or difficult is it to find information related to healthy eating for 
Parkinson’s?  
 
__ Very Difficult  
__ Difficult  
__ Somewhat Difficult  
__ Easy  





22. How helpful would it be to work with a nutrition professional to manage eating 
for Parkinson’s disease? 
___Very Unhelpful  
___Unhelpful  
___ Somewhat unhelpful  
___ Neither unhelpful or helpful  
___ Somewhat Helpful  
___ Helpful  





23. Since being diagnosed with Parkinson’s disease my appetite has: 










24. Since being diagnosed with Parkinson’s disease the overall amount you eat each 
day has: 









Script: This concludes the interview. Thank you for all your valuable information and 



















24-Hour Recall Questions 
Spring 2018  
 
All enrolled participants will complete two 24-hour recalls. During Sessions 3 
and 4 (via telephone), PwPD and caregivers will complete two 24-hour dietary 
recalls; detailed information about food and beverages intake from midnight to 
midnight the previous day. Each 24-hour recall will last about 30 minutes per 
participant.  
A 24HR is when a person is asked to list and describe all the foods they ate 
the previous day. Since people consume different foods and beverages, 
different questions are asked during each 24-hour. Participants will be 
encouraged to have labels of foods they eat available during the assessments 
so exact information can be entered. This project will be utilizing the Nutrition 
Data System for Research from the University of Minnesota to collect the 
dietary data. Information on the program is attached. For the most part, all 
participants will be asked the following questions. Many of these questions will 
be asked multiple times. 
• At what time did you get up yesterday? 
• What was the first thing you had to eat or drink after getting up 
yesterday? 
• What else did you have to eat with that (insert food or beverage)? 
• What was added to that beverage? 
• What else did you have at that meal? 
• Was the (insert food or beverage) eaten plain or did you put something 
on it? 
• What did you eat after that meal? 
• What did you have for snacks yesterday? 
• What was the brand of (insert food or beverage)? 
• How many cans/bottles or juice/soda/water did you have at that time? 
• What was the last thing you ate and drank yesterday? 
• What did you snack on after you last meal? 
• Did you get up during the night and eat anything? 
• About what size was the (insert food or beverage)? 
• Was the (insert food or beverage) an original product or was it modified 
in anyway? For example, was it low sodium, low fat, cholesterol free, 
etc.? 
• When was the first time you took your levodopa or levodopa containing 
medication? 
• When was the next time you took your levodopa or levodopa containing 





Depending on dietary intake, these additional questions may be asked. Many 
of these questions could be asked multiple times. 
• Did you add any cream, milk, milk substitute to the coffee or tea? 
• Did you add any sugar or sugar substitute to the coffee or tea? 
• How much of the (insert food or beverage) did you eat? 
• Were you able to finish all of that (insert food or beverage)? 
• Was this (insert food) prepared with fat? If so, what type of fat? 
• When preparing (insert food) was salt added? 
• Was there frosting on the (insert food)? 
• If so, about how much frosting? 
• What was the flavor/color of the frosting? 
• Did you add any condiments to (insert food)? 
• If so, what condiments and how much of each? 
• Was there ice in the (insert beverage)? 
• Was the cake a single, double, or triple layer cake? 
• Were there any seeds on the bagel? 
 
Session 3: Phone Call Script  
“Good Morning/Afternoon/Evening ____________, 
 
Today we will be discussing your dietary intake as part of the URI Parkinson’s disease 
research 
study. This is the third of four sessions. Both you and your loved one will each be 
completing a 24-hour recall today.  
We will go over all of the foods and beverages that you consumed yesterday, from 
midnight to midnight. This phone call should last approximately 60 minutes or about 
30 minutes per recall.” 
 
• Study staff will proceed to administer the 24-hour dietary recalls, one with 
the PwPD and one with the caregiver. Each recall is anticipated to be about 30 
minutes.  
  
“Thank you for your participation in this third assessment, I will be calling in the near 
future to complete your fourth and final session, another 24-hour dietary recall 
session by phone. “ 
 
Session 4: Phone Call Script  
“Good Morning/Afternoon/Evening ____________, 
 





study. This is the fourth and final session. Both you and your loved one will each be 
completing a 24-hour recall today.  
We will go over all of the foods and beverages that you consumed yesterday, from 
midnight to midnight. This phone call should last approximately 60 minutes or about 
30 minutes per recall.” 
 
• Study staff will proceed to administer the 24-hour dietary recalls, one with 
the PwPD and one with the caregiver. Each recall is anticipated to be about 30 
minutes.  
  
“Thank you for your participation in this final session. Both you and your loved one 
will be receiving individual dietary analyses and recommendations in the mail in the 













































































































































































APPENDIX X: Request for Personal Health Information  
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